Registration Form • Jun 11, 2025
Registration Form
Open in ViewerOpens in native device viewer
SUBJECT TO CERTAIN EXCEPTIONS, THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISCLOSURE OTHERWISE, WHETHER DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, THE UNITED KINGDOM OR ANY OTHER STATE OR JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF THAT JURISDICTION OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED, OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER BELGIAN LAW.
THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER, OR ANY SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN AEDIFICA OR COFINIMMO.
ANY OFFER WILL BE MADE ONLY IN COMPLIANCE WITH THE BELGIAN TAKEOVER ACT AND THE BELGIAN TAKEOVER DECREE (EACH AS DEFINED HEREIN), AND BY MEANS OF A PROSPECTUS TO BE APPROVED BY THE FSMA PURSUANT TO THE TAKEOVER DECREE AND SUBJECT TO THE TERMS AND CONDITIONS TO BE SET OUT THEREIN.
Limited liability company Public regulated real estate company under Belgian law Registered office: Rue Belliard 40 (box 11), 1040 Brussels Company number: 0877.248.501 (RPR Brussels) ("Aedifica" or the "Company")
This document and the information it contains are provided to you in accordance with the requirements of Belgian law and only in your capacity as a shareholder of Aedifica for the purpose of exercising your voting rights in Aedifica and in no other capacity, and may not be used or relied upon for any other purpose or for any other decision, including an investment decision to acquire, buy, subscribe for, sell or exchange securities (or any offer or solicitation of an offer to do so).
This document does not constitute an offer to acquire, buy, subscribe for, sell or exchange securities (or the solicitation of an offer to acquire, buy, subscribe for, sell or exchange securities) in or from the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Switzerland, South Africa, the United Kingdom or any other jurisdiction where it would constitute a violation of the laws of such jurisdiction, and no such offer (or solicitation) may be made in any such jurisdiction. Any failure to comply with this restriction may constitute a violation of US, Australian, Canadian, Hong Kong, Japanese, South African, Swiss, UK, New Zealand or other applicable securities law. Any persons reading this announcement should inform themselves of and observe any such restrictions.
The securities discussed herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act") or the securities laws of any state of the United States, and may not be offered, sold or delivered, directly or indirectly, in or into the United States without
registration, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable state and other securities laws of the United States. There will be no public offering of securities in the United States.
In the United Kingdom, this document is being communicated only to persons who are (i) existing members or creditors of Aedifica or other persons falling within Article 43 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or (ii) any other person to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000, as amended) may otherwise lawfully be communicated or caused to be communicated.
This document and the information contained herein are intended solely for the recipient of this document and the publication, distribution, transmission, forwarding or transmission of this document or the information contained herein to any other person may violate the US Securities Act or other applicable laws.
The Proposed Exchange Offer (as defined and as further described herein), if and when made, will be made for all of the issued and outstanding shares of Cofinimmo, which is a public regulated real estate company in the form of a public limited liability company under Belgian law, and will be subject to Belgian disclosure and procedural requirements. The Proposed Exchange Offer will be made to Cofinimmo shareholders in the United States in compliance with the applicable US tender offer rules under the US Securities Exchange Act of 1934, as amended (the "US Exchange Act"), and otherwise in accordance with the requirements of Belgian law. Accordingly, the Proposed Exchange Offer will be subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the proposed timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer law and practice. The financial information included in this document or to be included in the prospectus for the Proposed Exchange Offer has been prepared in accordance with (EU) IFRS, and will not have been prepared in accordance with US GAAP, or derived therefrom, and may therefore differ from, and not be comparable with, financial information of US companies.
Aedifica and Cofinimmo and their respective affiliates or brokers (acting as agents for Aedifica, Cofinimmo or their affiliates, as applicable) may from time to time, and other than pursuant to the Proposed Exchange Offer, directly or indirectly, purchase, or arrange to purchase outside the United States, shares in Cofinimmo or any securities that are convertible into, exchangeable for or exercisable for such shares before or during the period in which the Proposed Exchange Offer remains open for acceptance, to the extent permitted by, and in compliance with, Rule 14e-5 under the US Exchange Act. Any such purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. To the extent required in Belgium, any information about such purchases will be made public in Belgium in the manner required by Belgian law. To the extent information about such purchases or arrangements to purchase is made public in Belgium, such information will be disclosed by means of a press release or other means reasonably calculated to inform persons in the United States of such information. In addition, affiliates of the financial adviser to Aedifica may engage in ordinary course trading activities in securities of Cofinimmo, which may
include purchases or arrangements to purchase such securities.
Neither the US Securities and Exchange Commission nor any US state securities commission has approved or disapproved of the Proposed Exchange Offer, passed upon the merits or fairness of the Proposed Exchange Offer, or determined if this document, the prospectus or other Proposed Exchange Offer documents are accurate or complete. Any representation to the contrary is a criminal offence in the United States.
The Proposed Exchange Offer, if consummated, may have consequences under US federal income tax and applicable US state and local, as well as non-US, tax laws for Cofinimmo shareholders. Each Cofinimmo shareholder is urged to consult his or her independent professional adviser regarding the tax consequences of the Proposed Exchange Offer.
It may not be possible for Cofinimmo shareholders in the United States to effect service of process within the United States upon Aedifica, Cofinimmo, or their respective officers or directors, some or all of which may reside outside the United States, or to enforce against any of them judgments of the United States courts predicated upon the civil liability provisions of the federal securities laws of the United States or other US law. It may not be possible to bring an action against Aedifica, Cofinimmo, or their respective officers or directors (as applicable), in a non-US court for violations of US law, including the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement. In addition, it may be difficult to enforce in Belgium original actions, or actions for the enforcement of judgments of US courts, based on the civil liability provisions of the US federal securities laws
The securities mentioned herein may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act ("FinSA") (unless in circumstances falling within article 36 of the FinSA), and no application has been made or will be made to admit the securities to trading on any trading venue (i.e., exchange or multilateral trading facility) in Switzerland. Neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities constitutes a prospectus within the meaning of the FinSA, and neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities may be publicly distributed or otherwise made publicly available in Switzerland.
Neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities has been or will be filed with or approved by any Swiss regulatory authority. In particular, the prospectus will not be reviewed or approved by a Swiss reviewing body (Prüfstelle) pursuant to article 51 of the FinSA and does not comply with the disclosure requirements applicable to a prospectus within the meaning of article 35 of the FinSA.
The Board of Directors of the Company hereby submits to the shareholders of the Company its special report, which has been prepared in accordance with Articles 7:179, §1, first subparagraph and 7:197, §1, first subparagraph of the Belgian Code of Companies and Associations (the "BCCA") and Article 26, §2 of the Belgian Act of 12 May 2014 on regulated real estate companies, as amended (the "RREC Act"). The special report relates to the proposed capital increase by contribution in kind of shares of Cofinimmo against the issue of new shares of the Company in the context of the Proposed Exchange Offer (as defined below) which the Company intends to issue on all shares issued by Cofinimmo.
In accordance with Article 7:197, §1, first subparagraph of the BCCA, the Board of Directors, in this report, justifies why the contribution is in the interest of the Company, describes each contribution in kind, motivates the valuation of each contribution in kind and indicates the consideration for the contribution. In accordance with Article 7:179, §1, first subparagraph of the BCCA, the Board of Directors also justifies the issue price and describes the impact of the transaction on the shareholders' property and membership rights. In accordance with 7:197, §1, first subparagraph of the BCCA, this report has been submitted in draft form to the Company's Statutory Auditor, Ernst & Young Bedrijfsrevisoren BV, represented by Mr. Christophe Boschmans (the "Statutory Auditor").
Pursuant to Article 26, §2 of the RREC Act, in the event of a capital increase by contribution in kind in a regulated real estate company, the contribution report of the Board of Directors of the company in which the contribution is made must also mention the identity of the contributors (see section 1 of this report), as well as the impact of the proposed contribution on the situation of the former shareholders, in particular as regards their share in the profit, in the net value per share and in the capital, and the impact in terms of voting rights (see section 4 of this report).
The Statutory Auditor has subsequently, in accordance with Articles 7:179, §1, second subparagraph and 7:197, §1, second subparagraph of the BCCA prepared his own report in which he (i) assesses whether the financial and accounting information contained in this report of the Board of Directors is true and fair in all material respects and sufficient to inform the reader thereof and (ii) examines the valuation applied by the Board of Directors in this report and the valuation methods used for that purpose and indicates whether the valuations to which the valuation methods applied by the Board of Directors in this report have led, correspond at least to the number and par value and, if applicable, the issue premium, of the shares to be issued against the contribution (see section 5 of this report). The Statutory Auditor's full report is attached as Annex 1 to this report
This report, as well as the Statutory Auditor's report, will be filed with the registry of the Commercial Court of Brussels in accordance with Articles 7:179, §1, third subparagraph and 7:197, §1, fourth subparagraph of the BCCA.
Both reports will be submitted to the Company's Extraordinary General Meeting to be held on or about 11 July 2025 which will decide, inter alia, on the proposed capital increase by contribution in kind in the context of the Proposed Exchange Offer which the Company intends to launch on all shares issued by Cofinimmo.
Cofinimmo is a public regulated real estate company under the form of a public limited liability company under Belgian law, with its registered office at Tervurenlaan 270, 1150 Sint-Pieters-Woluwe (Belgium) and registered with the Belgian Crossroads Bank for Enterprises under number 0426.184.049 (RLE Brussels), whose shares are listed on the regulated market of Euronext Brussels.
The capital of Cofinimmo at the date of this report amounts to EUR 2.041.523.111,02 and is represented by 38.096.217 ordinary shares, without nominal value, which are fully paid up. The Company intends to launch a voluntary and conditional (see section 2.1 of this report) public takeover offer by way of exchange for all shares issued by Cofinimmo (with coupon no. 411 et seq. attached) (the "Cofinimmo Shares") against the issuance of new shares of the Company (the "Proposed Exchange Offer").
Accordingly, during the acceptance period of the Proposed Exchange Offer, which may/will be reopened voluntarily or compulsorily in certain cases (including but not limited to reopening pursuant to Article 35 and/or Articles 42 and 43 of the Belgian Royal Decree of 27 April 2007 on public tender offers as amended (the "Takeover Decree")) or as required by the applicable US tender offer rules under the US Securities Exchange Act of 1934, as amended (the "US Exchange Act") (hereinafter also referred to as "Voluntary and/or Mandatory Reopening(s)"), all shareholders of Cofinimmo will be offered the opportunity to tender their Cofinimmo Shares with a view to contributing them in kind to the Company in exchange for new shares to be issued by the Company.
With the exception of BlackRock Inc, which, according to the transparency notification published by Cofinimmo on its website pursuant to the Belgian Law of 2 May 2007 on disclosure of major shareholdings, held 5.42% of the Cofinimmo Shares on 23 May 2025 (being 2.064.046 shares), the specific identity of the remaining shareholders of Cofinimmo is not known to the Company. For purposes of Article 26, §2, 1° RREC Act, the contributors are thus identified as being the shareholders of Cofinimmo who will accept the Proposed Exchange Offer, as well as, as the case may be, the shareholders whose Cofinimmo Shares would pass to the Company by operation of law in the context of any (simplified) squeeze-out following the Proposed Exchange Offer pursuant to Articles 42 and 43 of the Takeover Decree (a "Squeeze-out Offer").
1 Coupon no. 41 is the dividend coupon that goes attached to the Cofinimmo Share at the moment when the acceptance period of the Proposed Exchange Offer is opened. Coupon no. 40, representing Cofinimmo's Distributed 2024 Gross Dividend, was , following the decision of Cofinimmo's general meeting of shareholders on 14 May 2025, detached from the Cofinimmo share on 19 May 2025 and became payable as of 22 May 2025..
On 30 April 2025, the stock prices of Cofinimmo and Aedifica were suspended by the FSMA2 due to a significant increase in the trading volume of the Cofinimmo Share on Euronext Brussels. Therefore, (i) the undisturbed stock price of Cofinimmo of EUR 67.00 on April 30, 2025, at 16:02 Brussels time (i.e., Cofinimmo's stock price before the significant increase in trading volume that led to the suspension) ("Cofinimmo's Undisturbed Share Price") and (ii) the undisturbed stock price of Aedifica of EUR 69.75 on April 30, 2025, at 16:02 Brussels time (i.e., Aedifica's stock price before the significant increase in trading volume of the Cofinimmo Share, which subsequently also led to the suspension of the Aedifica share on Euronext Brussels) ("Aedifica's Undisturbed Share Price") are taken into account in the context of the Proposed Exchange Offer.
Following discussions between the boards of directors of Aedifica and Cofinimmo in the wake of the Announcement (as defined hereafter in section 2 of this report) and Aedifica's initial convening of its extraordinary general meeting of shareholders on 13 May 2025 to approve the proposed exchange offer at an exchange ratio of 1.163 , the board of directors of Cofinimmo agreed to support the proposed exchange offer, provided that an exchange ratio of 1.185 is applied.
The board of directors of Aedifica acknowledges that this support significantly increases the likelihood of the proposed exchange offer's success and will greatly facilitate the integration of Cofinimmo into Aedifica following the transaction. As a result, Aedifica's board has decided to adjust the exchange ratio to 1.185 New Sharesshares per Cofinimmo Share. According to Aedifica, this revised ratio reflects a fair value distribution for the shareholders of both companies. Moreover, it enhances the certainty of acceptance of the Proposed Exchange Offer, supports a smooth integration process, and creates long-term value for all stakeholders.
Through the joint press release of 3 June 2025, (i) Aedifica announced the adjustment of the original exchange ratio of 1.16 under the proposed exchange offer to the revised ratio of 1.185, and the cancellation of its previously scheduled extraordinary general meeting of shareholders on 12 June 2025, replacing it with a newly convened extraordinary general meeting on 11 July 2025, during which the revised Proposed Exchange Offer with an Exchange Ratio of 1.185 will be submitted for approval; and (ii) the board of directors of Cofinimmo formally expressed its support for the revised Proposed Exchange Offer.4
The Board of Directors proposes to increase the capital of the Company by contribution in kind of all Cofinimmo Shares effectively offered by the shareholders of Cofinimmo under the Proposed Exchange Offer against new shares issued by the Company.
The aspects of the proposed transaction are explained in detail below. In this context, reference is also made to the contents of the announcement of the intention to make the Proposed Exchange Offer, published by the Company, in application of Article 8 §1 of the Takeover Decree, on 1 May 2025 ( (the "Announcement"). 5
2 The Belgian Financial Services and Markets Authority.
3 https://aedifica.eu/transactions-2025/
4 https://aedifica.eu/transactions-2025/
5 See https://aedifica.eu/transactions-2025/
To maintain consistency with Cofinimmo's financial reporting, the EPRA net tangible asset value ("EPRA NTA")6 per Cofinimmo Share as communicated by Cofinimmo was used in the Announcement. For the calculation of the EPRA NTA per share (a financial parameter used in this report to determine the contribution value per Cofinimmo Share in the context of the Proposed Exchange Offer, see section 2.4.1 of this report), as well as the IFRS NAV7 per share, the EPRA NRV8 per share, and the EPRA NDV9 per share (all financial parameters used in this report to provide additional context to the Exchange Ratio, see section 2.5.1(c) of this report), Cofinimmo does not take into account the (18,298) treasury shares it holds. Therefore, these financial parameters as communicated by Cofinimmo only consider 38,077,919 Cofinimmo Shares instead of the total number of outstanding Cofinimmo Shares (38,096,217). Since the Proposed Exchange Offer pertains to all outstanding (38,096,217) Cofinimmo Shares, the mentioned financial parameters, when used in this report10, must take into account all outstanding (38,096,217) Cofinimmo Shares.11 Consequently, the values of these financial parameters in this report differ from those communicated by Cofinimmo, as follows:
Therefore, when this report refers to these financial parameters "as published by Cofinimmo on 25 April 2025, in its Q1 2025" or "as of 31 March 2025," the above corrected values are meant13 .
The realization of the Proposed Exchange Offer, and as a consequence, the realization of the proposed capital increase by contribution in kind of the Cofinimmo Shares, is subject to the realization of the following conditions precedent (the " Conditions Precedent"):
6 EPRA NTA is a generally recognised financial parameter publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association, and is calculated as IFRS Equity - hybrid instruments that do not contribute to equity attributable to owners + revaluation of investment property (IP) if the IAS 40 cost option is used + revaluation of long-term investments + revaluation of leases held as finance leases + revaluation of trading properties - deferred tax (DT) relating to fair value gains on IP (rules based approach with three options for adding a certain percentage of DT) - fair value of financial instruments - goodwill due to deferred taxes - goodwill as per the IFRS balance sheet - intangible assets as per the IFRS balance sheet + fair value of fixed-income debt + revaluation of intangible assets to fair value + property transfer taxes.
7 The IFRS Net Asset Value ("IFRS NAV") refers to the net asset value calculated in accordance with IFRS.
8 The EPRA Net Reinstatement Value ("EPRA NRV") assumes that the company will never sell its assets and provides an estimate of the amount needed to reconstitute the company's assets.
9 The EPRA Net Disposal Value ("EPRA NDV") represents the value attributable to the company's shareholders in a scenario where the assets are sold, leading to the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, all net after tax.
10 With the exception of the EPRA NTA per share used in the context of the Conditions Precedent (as defined in section 2.1 of this report), which pertains to the EPRA NTA per Cofinimmo Share as calculated and communicated by Cofinimmo in its Q1 2025 results.
11 For clarity, the financial parameters as communicated by Aedifica do take into account the total number of outstanding Aedifica shares, and therefore such a correction is not necessary on Aedifica's side. For readability purposes, these figures are rounded to two decimal places throughout this report.
12 For readability purposes, these figures are rounded to two decimal places throughout this report.
13 Unless expressly stated otherwise, as in section 2.1 of this report.
14 The benchmark stock market index of Euronext Brussels
15 The FTSE EPRA Nareit Developed Europe Index tracks European listed real estate investment trusts (REITs) and real estate companies and provides a diverse representation of the real estate market in developed countries in Europe, both geographically and by property type.
These Conditions Precedent are determined for the sole benefit of the Company, which, in the context of the Proposed Exchange Offer will reserve the right to, pursuant to a decision of its Board of Directors, waive them, in whole or in part. No later than the day of the announcement of the results of the initial acceptance period of the Proposed Exchange Offer, Aedifica will announce whether or not the above Conditions Precedent have been satisfied and, as the case may be, if any of the above Conditions Precedent have not been satisfied, whether or not it waives them. In case the Company choses to waive such Condition Precedent at that point in time, the (initial) acceptance period of the Proposed Exchange Offer will be closed and the Proposed Exchange Offer will be voluntarily reopened by the Company, in order to comply with the requirement under US law that the Proposed Exchange Offer must then remain open for at least 5 (US) business days (the voluntary reopening then being deemed an extension of the (initial) acceptance period for US purposes), the foregoing without prejudice to the right not to waive the Conditions Precedent yet and to voluntarily extend the Proposed Exchange Offer.
At the date of this report, the Company has a capital amounting to EUR 1,254,742,260.03 represented by 47,550,119 ordinary shares, without nominal value, which are fully paid up. The par value per share is therefore EUR 26.39 (rounded to the euro cent for readability reasons). The shareholder structure of the Company at the date of this report is as follows:
| Shareholder | Number of shares/voting rights |
Percentage (rounded) |
|---|---|---|
| BlackRock Inc.16 | 3,496,568 | 7.35% |
| Other shareholders | 44,053,551 | 92.65% |
| Total | 47,550,119 | 100% |
The proposed contribution in kind consists of the Cofinimmo Shares to be effectively tendered to the Company by the shareholders of Cofinimmo under the Proposed Exchange Offer (the "Contribution")
At present, the Company does not hold any Shares in Cofinimmo. Accordingly, the extent to which the Company will succeed in acquiring the issued Cofinimmo Shares through the Proposed Exchange Offer
16 On the basis of the transparency notification of 7 October 2024 that was provided to the Company. The capital of the Company (and thus the total number of outstanding shares in the Company) has not changed since the date of this notification.
will depend entirely on the extent to which the shareholders of Cofinimmo will accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings).
In connection with the Proposed Exchange Offer and any subsequent Voluntary and/or Mandatory Reopenings, a maximum total of 38,096,217 Cofinimmo Shares will be contributed to the Company by way of contribution in kind in exchange for a maximum of 45,144,018 New Shares (as defined below) issued by the Company based on the Exchange Ratio (as defined below).
In respect of shareholders of Cofinimmo outside the Member States of the European Economic Area (whereby applicable securities laws may affect the offer), the sale and delivery of the New Shares pursuant to the Proposed Exchange Offer will take place as follows in the specific below jurisdictions:
(iii) only shareholders of Cofinimmo in Switzerland who qualify as "professional clients" as defined in Article 4 of the Swiss Financial Services Act ("Finanzdienstleistungsgesetz") of 15 June 2018, as amended (the "FinSA") ("Swiss QIBs"), will be entitled to participate in the Proposed Exchange Offer in accordance with the prospectus exemption provided for in Article 36 FinSA.
The Proposed Exchange Offer will not be made in or into, and cannot be accepted in or from, Australia, Canada, Hong Kong, Japan, South Africa, New Zealand, or any other jurisdiction where doing so would constitute a violation of the laws of that jurisdiction.
Any fractions of New Shares that should be issued pursuant to the Exchange Ratio to a particular Cofinimmo sharehodler (i.e, a holder of Cofinimmo Shares who should receive in exchange for his/her Cofinimmo Shares a number of New Shares which does not solely consist of a whole number and is therefore partly a fraction of a New Share) who accepts the (initial) Proposed Exchange Offer or any Voluntary and/or Mandatory Reopenings (the "Fractions of New Shares"), will not be issued as such to the relevant Cofinimmo shareholder, but will, together with any New Shares that would have been payable to US Non-QIBs pursuant to their contribution of Cofinimmo Shares in the Proposed Exchange Offer, be included in the Dribbling Out (or alternatively - depending on volume - Vendor Placement) at the closing of the (initial) acceptance period of the Proposed Exchange Offer or at the closing of any Voluntary and/or Mandatory Reopenings, as defined and further set out in section 2.8 of this report.
The aforementioned Contribution and the resulting capital increase of the Company under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, will be submitted as a whole for approval to the Extraordinary General Meeting of shareholders of the Company to be held on or about 11 July 2025. The Extraordinary General Meeting of shareholders of the Company will also be asked to grant a delegation to any two members of the Board of Directors (acting together) to, inter alia, in the event of a successful Proposed Exchange Offer (being upon fulfilment - or waiver – of all Conditions Precedent) and, as the case may be, in one or more instances, subject to any Voluntary and/or Mandatory Reopenings based on the number of holders of Cofinimmo Shares who, during such acceptance period(s),accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)), to determine the number of Cofinimmo Shares that were tendered by the shareholders of Cofinimmo in the context of the Proposed Exchange Offer, and thus to determine and implement the realization of the capital increase by contribution in kind to the Company on that basis in one or more times in accordance with Article 7:186 of the BCCA.
If the Proposed Exchange Offer is successful, but the Company has failed to acquire at least 95% of the Cofinimmo Shares during the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)17, the capital, in application of Section 7:181 of the BCCA, will only be increased by the amount of the subscriptions issued.
17 If, following the acceptance period under the Proposed Exchange Offer, the Company holds at least 95% of the Cofinimmo Shares and has acquired at least 90% of the Cofinimmo Shares that were the subject of the Proposed Exchange Offer (as the Proposed Exchange Offer relates to all Cofinimmo Shares issued by Cofinimmo, the latter condition will always be fulfilled in the event the Company holds 95% of the Cofinimmo Shares following the acceptance period), the Company has the right and the intention, in accordance with Article 7:82, §1 CC and Articles 42 and 43 of the Takeover Decree, to require the remaining Cofinimmo Shareholders to exchange their Cofinimmo Shares for the shares in the Company at the Exchange Ratio.
The value per Cofinimmo Share to be contributed by Cofinimmo shareholders under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, has been determined starting from the EPRA NTA per Cofinimmo Share as per 31 March 2025 of EUR 94.53, as published by Cofinimmo on 25 April 2025 in its Q1 2025 results, where:
observed on a sample of companies (admitted to trading on regulated markets) comparable to Cofinimmo's office portfolio.
Other than as part of the amount of the EPRA NTA as per 31 March 2025, in determining the Contribution Value of the Cofinimmo Shares and the Issue Price of the New Shares (see section 2.5.2 of this report), and therefore in determining the Exchange Ratio (see section 2.5.1 of this report), no further adjustments have been made for the pro rata earnings for the remainder of 2025, as these earnings appear to be subject to seasonal influences after 31 March 2025 and, in addition, are affected by the commencement of leasing of just-completed development projects (which are often delayed), making a reasonable and accurate forecast thereof impossible.
18 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places throughout this report.
19 For reasons of readability, this number is rounded to two decimal places throughout this report.
Based on the foregoing and the adjustments described in (i) and (ii) above, the contribution value per Cofinimmo Share has thus been established at EUR 87.6420 (the "Contribution Value").
Section 2.5.1 of this report provides an overview of the valuation methods used to determine the Exchange Ratio and the reference points that provide context to the Exchange Ratio, which after the adjustment remains within these reference points.
A detailed explanation of the method and rationale used to determine the value of Cofinimmo and the Cofinimmo Share in connection with this Proposed Exchange Offer is attached to this report as Annex 2. Annex 2 also indicates which valuation methods were not retained given the nature of the transaction and the activities of Cofinimmo and the Company.
In accordance with Article 49, §1, first paragraph of the RREC Act, the fair value of any asset to be acquired or transferred by the Company (and its subsidiaries) that is mentioned in Article 47, §1, of the RREC Act must be appraised by the real estate expert(s) before the transaction takes place. This applies if the transaction, considered as a whole, represents an amount higher than the lower of either 1% of the Company's consolidated assets or EUR 2,500,000.
Since shares in a public regulated company (such as the Cofinimmo Shares) are not included in the assets listed in Article 47, §1, of the RREC Act, the aforementioned rule of Article 49 of the RREC Act does not apply to the present contribution in kind of Cofinimmo Shares to the Company in the context of the Proposed Exchange Offer.
Furthermore, it should be noted that:
Taking the above points into account, the valuation of the assets, listed in Article 47, §1, of the RREC Act, held by Cofinimmo as of 31 March 2025, is thus included in the net value per Cofinimmo Share as per 31 March 2025, of EUR 94.53, which, as indicated above, is used as the basis for the valuation of the Contribution
Based on the foregoing, the method for valuing the Cofinimmo Share is considered adequate for the proposed contribution of Cofinimmo Shares in the context of the Proposed Exchange Offer and is
20 For reasons of readability, this number is rounded to two decimal places throughout this report.
deemed to be an economically justified method. There is no deviation from the report of the Statutory Auditor, attached as Annex 1 to this report.
The Contribution Value per Cofinimmo Share is thus EUR 87.64. Taking into account that the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, covers 38,096,217 Cofinimmo Shares, this means that the total Contribution Value will amount to a maximum of EUR 3,338,746,822.28 .
The Company offers, for each Cofinimmo Share contributed in the Proposed Exchange Offer, 1.185 newly issued shares by the Company (the "New Shares") (the "Exchange Ratio").
The determination of the Exchange Ratio is based on the valuation of both Cofinimmo and the Company, resulting in the Contribution Value of the Cofinimmo Shares and the Issue Price of the New Shares of the Company.
The valuation method used to obtain these values, which lead to the Exchange Ratio, is the "Adjusted EPRA NTA Analysis," as previously mentioned and briefly outlined below in this report, as well as in more detail in section 2.1, I of Annex 2 to this report. To further substantiate the Exchange Ratio (determined based on the aforementioned "Adjusted EPRA NTA Analysis") and provide a comparison point, the Company has also conducted a valuation based on a "Discounted Cash Flow Analysis", briefly outlined below in this report and in more detail in section 2.1, II of Annex 2 to this report.
Additionally, the Company has provided further reference points (for both Cofinimmo and the Company) to give context to the Contribution Value of Cofinimmo and the Issue Price of the Company, and thus to the Exchange Ratio, based on:
These additional reference points are also briefly outlined below in this report and in more detail in section 2.2 of Annex 2 to this report. For information, the transaction comparables valuation approach was not deemed to be appropriate given the lack of recent all-share completed transactions within the listed universe of Healthcare focused Real Estate Investment Trusts in Europe.
Finally, the Company also outlines in this report, as well as in more detail in section 2.3 of Annex 2 to this report, the premium, respectively, discount to which the Implied Offer Price (as defined hereinafter), respectively, the Exchange Ratio lead with respect to a number of reference points.
Both parties operate healthcare-focused real estate portfolios with the same core locations (Belgium, Germany, Ireland, the Netherlands, the UK, and Finland) and use similar methods to evaluate the fair value of their respective assets. The Exchange Ratio is calculated based on the Company's knowledge as of 30 April 2025 (at 16h02 Brussels time), particularly based on the public Q1 2025 results of the Company and Cofinimmo with figures as of 31 March 2025.
EPRA NTA is a generally recognised financial measure publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association. The Company considers EPRA NTA to be the most common and recognised valuation model for assessing the market value of a real estate company's net assets.
In evaluating the relative value of the Company and Cofinimmo to determine the Exchange Ratio, the Company adopted an industry-specific approach. This method effectively takes into account the unique market dynamics and prospects of each segment within the portfolios of Cofinimmo and the Company, particularly healthcare for both entities and office and distribution networks for Cofinimmo.
Since the start of the COVID-19 pandemic, shares of companies in the office real estate sector have consistently traded at a structural undervaluation relative to their GAV. This trend reflects equity investors' view of the sector, given the pandemic's lasting impact on office real estate and concerns about remote working and hybrid work models. These factors have led to decreased demand for traditional office space, highlighting structural challenges and a low growth profile within the sector. Moreover, the Company has evaluated the observed GAV discount for listed office companies comparable to Cofinimmo's office portfolio, consisting of Merlin Properties, Icade, Fabege, CPI Europe, NSI, and CA Immo (the "Office Reference Group"), with an average and median Implied GAV Discount as of 30 April 2025, of 22.8% and 24.9%, respectively. For reference, the current Implied GAV Discount for Aedifica is 6.3%, highlighting the relative undervaluation of office portfolios compared to healthcare portfolios, which are valued without a GAV discount for both the Company and Cofinimmo. Partly based on this, the Company has decided to apply a discount to the GAV of Cofinimmo's office portfolio to account for observed market developments in the office sector, adjusted in function of the agreement reached between the board of directors of both companies (see also section 1 of this report) from 10.45% to 2.85%21. Further details on the observed discounts are described in section 2.1, I, a) of Annex 2 to this report.
Conversely, the Company has valued the assets in the healthcare sector at their full value, disregarding the current listing below GAV in this segment. Since the consideration for the transaction consists entirely of shares and given the comparability of the Company's portfolio with that of Cofinimmo in healthcare, the Company has valued the assets in the healthcare segment for both the Company and
21 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places in this report.
Cofinimmo at their full value. This decision reflects the positive market dynamics and growth potential inherent in the segment, as the healthcare sector continues to show strong growth prospects driven by favorable demographic trends, such as an aging population and increased life expectancy, which fuel the demand for healthcare services and facilities.
Given these factors, the Company has adjusted the reported EPRA NTA of both Cofinimmo and the Company for the calculation of the Exchange Ratio as follows:
"Cofinimmo's Adjusted EPRA NTA" (this is the total Contribution Value) is calculated based on the last reported EPRA NTA as of 31 March 2025:
| Portfolio segment | A | B | A x (1+B) = C |
|---|---|---|---|
| GAV (EUR million) as per 31 March 2025 |
Implied GAV Discount |
Market implied GAV (EUR million) |
|
| Healthcare | 4,626 | 0% | 4,626 |
| Office | 927 | (2.85%) 23 |
900 |
| Distribution networks | 470 | 0% | 470 |
| Total | 6,023 | 5,996 | |
| Cofinimmo's GAV Adjustment (Delta between market implied GAV (C) and GAV (A) (EUR million) |
(26.5) |
A summary of Cofinimmo's GAV Adjustment is presented in the table below:
22 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places in this report.
23
Based on the above, the Adjusted EPRA NTA of Cofinimmo is set out below:
| EUR million | |
|---|---|
| Cofinimmo's EPRA NTA as per 31 March 2025 | 3,601 |
| (-) Cofinimmo's Distributed 2024 Gross Dividend | (236) |
| (-) Cofinimmo's GAV Adjustment | (26.5) |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 | 3,339 |
| (/)Last reported number of shares outstanding for Cofinimmo | |
| as per 31 March 2025 (million) | 38.1 |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 per | |
| share (EUR) (Contribution Value) | 87.64 |
For more details, reference is made to section 2.1, I, a) of Annex 2 attached to this report.
"Aedifica's Adjusted EPRA NTA" (this is the total Issue Price) is calculated based on the last reported EPRA NTA as of March 31, 2025, adjusted for Aedifica's Distributed 2024 Gross Dividend (as defined in section 2.5.2, (b) of this report), and is outlined in the table below:
| EUR million | |
|---|---|
| Aedifica's EPRA NTA as per 31 March 2025 | 3,702 |
| (-)Aedifica's Distributed 2024 Gross Dividend | (185) |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 | 3,517 |
| (/)Last reported number of shares outstanding for Aedifica as per 31 March 2025 (million) |
47.6 |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 per share (EUR) (Issue Price) |
73.9624 |
Subsequently, the Exchange Ratio was determined by dividing Cofinimmo's Adjusted EPRA NTA per share (being the Contribution Value) (based on 38,096,217, the last reported number of outstanding shares for Cofinimmo as of 31 March 2025) by Aedifica's Adjusted EPRA NTA per share (being the Issue Price) (based on 47,550,119, the last reported number of outstanding shares for the Company as of 31 March 2025).
| Contribution Value - Cofinimmo (EUR) | 87.64 |
|---|---|
| (/) Issue Price - the Company (EUR) | 73.96 |
| Exchange Ratio | 1.185 |
This methodology is to calculate the value of the assets (net asset value) by discounting the expected unlevered free cash flows (where "Unlevered Free Cash Flow" means earnings before interest, taxes,
24 For reasons of readability, this number is rounded to two decimal places throughout this report.
depreciation and amortisation, less cash taxes and capital expenditure) that will be generated by these assets based on the business plans (based on equity research analyst estimates) of both Cofinimmo and the Company (with detailed assumptions set out in Annex 2 to this report).
The equity value attributable to the respective shareholders is detailed in the "Cofinimmo DCF valuation summary" and in the "Company DCF valuation summary" in section 2.1, II of Annex 2 to this report.
The valuation period of the DCF analysis includes 1 April 2025 (inclusive) up to and including 31 December 2027. The Unlevered Free Cash Flows were discounted using a conventional mid-year cash flow receipt, with the terminal value calculated using the Gordon Growth formula based on a normalized Unlevered Free Cash Flow. The terminal value was also discounted based on a conventional mid-year cash flow receipt.25
For both Cofinimmo and the Company, the DCF range was calculated based on a low range of 6.76% and 6.75% WACC and 1.50% TGP rate and a high range calculated as 5.76% and 5.75% WACC and 2.50% TGP. After separate DCF calculations for Cofinimmo and the Company, the implied DCF exchange ratio was derived based on:
| Low | Mid | High | |
|---|---|---|---|
| WACC: | WACC: | WACC: | |
| 6.76% / | 6.26% / | 5.76% / | |
| 6.75%26 | 6.25% | 5.75% | |
| TGR: 1.50% | TGR: 2.00% | TGR: 2.50% | |
| DCF Equity Value per share – Cofinimmo (EUR) | 65.20 | 95.33 | 143.95 |
| (/) DCF Equity Value per share – Aedifica (EUR) | 63.80 | 90.06 | 132.50 |
| DCF implied exchange ratio | 1.022x | 1.058x | 1.086x |
The table below shows the (implied) exchange ratios on the basis of historical share prices.
| Summary of the premium of the implied exchange ratio compared to historical exchange ratios: |
Value per Cofinimmo Share |
Value per share of the Company |
exchange ratio |
|---|---|---|---|
| EUR | EUR | X Shares of the Company per 1 Cofinimmo Share |
|
| Undisturbed Share price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x |
| Undisturbed Share price | 67.00 | 69.75 | 0.961x |
25 The terminal value was calculated using the Gordon Growth formula, in which the 2027 Unlevered Free Cash Flow is increased by the terminal growth rate ("TGP") – to reflect the value of future Unlevered Free Cash Flows beyond 2027 – and divided by the weighted average cost of capital or WACC (as defined below) less the TGP (the "Terminal Value").
26 Respectively for Cofinimmo and Aedifica.
| 1-month VWAP up to 29 April 2025 | 61.76 | 63.31 | 0.976x |
|---|---|---|---|
| 3-month VWAP up to 29 April 2025 | 58.00 | 60.37 | 0.961x |
| 6-month VWAP up to 29 April 2025 | 59.16 | 60.47 | 0.978x |
| 12-month VWAP up to 29 April 2025 | 60.43 | 59.41 | 1.017x |
Cofinimmo's adjusted last reported EPRA NTA per share as of 31 March 2025 amounts to EUR 88.33, and is obtained by adjusting Cofinimmo's last reported EPRA NTA per share of EUR 94.53 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NTA per share of the Company as of 31 March 2025, amounts to EUR 73.96, and is obtained by adjusting the Company's last reported EPRA NTA per share of EUR 77.86 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NTA per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 88.33 and EUR 73.96 respectively, implies an exchange ratio of 1.194 New Shares per Cofinimmo Share.
Cofinimmo's adjusted last reported IFRS NAV per share as of 31 March 2025, amounts to EUR 88.27, and is obtained by adjusting Cofinimmo's last reported IFRS NAV per share of EUR 94.47 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported IFRS NAV per share of the Company as of 31 March 2025, amounts to EUR 74.00, and is obtained by adjusting the Company's last reported IFRS NAV per share of EUR 77.90 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported IFRS NAV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 88.27 and EUR 74.00 respectively, implies an exchange ratio of 1.193 New Shares per Cofinimmo Share.
Cofinimmo's adjusted last reported EPRA NRV per share as of 31 March 2025, amounts to EUR 96.63, and is obtained by adjusting Cofinimmo's last reported EPRA NRV per share of EUR 102.83 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NRV per share of the Company as of 31 March 2025, amounts to EUR 83.68, and is obtained by adjusting the Company's last reported EPRA NRV per share of EUR 87.58 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NRV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 96.63 and EUR 83.68 respectively, implies an exchange ratio of 1.155 New Shares per Cofinimmo Share.
• Last reported EPRA NDV adjusted for the Distributed 2024 Gross Dividends
Cofinimmo's adjusted last reported EPRA NDV per share as of 31 March 2025, amounts to EUR 92.03, and is obtained by adjusting Cofinimmo's last reported EPRA NDV per share of EUR 98.23 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NDV per share of the Company as of 31 March 2025, amounts to EUR 74.76, and is obtained by adjusting the Company's last reported EPRA NDV per share of EUR 78.66 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NDV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 92.03 and EUR 74.76 respectively, implies an exchange ratio of 1.231 New Shares per Cofinimmo Share.
The median and average target prices of equity research analysts for Cofinimmo are EUR 65.00 and EUR 65.01 respectively as of 30 April 2025 (i.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend).
The median and average target prices of equity research analysts for the Company are EUR 71.00 and EUR 70.59 respectively as of 30 April 2025 (i.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend).
An exchange ratio based on the median and average target prices of equity research analysts for Cofinimmo and the Company implies respective exchange ratios of 0.915 and 0.921 New Shares per Cofinimmo Share.
The table below provides an overview of the (implicit) exchange ratios resulting from the Adjusted EPRA NTA analysis (resulting in the Exchange Ratio), the valuation method based on the "Discounted Cash Flow analysis" (to support and compare with the Exchange Ratio), as well as those resulting from the aforementioned reference points:
| Summary of the implied exchange ratios | A Value per Cofinimmo share |
B Value per Aedifica share |
A / B exchange ratio |
||
|---|---|---|---|---|---|
| EUR | EUR | X Shares of Aedifica per 1 Cofinimmo Share |
|||
| Adjusted EPRA NTA analysis (the valuation method) |
Cofinimmo 2.85%27 discount to Office Portfolio |
87.64 | 73.96 | 1.185 | |
| Valuation methodologies |
Low: Company: 6.75% WACC; Cofinimmo: 6.76% WACC, 1.50% TGR |
65.20 | 63.80 | 1.022 | |
| DCF | Mid: Company: 6.25% WACC; Cofinimmo: 6.26% WACC, 2.0% TGR High: Company: 5.75% WACC; |
95.33 | 90.06 | 1.058 | |
| Cofinimmo: 5.76% WACC, 2.50% TGR |
143.95 | 132.50 | 1.086 | ||
| Reference points to give |
Historical share price |
Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923 |
27 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability reasons, it is rounded to two decimal places in this report.
| context to the Exchange Ratio |
performan ce analysis |
Undisturbed Share Price | 67.00 | 69.75 | 0.961 |
|---|---|---|---|---|---|
| 1 month VWAP up to 29 April 2025 | 61.76 | 63.31 | 0.976 | ||
| 3 month VWAP up to 29 April 2025 | 58.00 | 60.37 | 0.961 | ||
| 6 month VWAP up to 29 April 2025 | 59.16 | 60.47 | 0.978 | ||
| 12 month VWAP up to 29 April 2025 |
60.43 | 59.41 | 1.017 | ||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NTA adjusted for Distributed 2024 | 88.33 | 73.96 | 1.194 | |
| EPRA NTA | Gross Dividend | ||||
| Last | 31 March 2025 last reported IFRS | ||||
| reported | NAV adjusted for Distributed 2024 | 88.27 | 74.00 | 1.193 | |
| IFRS NAV | Gross Dividend | ||||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NRV adjusted for Distributed 2024 | 96.63 | 83.68 | 1.155 | |
| EPRA NRV | Gross Dividend | ||||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NDV adjusted for Distributed 2024 | 92.03 | 74.76 | 1.231 | |
| EPRA NDV | Gross Dividend | ||||
| Equity | Median | 65.00 | 71.00 | 0.915 | |
| research | |||||
| analysts' | |||||
| target price | Mean | 65.01 | 70.59 | 0.921 | |
| analysis28 |
The Exchange Ratio was determined based on the modified EPRA NTA, which is also shaded in the table.
Taking into account Aedifica's Undisturbed Share Price of EUR 69.75, the Exchange Ratio of 1.185 New Shares per Cofinimmo Share represents a value of EUR 82.6529 per Cofinimmo Share (the "Implied Offer Price"). By adjusting Aedifica's Undisturbed Share Price with Aedifica's Distributed 2024 Gross Dividend for the 2024 financial year of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), and multiplying the result by the Exchange Ratio of 1.185 New Shares per Cofinimmo Share, this represents a value of EUR 78.0330 per Cofinimmo Share (the "Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend"), as shown in the table below.
| Exchange Ratio (number of New Shares per Cofinimmo Share) - [A] | 1.185 | 1.185 |
|---|---|---|
| Aedifica's Undisturbed Share Price | 69.75 | 69.75 |
| Decreased with Aedifica's Distributed 2024 Gross Dividend | (3.90) | |
| Aedifica's Undisturbed Share Price adjusted for Aedifica's Distributed 2024 Gross Dividend - [B] |
65.85 | 69.75 |
| Implied Offer Price per Cofinimmo Share (AxB) | 78.03 | 82.65 |
28 Prior to the payment of Cofinimmo's, respectively, Aedifica's Distributed 2024 Gross Dividend.
29 For readability reasons, this number is rounded to two decimal places throughout this report.
30 For readability reasons, this number is rounded to two decimal places throughout this report.
After analyzing various valuation methods, the Company is convinced that the Implied Offer Price per Cofinimmo Share and the Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend represent attractive and fair value propositions for Cofinimmo shareholders:
The Implied Offer Price of EUR 82.65 per Cofinimmo Share represents:
The Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 78.03 per Cofinimmo Share represents:
• a premium of 28.3% on Cofinimmo's Undisturbed Share Price, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the 2024 financial year (resulting in an adjusted share price of EUR 60.80).
The Exchange Ratio of 1.185 New Shares per Cofinimmo Share represents:
31 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
32 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
IFRS NAV per Aedifica share of 31 March 2025, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the 2024 financial year (resulting in an adjusted share price of EUR 74.00);
The aforesaid Exchange Ratio was determined starting from the Adjusted EPRA NTA of the Cofinimmo Share as per 31 March 2025, as set out in section 2.5.1 of this report, and the Adjusted EPRA NTA of the Company's share, which was determined at EUR 73.9633 per share (the "Issue Price") as further explained immediately below.
In accordance with Article 26, §2, 2°, first paragraph of the RREC Act, the Issue Price may not be less than the lower value of (a) a net asset value per share dating from no more than four months prior to the date of the Contribution Agreement or, at the option of the public regulated real estate company, prior to the date of the deed of capital increase, and (b) the average closing price during the thirty calendar days preceding the same date. The reference date was set by the Company as 31 March 2025, being less than four months before 1 May 2025 (i.e. the date on which the intention to launch the Proposed Exchange Offer was published by the Company pursuant to Article 8, §1 of the Takeover Decree). For purposes of the Proposed Exchange Offer, where (i) a public regulated property company makes an exchange offer to another public regulated property company, and (ii) the Extraordinary General Meeting of the bidder must be asked for approval of the Capital Increase, before giving notice of an exchange offer pursuant to Article 5 of the Takeover Decree, "contribution agreement" within the meaning of Article 26, §2, 2°, first paragraph of the RREC Act is to be read, according to the Company, as "the date on which the intention to launch the Proposed Exchange Offer in accordance with Article 8, §1 of the Takeover Decree was published by the Company".
Next, Article 26, §2, 2°, second paragraph of the RREC Act clarifies that, for the purposes of the first paragraph, it is allowed to deduct from the amount thus obtained an amount corresponding to the part of the undistributed gross dividend to which the new shares might not be entitled, provided that
33 For readability reasons, this number is rounded to two decimal places throughout this report.
the Board of Directors specifically justifies the amount to be deducted from the accumulated dividend in its special report and explains the financial terms of the transaction in its Annual Financial Report.
Article 26, §2 of the RREC Act determines the minimum issue price with which the New Shares issued in the context of the Proposed Exchange Offer must comply (and thus implicitly also the Exchange Ratio), referring for the determination of one of the two parameters to "the date of the contribution agreement" as the reference date for determining the minimum issue price of the New Shares to be issued.
In the case of a public takeover bid, there is strictly speaking no "contribution agreement". For the purposes of §2 of article 26 of the RREC Act, the disclosure in accordance with article 8, §1 Takeover Decree (whereby the Company expressed its intention to issue the Proposed Exchange Offer) should in this case be equated with a "contribution agreement", given that at that time the issue price and thus Exchange Ratio were also fixed and communicated.
Thus, (i) the maximum period of four months provided for in article 26, §2, 3° RREC Act does not apply in the context of the Proposed Exchange Offer and (ii) this allows the determination of the Issue Price and Exchange Ratio that are underlying the Proposed Exchange Offer at the time of disclosure of the Proposed Exchange Offer, on the basis of the most recent financial information at that time (by analogy with the FSMA's practice in the context of a mandatory takeover bid, of allowing the average stock price prior to the announcement of the proposed exchange offer (i.e., the moment of expressing the intention to make the proposed exchange offer) to be used as a reference point for the application of Article 53 of the Takeover Decree, instead of the average stock price prior to the time when the obligation to bid formally and legally comes to rest on the bidder). This reasoning is also analogous to the situation in mergers and demergers, where the RREC Act (Article 26, §3) explicitly equates the date of the transaction proposal with the date of the contribution agreement
As explained in section 1 of this report, pursuant to article 26, §2, 1° of the RREC Act, the identity of the contributors must be disclosed in this report. By definition, a public takeover bid is addressed to all shareholders of the target company at the time the takeover bid is open for acceptance. With the exception of BlackRock Inc, which, according to the transparency notification published by Cofinimmo on its website in accordance with the Belgian Law of 2 May 2007 on the disclosure of major shareholdings, held 5.42% of the Cofinimmo Shares on 23 May 2025, the specific identity of the other shareholders of Cofinimmo is not known to Aedifica. For purposes of Article 26, §2, 1° RREC Act, the contributors are thus identified in this report as being the Cofinimmo shareholders who will accept the Proposed Exchange Offer, as well as, as the case may be, the Cofinimmo shareholders whose Cofinimmo Shares would automatically pass to Aedifica in the context of any Squeeze-out Offer following the Proposed Exchange Offer.
The Issue Price has been determined starting from the Company's EPRA NTA as per 31 March 2025 of EUR 77.8634 , as published by the Company on 29 April 2025 in its Q1 2025 results, deducting Aedifica's gross dividend in respect of financial year 2024 of EUR 3.90 per share (represented by coupon no. 35), which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was
34 For readability reasons, this number is rounded to two decimal places throughout this report.
detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025 ("Aedifica's Distributed 2024 Gross Dividend"). 35
A detailed explanation of the method and rationale used to determine the value of the Company and the Issue Price (and therefore, when combined with the valuation of Cofinimmo and the Cofinimmo Share, the Exchange Ratio) is referred to the notes in Annex 2 to this report.
The EPRA NTA of the Company's share as per 31 March 2025, as published on 29 April 2025 in the Company's Q1 2025 results, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 73.96, while the average closing price of the Company's share on the regulated market of Euronext Brussels during the thirty calendar days preceding 1 May 2025 (being EUR 64.17), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 60.27. Therefore, the determination of the Issue Price of EUR 73.96 is in accordance with the RREC Act.
As shown in the table below, the Issue Price of EUR 73.96 per New Share, as used in determining the Exchange Ratio, represents:
35 This deduction constitutes the application of the possibility thereof provided for in Article 26, §2, 2°, second paragraph of the GVV Act. The deduction is applied because Aedifica Distributed 2024 Gross Dividend of EUR 3,90 per existing share has been paid on 20 May 2025, i.e. in any event long in advance of the expected payment date under the Proposed Exchange Offer (see also section 2.6.2 of this report). Consequently, the New Shares will only share in the Company's result from 1 January 2025 (see also paragraph 2.6.1 of this report).
36 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
| Value Aedifica-share | Issue Price of EUR 73.96 per New Share (premium c.q., (discount)) |
|
|---|---|---|
| Aedifica's Undisturbed Share Price | ||
| Aedifica's Undisturbed Share Price, adjusted for Aedifica's Distributed 2024 Gross Dividend | 65.85 | 12.3% |
| Historical share price performance of the Aedifica share | VWAP | VWAP |
| Last 1 month, until 29 April 2025 | 63.31 | 16.8% |
| Last 3 months, until 29 April 2025 | 60.37 | 22.5% |
| Last 6 months, until 29 April 2025 | 60.48 | 22.3% |
| Last 12 months, until 29 April 2025 | 59.41 | 24.5% |
| Most recently reported EPRA NTA per Aedifica share | ||
| Most recently reported EPRA NTA per Aedifica share (EUR), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 |
73.96 | - |
| Most recently reported EPRA NDV per Aedifica share | ||
| Most recently reported EPRA NDV per Aedifica share (EUR), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 |
74.76 | (1.0%) |
| Target price of equity research analysts (on 30 April 2025)38 | ||
| Median target price | 71.00 | 4.2% |
| Average target price | 70.59 | 4.8% |
Pursuant to section 48 of the RREC Act, the fair value of the assets held by the Company (and its subsidiaries) as referred to in section 47, §1 of the GVV Act must be valued by the expert(s) when the Company issues shares or applies for the admission of shares to trading on a regulated market. However, such valuation is not required when such transaction takes place within four months of the last valuation or update of the valuation of the relevant assets and insofar as the expert(s) confirm that, given the general economic condition and state of such property, no new valuation is required.
In the context of an exchange offer, such as the Proposed Exchange Offer, the relevant reference point for the purposes mentioned above, according to the Company, is the moment of publication by the Company, in accordance with Article 8, §1 of the Takeover Decree, of the intention to make the Proposed Exchange Offer and to proceed with the issuance of the New Shares (instead of the moment
37 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
38 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
when the New Shares are issued or the admission of the New Shares to trading on a regulated market is requested).
The latest (updated) valuation, which relates to the fair value of the assets, is that as per 31 March 2025 (so that the Company has a (updated) valuation which is not older than 4 months at the time of the publication in accordance with Article 8 § 1 of the Takeover Decree by the Company of the intention to launch the Proposed Exchange Offer and to proceed with the issue of the new shares for that purpose). Accordingly, in the context of the present Proposed Exchange Offer and the consequent possible issue, and admission to trading on a regulated market, of the New Shares, the Company's valuation experts were asked to confirm that the underlying premises of the valuation have not changed. The Company's valuation experts confirmed on 2 May 2025 that, given the general economic condition and state of this property, to the extent necessary, no new valuation is required in the context of the (decision in principle to issue) the new shares.
J.P. Morgan Securities plc has provided an opinion to the board of directors of the Company, dated 2 June 2025 and subject to the qualifications, limitations, and assumptions set forth therein, regarding the fairness, from a financial point of view, to the Company of the currently proposed Exchange Ratio.
The opinion has been provided solely for the benefit of the Board of Directors of the Company and no other party may rely on it.
Based on the foregoing, the method of valuing the Company's shares is considered adequate for the purpose of determining the Issue Price under the Proposed Exchange Offer and is deemed to be an economically sound method. There is no deviation from the Auditor's Report, attached as Annex 1.
Taking into account the total number of Cofinimmo Shares that are the subject of the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, a maximum of 45,144,018 New Shares of the Company will be issued according to the above Exchange Ratio as a result of the contribution in kind under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings.
The number of New Shares to be effectively issued will depend on the number of Cofinimmo Shares tendered during the initial acceptance period of the Proposed Exchange Offer, or, as a result of a Voluntary and/or Mandatory Reopening thereof, during additional acceptance period(s) of the Proposed Exchange Offer.
In consideration for the contribution of Cofinimmo Shares to its capital, the Company will issue New Shares, according to the Exchange Ratio of 1.185 New Shares per contributed Cofinimmo Share.
The New Shares will be ordinary shares issued by the Company and created under Belgian law. They will have the same property and membership rights as the Company's pre-existing shares. They will share in the result of the Company as from 1 January 2025 and will be issued with coupons no. 3639 and following attached. From the actual issue of the New Shares (expected mid-October 2025 for the initial acceptance period, and possibly later due to any Voluntary and/or Mandatory Reopenings), both the existing shares and the New Shares will be traded with coupon no. 36 and following attached and will therefore have the same dividend rights.
The New Shares that will be issued to the Cofinimmo shareholders (subject to the limitations set out in section 2.3 of this report) in exchange for their contribution of Cofinimmo Shares into the capital of the Company as part of the Proposed Exchange Offer, will, at the choice of the Cofinimmo shareholder, be either dematerialized shares or registered shares. The dematerialised New Shares will be represented by an entry on account, in the name of the owner or holder, with an authorised account holder or with a settlement institution. The registered New Shares will be registered by the Board of Directors in the Company's share register. The holder of New Shares shall, in accordance with Article 7 of the Company's Articles of Association, request the conversion of registered shares into dematerialised shares or vice versa at any time in writing and at its own expense. The Company itself will not charge for such conversion.
The Company will in connection with the Proposed Exchange Offer, and subject to the condition precedent of their effective issuance (which, if any, will take place in one or more tranches depending on any Voluntary and/or Mandatory Re-openings of the acceptance period of the Proposed Exchange Offer based on the number of holders of Cofinimmo Shares that accept the Proposed Exchange Offer during such acceptance period(s)), apply to Euronext for the listing of the New Shares on the regulated markets of Euronext Brussels and Euronext Amsterdam . The New Shares with coupon no. 36 and following attached will at the earliest and expectedly be admitted to trading on those markets from the date of their issue, in particular on their Payment Date (as defined below) in the context of a successful Proposed Exchange Offer.
The New Shares will not be listed on any stock exchange in the United States or quoted on any interdealer quotation system in the United States. The Company does not intend to take any action to facilitate a market in the New Shares in the United States.
The New Shares will not be listed on any regulated market in the UK.
No application will be submitted to admit the New Shares to trading on any trading platform (i.e., stock exchange or multilateral trading facility) in Switzerland.
European Economic Area
39 Coupon No. 35 represented Aedifica's Distributed 2024 Gross Dividend, which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025 .
In principle, for the offer of the New Shares to the Cofinimmo shareholders and for the admission of the New Shares to trading on a Belgian regulated market, pursuant to Regulation 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"), a prospectus must be published.
However, there is an exception to this rule, applying Articles 1(4)(f) and 1(5)(e) of the Prospectus Regulation for securities offered in a takeover by way of a public exchange offer, provided that a document is made available to the public containing information describing the transaction and its effect on the issuer.
Commission Delegated Regulation (EU) 2021/528 of 16 December 2020 supplementing Regulation (EU) 2017/1129 of the European Parliament and of the Council as regards the minimum information to be included in the document to be published for a prospectus exemption in connection with an acquisition by means of a public exchange offer, a merger or a demerger determines the further content of the exemption document.
In accordance with the aforementioned European regulations, the Board of Directors will prepare an exemption document in relation to the Proposed Exchange Offer (the "Exemption Document"). The Exemption Document is not a prospectus within the meaning of the Prospectus Regulation. The Exemption Document is not subject to review and approval by the relevant competent authority pursuant to Article 20 of the Prospectus Regulation.
In light of Belgian legislation on public takeover bids40, the Board of Directors will also prepare a prospectus in relation to the Proposed Exchange Offer (the "Prospectus"). The Prospectus will be filed with the FSMA for approval in accordance with Article 5 io Article 6 of the Takeover Decree on or shortly after the date of approval of the Proposed Capital Increase by the Extraordinary General Meeting of the Company.
The UK Prospectus Regulation and the FSMA 2000 require that, prior to making an offer of the New Shares to the Cofinimmo shareholders in the United Kingdom, an approved prospectus must be published and made available to the public.
Article 1(4)(f) of the UK Prospectus Regulation, subject to certain conditions, provides for an exception to this rule in relation to offers of securities to the public in connection with an acquisition by way of an exchange offer, including the condition that a document is made available to the public containing information about the transaction and its impact on the issuer.
Accordingly, the Board of Directors of Aedifica will prepare an exemption document in relation to the Proposed Exchange Offer (the "UK Exemption Document"). The UK Exemption Document is not a prospectus within the meaning of the UK Prospectus Regulation. The UK Exemption Document is not subject to review and approval by the relevant competent authority under Article 20 of the UK
40 The Law of 1 April 2007 on public takeover bids, BS 26 April 2007, as amended (the "Takeover Law") and the Takeover Decree.
The Proposed Exchange Offer will be made for all issued and outstanding shares of Cofinimmo, a public regulated real estate company in the form of a public limited company under Belgian law, and will be subject to Belgian disclosure and procedural requirements. With respect to Cofinimmo shareholders in the United States, the Proposed Exchange Offer will be made in accordance with the applicable US tender offer rules under the US Exchange Act, and otherwise in accordance with the requirements of Belgian law. Consequently, the Proposed Exchange Offer will be subject to disclosures and other procedural requirements, including withdrawal rights, proposed timetable, settlement procedures, and timing of payments, which differ from those applicable under US national legislation and public offer practices.
The financial information included or to be included in the Exemption Document, the Prospectus, or other documents related to the Proposed Exchange Offer is prepared in accordance with (EU) IFRS and is not prepared in accordance with, or derived from, US GAAP, and may therefore differ from, and not be comparable to, financial information of US companies.
Neither the US Securities and Exchange Commission nor any US state securities commission has approved or disapproved the Proposed Exchange Offer, passed judgment on the merits or fairness of the Proposed Exchange Offer, or determined whether the Exemption Document, the Prospectus, or other documents related to the Proposed Exchange Offer are accurate or complete, nor will any of these authorities do so.
Further details on which Cofinimmo shareholders in the United States are eligible to receive the New Shares, and the procedural steps these individuals must take to receive these New Shares, as well as the procedures for US shareholders who are not eligible to receive the New Shares, will be set out in the Prospectus and the Exemption Document.
The FinSA requires an approved prospectus to be published and made available to the public prior to making a public offer to shareholders in Switzerland.
However, Article 36(1)(a) FinSA provides an exception for offers directed exclusively at Swiss QIBs, as defined in Article 4(3) FinSA. The Proposed Exchange Offer will thus be open in Switzerland exclusively to Swiss QIBs. Cofinimmo shareholders who do not qualify as Swiss QIBs will not be able to participate in the Proposed Exchange Offer.
In the event of a successful Proposed Exchange Offer (being upon the fulfilment of - or waiver of - all Conditions Precedent) the amount by which the capital of the Company (as the case may be in one or more instalments, depending on any Voluntary and/or Mandatory Reopenings of the acceptance period of the Proposed Exchange Offer based on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) will be obtained by multiplying the
number of New Shares by the (exact) fractional value of the existing shares (i.e., for reasons of readability, rounded off, EUR 26.39 per share), with the result of this calculation then being rounded upwards to the euro cent. The capital representative value of all existing shares of the Company and all New Shares will then be equalised.
The difference between the capital increase and the total contribution value will be shown as an available issue premium in one or more separate accounts "Available Issue Premiums", under equity on the liabilities side of the balance sheet.
Taking into account:
as a result of the proposed contribution and the capital increase arising from a successful Proposed Exchange Offer (considering the Conditions Precedent), including any Voluntary and/or Mandatory Reopenings, a minimum of 22,572,011 New Shares (with a total Issue Price of EUR 1,669,373,590.67) and a maximum of 45,144,018 New Shares (with a total Issue Price of EUR 3,338,746,885.52) will be issued. Consequently, the capital of the Company will be increased by a minimum of EUR 595,625,346.30 (rounded up to the nearest euro cent) (with the balance of EUR 1,073,748,244.37 booked as issue premium) and a maximum of EUR 1,191,250,587.04 (rounded up to the nearest euro cent) (with the balance of EUR 2,147,496,298.48 booked as issue premium).
After the capital increase, the capital of the Company (excluding issue premium) will amount to a minimum of EUR 1,850,367,606.33, represented by a minimum of 70.122.130 shares, and a maximum of EUR 2.445.992.847,07, represented by a maximum of 92.694.137 shares. The actual number of New Shares to be issued will depend on the number of Cofinimmo shareholders who accept the Proposed Exchange Offer during the initial acceptance period, or, as a result of any Voluntary and/or Mandatory Reopenings, during additional acceptance periods. Consequently, the capital increase may be determined and executed in one or more instances in accordance with Article 7:186 of the BCCA.
Any:
(i) Fractions of New Shares that, based on the Exchange Ratio, would have to be delivered to certain Cofinimmo shareholders as consideration for the contribution of their Cofinimmo Shares under the Proposed Exchange Offer (i.e., a Cofinimmo shareholder who, in exchange
41 For readability reasons, rounded to two decimal places throughout this report.
for their Cofinimmo Shares, would be entitled to receive a number of New Shares that does not consist solely of a whole number and thus includes a fraction of a New Share); and
(ii) New Shares that would otherwise have to be delivered to US Non-QIBs as consideration for the contribution of their Cofinimmo Shares under the Proposed Exchange Offer,
will not be delivered as such to the relevant Cofinimmo shareholder but will instead:
will be offered and sold by banks yet to be appointed by the Company:
Cofinimmo shareholders who will tender their Cofinimmo Shares in the Proposed Exchange Offer but to whom it is not permitted to deliver New Shares (i.e., the US Non-QIBs) or are only entitled to Fractions of New Shares, will appoint the Company, c.q., the banks appointed by the Company, as their representative in accordance with the terms of the acceptance form by way of which they confirm the tender of their Cofinimmo Shares in the Proposed Exchange Offer. This will allow the Company, c.q., the banks appointed by the Company, in the name and on behalf of each such Cofinimmo shareholder, to sell their (potential Fractions of) New Shares through a Dribbling Out c.q. Vendor Placement.
A Dribbling Out c.q. Vendor Placement will each time be organised to the extent that, at the close of the relevant acceptance period, (i) sufficient Fractions of New Shares would need to be allotted to constitute at least one whole New Share and/or (ii) New Shares would need to be allotted to US Non-QIBs.
If, following the acceptance of Cofinimmo Shares during the relevant acceptance period, a Vendor Placement is required, and if the (Fractions of) New Shares included in that Vendor Placement have not yet been fully placed and the Vendor Placement has not yet been completed, then, at the opening
42 Being, in the context of a successful Proposed Exchange Offer upon fulfilment of - or waiver of - all Conditions Precedent; the payment date of the initial acceptance period or of any additional acceptance period(s) following a Voluntary and/or Mandatory Reopening thereof, such payment date(s) (the "Payment Date").
of the regulated markets of Euronext Brussels and Euronext Amsterdam, trading in Aedifica shares (including the newly issued New Shares) shall, at Aedifica's request, be immediately suspended until the time of publication of the results of the relevant Vendor Placement.
The ask price of the (bundled Fractions of) New Shares in a Dribbling Out will be determined by the Company in consultation with banks yet to be appointed by the Company in function of the market conditions with a view to a realisation of the sale within a reasonable time after the opening of the market on the trading day on which the sale transactions will be realised.
The sale price of the (bundled Fractions of) New Shares in a Vendor Placement will be determined by the Company in consultation with banks yet to be appointed by the Company, based on the results of the accelerated private placement under the Vendor Placement.
The net proceeds of the sale of the (bundled Fractions of) New Shares that are the subject of a Dribbling Out c.q. Vendor Placement, i.e. after deduction of the costs, expenses and charges of all nature incurred by Aedifica in the context of the Dribbling Out c.q. Vendor Placement (whereby the tax on stock exchange transactions payable by Belgian residents will be borne by the Company) (the "Proceeds"), will be distributed on a pro rata basis to the original beneficial owners of the (Fractions of) New Shares sold in the Dribbling Out c.q. Vendor Placement. Neither Aedifica nor the banks appointed by the Company guarantee the amount of the Proceeds from the Dribbling Out c.q., Vendor Placement. The proceeds may therefore be lower than the value of the New Shares at the time of the Dribbling Out c.q., Vendor Placement. Aedifica and the banks appointed by the Company will act reasonably to maximize the proceeds but accept no liability in this regard and provide no guarantees whatsoever.
As soon as possible after the closing of a Dribbling Out or Vendor Placement, as the case may be, the Proceeds per New Share will be communicated through a press release, and delivered to the relevant Cofinimmo shareholders as set out below.
Delivery in cash (euro) of the relevant portion of the Proceeds to the relevant Cofinimmo shareholders who have validly contributed their Cofinimmo Shares in the Proposed Exchange Offer will be made as soon as practicable after the closing of the relevant Dribbling Out c.q. Vendor Placement to the bank account specified by the relevant Cofinimmo shareholder in the Acceptance Form.
Through the transaction, Aedifica's portfolio in its existing core markets (Belgium, Germany, the Netherlands, the United Kingdom, Finland, and Ireland) is combined with that of Cofinimmo, expanding Aedifica's presence in Spain and establishing a foothold in France and Italy.
It is expected that the combined portfolio will further diversify the tenant profile, with the weight of top-10 tenants decreasing from about 47% 43 at the Company to about 43% 44 in the combined group.
The enhanced size of the combined group, with a GAV of EUR 12.1 billion45 and a free float market capitalisation exceeding EUR 5.8 billion46, will strengthen the group's strategic positioning and improve its recourse to capital markets.
The shareholders of the Company will continue to benefit from a strong capital structure, supported by a robust financial framework and a balanced debt profile, with a potential path towards a positive credit rating action by S&P.
Through the combination, the shareholders of the Company are expected to benefit from operational synergies, which are anticipated to lead to a mid-single digit increase in EPRA earnings per share.
In the event of a rating upgrade by S&P from "BBB" to "BBB+", the combined entity could benefit from obtaining financing under more favorable conditions, particularly in the bond market. This would enable the shareholders of the Company to take advantage of financial synergies, in addition to the operational synergies.
Finally, the expected growth in EPRA earnings per share will create additional room to increase future dividend distributions to the shareholders of the Company, while maintaining a sustainable payout ratio of the consolidated EPRA earnings.
The transaction will result in improved geographical diversification, with increased exposure in the United Kingdom, Finland (with its in-house development team), and Ireland. It will also lead to a reduction in Belgium's contribution to the real estate portfolio from approximately 47%47 to 34%48 , resulting in a more balanced geographical presence.
The combined portfolio will improve tenant diversification, with the share of Cofinimmo's top-10 tenants decreasing from approximately 62%49 to about 43% 50 based on contractual (combined) rents, while the WAULT51 will increase to 1652 years (from 13 years at present).
43 As published by the Company on 29 April 2025 in its Q1 2025 results.
44 Based on the combined contractual rent of the Company and Cofinimmo as per 31 March 2025.
45 Based on the combined reported GAV of the Company and Cofinimmo as per 31 March 2025.
46 Combined market capitalisation of the Company and Cofinimmo based on FactSet data on 30 April 2025 at 16h02 Brussels time.
47 Based on the GAV of Cofinimmo as per 31 March 2025.
48 Based on the combined GAV of the Company and Cofinimmo as per 31 March 2025.
49 As published by Cofinimmo on 25 April 2025 in its Q1 2025 results.
50 Based on the combined contractual rent of the Company and Cofinimmo as per 31 March 2025.
51 Weighted average unexpired lease term.
52 Based on the weighted average remaining lease terms of the Company and Cofinimmo, weighted by each company's respective GAV as per 31 March 2025.
The weight of the structurally pressured and slow-growing office segement, as wel as the weight of the distribution network within Cofinimmo's portfolio is expected to be halved in the combined portfolio. It would be reduced from GAV's current 15%53 and 8%54 to 8% 55 and 4%56 , respectively.
Additionally, the shareholders of Cofinimmo are expected to benefit from improved scale and stock liquidity, as well as a more robust financial structure. This includes a potential path towards a positive credit rating action by S&P, linked to an anticipated reduction in the debt ratio to 40.9%57 .
By being part of the combined group, the shareholders of Cofinimmo are expected to benefit from operational and financial synergies.
The Proposed Exchange Offer will result in immediate value creation for the shareholders of Cofinimmo as it represents a premium of 23.4% 58 and 28.3% 59 compared to Cofinimmo's Undisturbed Share Price, respectively, Cofinimmo's Undisturbed Share Price adjusted for Cofinimmo's Distributed 2024 Gross Dividend.
Overall, the shareholders of Cofinimmo are expected to benefit from a stronger, more competitive entity that is better positioned to capitalize on market opportunities.
The exact number of Cofinimmo Shares that will be contributed (and therefore the number of New Shares in the Company that will be issued in exchange) will depend on the degree of acceptance of the Proposed Exchange Offer by the shareholders of Cofinimmo.
If the Proposed Exchange Offer is successful, but only the minimum number of Cofinimmo Shares (i.e., 50% + 1 of the Cofinimmo Shares) are tendered under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings (without prejudice to the Company's ability to waive the minimum acceptance threshold condition), a total of 22.572.011 New Shares will be issued. If the Proposed Exchange Offer is successful and (ultimately) all Cofinimmo Shares are tendered under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, a total of 45,144,018 New Shares will be issued.
The table below shows, based on the minimum scenario (contribution of 50%+1 of the Cofinimmo Shares, i.e., 19,048,110 Cofinimmo Shares) and the maximum scenario (contribution of 100% of the Cofinimmo Shares, i.e., 38,096,217 Cofinimmo Shares), the dilution of voting rights, dividend rights, the proceeds from the liquidation of the Company, and other rights attached to the shares of the
53 Based on the GAV of Cofinimmo as per 31 March 2025.
54 Based on the GAV of Cofinimmo as per 31 March 2025.
55 Based on the combined GAV of the Company and Cofinimmo as per 31 March 2025.
56 Based on the combined GAV of the Company and Cofinimmo as at 31 March 2025.
57 Based on the Company's debt-to-asset ratio of 39.9% and of Cofinimmo of 41.8% as per 31 March 2025.
58 Based on a comparison of the Implied Offer Price with Cofinimmo's Undisturbed Share Price of EUR 67.00.
59 Based on a comparison of EUR 78.03 per Cofinimmo Share, calculated using the Exchange Ratio of 1.185 multiplied by Aedifica's Undisturbed Share Price of EUR 69.75, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), with EUR 60.80, calculated based on Cofinimmo's Undisturbed Share Price of EUR 67.00, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
Company (such as the statutory pre-emptive right or irreducible allocation right in the event of a capital increase in cash, where applicable), which an existing shareholder of the Company who held 1% of the Company's capital before the issuance will undergo with respect to the financial year 2025 and beyond, if the Proposed Exchange Offer (as the case may be after any Voluntary and/or Mandatory Reopenings) is successful.
| Shareholding participation | |
|---|---|
| Prior to the issue of the New Shares | 1% |
| Following the issue of the New Shares (minimum scenario) |
0.68% |
| After the issue of the New Shares (maximum scenario) | 0.51% |
Pursuant to the assumptions and forecasts taken into account to determine the Issue Price of the New Shares (see section 2.5.2 of this report), the contribution in kind and the resulting capital increase in the context of the Proposed Exchange Offer will not result in any financial dilution relative to the net value of the existing shares for existing shareholders.
Currently, the withholding tax on dividends paid by the Company is only 15% as the Company is a public regulated real estate company that invests more than 80% of its property portfolio in "qualifying" (residential located in the European Economic Area) "care real estate" and whereby it can invoke the so-called "grandfathering" provided for in article 545 of the Belgian Income Tax Code '92, as a result of which the healthcare property held by the Company in the UK is still considered to be located in the European Economic Area, subject to conditions, until 31 December 2025.
As previously indicated by the Company, the ratio of "qualifying healthcare property" will fall below the 80% threshold from 1 January 2026, as a significant proportion of Aedifica's healthcare property is located in the UK (approximately 20%) and that property will no longer qualify as "qualifying healthcare property" due to the expiry as per 31 December 2025 of the so-called "grandfathering".
Thus, for dividends payable in 2026, the reduced rate of 15% withholding tax will no longer apply but the ordinary rate of 30%.
If the Proposed Exchange Offer is successful, in light of the composition of Cofinimmo's portfolio, which also does not meet that condition, this will not result in more than 80% of the consolidated property portfolio of the Company and Cofinimmo again being held in "qualifying" residential European "care property" for the time being.
The Proposed Exchange Offer therefore does not change anything in terms of the applicable withholding tax rate for dividends payable by the Company in 2026.
Pursuant to Articles 7:179, §1, second subparagraph and 7:197, §1, second subparagraph2 of the WVV, the Board of Directors requested the Statutory Auditor to prepare an audit report on the contribution in kind discussed in this report. This report is attached as Annex 1.
The conclusion of the Statutory Auditor's report on the contribution in kind is as follows:
"In accordance with articles 7:197 and 7:179 of the Belgian Code of Companies and Associations (hereinafter referred to as the "BCCA"), we hereafter submit to the extraordinary general meeting of the public limited liability company Aedifica (hereinafter the "Company") our conclusions in the context of our assignment as Statutory Auditor, for which we were appointed by letter of engagement of 17 April 2025.
We have carried out our mission in accordance with the Standard on the mission of the auditor in the context of contribution in kind and quasi-contribution of the Institute of Auditors ("Instituut van de Bedrijfsrevisoren").
Our responsibilities under this standard are further described in the section « Responsibilities of the Statutory Auditor with regard to the contribution in kind and the issue of shares ».
In accordance with Article 7:197 of the BCCA, we have examined the following aspects, as included in the report of the board of directors received on 4 June 2025, and have no material findings to report regarding:
We also conclude that the values to which the methods of valuation of the contribution in kind are used correspond at least to the number and nominal value or, in the absence of a nominal value, the par value of the shares to be issued against the contribution that are mentioned in the report of the board of directors, where applicable, increased by the issue premium.
The realisation of the intended capital increase by contribution in kind of the Cofinimmo Shares is subject to the realisation of the conditions precedent as described in chapter 2.3 of this report and for this reason no draft notarial deed is available on the date of signature of the present report."
The actual remuneration of the contribution in kind consists of 1.185 new shares of the Company per share issued by Cofinimmo in the context of the proposed exchange offer. Consequently, the total actual remuneration consists of a maximum of 45,144,018 new shares of the Company, without nominal value, and is related to the choice of the shareholders of
Cofinimmo to make use of the proposed exchange offer of Aedifica nv for all shares issued by Cofinimmo in exchange for new shares of Aedifica nv. Taking into account the total value of the contribution, an amount of maximum EUR 1,191,250,587.04 will be subscribed as capital (with the balance of maximum EUR 2,147,496,298.48 being booked as issue premium). The new shares, with coupon no. 3660 attached, issued as a result of this capital increase, will be included in the result as of 1 January 2025.
Based on our assessment of the accounting and financial data included in the special report of the board of directors, which has been prepared in accordance with article 7:179 of the BCCA, nothing has come to our attention that leads us to believe that these data, which include the justification of the issue price and the consequences for the property and membership rights of the shareholders, are not faithful in all material respects and sufficient in all their significant aspects to inform the general meeting which is to vote on the proposed transaction.
Our assignment in accordance with Article 7:197 of the BCCA is not to rule on the suitability or opportunity of the transaction, including the valuation of the remuneration given in return for the contribution, nor on the question whether that transaction is lawful and equitable (« no fairness opinion »).
Due to adjustments to the proposed exchange offer, this current report replaces the earlier signed report dated 5 May 2025.
The board of directors is responsible for:
The board of directors is responsible for:
• the justification of the issue price; and
60 Coupon No. 35 represented Aedifica's Distributed 2024 Gross Dividend, which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025.
• the description of the impact of the transaction on the property and membership rights of the shareholders.
The Statutory Auditor is responsible for:
The Statutory Auditor is responsible for:
• the assessment of whether the financial and accounting information – included in the special report of the board of directors that includes the justification of the issue price and the impact on the property and membership rights of the shareholders – is true in all material respects and sufficient to enable the general meeting to vote on the proposal.
This report was drawn up solely pursuant to articles 7:197 and 7:179 of the BCCA in the context of the capital increase of the public limited liability company Aedifica by means of a contribution in kind and the issue of new shares and may not be used for any other purpose.
Brussels, 4 June 2025
EY Bedrijfsrevisoren bv Statutory Auditor Represented by
Christophe Boschmans* Partner *Acting on behalf of a bv"
The Board of Directors agrees with the findings as set out in the Statutory Auditor's audit report and makes no additional comments. The Board of Directors agrees and therefore does not deviate from the conclusion of the Statutory Auditor as set out in his audit report.
The Extraordinary General Meeting of shareholders of the Company shall also resolve to amend accordingly (as the case may be, in one or more times, depending on any Voluntary and/or Mandatory Reopenings of the (initial) acceptance period of the Proposed Exchange Offer depending on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) to amend Article 6 of the coordinated articles of association of the Company in the event of a successful Proposed Exchange Offer (being upon fulfilment of - or waiver of - all Conditions Precedent) and each time when required in the context of any Voluntary and/or Mandatory Reopenings. In this respect, the Extraordinary General Meeting of shareholders of the Company will be asked to grant a delegation to any two members of the Board of Directors (acting together).
The FSMA's prior approval of the amendment to the Articles of Association resulting (as the case may be, in one or more times, depending on any Voluntary and/or Mandatory Reopenings of the (initial) acceptance period of the Proposed Exchange Offer, based on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) from the capital increase of the Company in the event of a successful Proposed Exchange Offer has(in accordance with Article 12 RREC Act) been obtained.
As the present contribution in kind will be decided by the general meeting of shareholders of the Company, article 37 RREC Act, in accordance with article 38, 3° GVV Act, is not applicable.
As explained in section 3 of this report, the planned transaction is in the interest of the Company. This transaction will also be carried out under normal market conditions, treating all shareholders equally.
* * *
In view of the presentation, explanation and justification of the legal, prudential and financial considerations in this report, the Board of Directorsis of the opinion that the proposed capital increase by contribution in kind of shares under the Proposed Exchange Offer is in the interest of the Company.
For this reason, the Board of Directors wishes to request the Company's shareholders to approve the present proposal at the Extraordinary General Meeting of shareholders be held on or around 11 July 2025, and therefore vote in favour of the capital increase by contribution in kind of shares.
[signature page follows immediately below]
Approved on 4 June 2025
On behalf of the Board of Directors of Aedifica NV,
Name: Serge Wibaut Name: Stefaan Gielens
Function: Director Function: Director

EY Bedrijfsrevisoren EY Réviseurs d'Entreprises Kouterveldstraat 7B 001 B-1831 Diegem
Tel: +32 (0)2 774 91 11 ey.com
Free translation of the original version in Dutch
Report of the Statutory Auditor to the extraordinary general meeting of the public limited liability company
on the capital increase by means of the contribution in kind and the issue of new shares in the context of the aforementioned contribution
EY Bedrijfsrevisoren bv Statutory Auditor represented by
Christophe Boschmans* Partner *Acting on behalf of a bv
4 June 2025
Besloten Vennootschap Société à responsabilité limitée RPR Brussel - RPM Bruxelles – BTW–TVA BE 0446.334.711 – IBAN N° BE71 2100 9059 0069 * handelend in naam van een vennootschap/agissant au nom d'une société

| 1. | Mission 1 |
|---|---|
| 2. | Identification of the operation 2 |
| 3. | Actual remuneration granted in return for the contribution15 |
| 4. | Conclusions of the Statutory Auditor to the extraordinary general meeting of the public wlimited liability company Aedifica 16 |
Draft of the special report of the board of directors in accordance with articles 7:197 and 7:179 of the Belgian Code of Companies and Associations.
Unless otherwise stated, all amounts in this report are expressed in euros (EUR).

In accordance with Article 7:197 of the Belgian Code of Companies and Associations (hereinafter referred to as « BCCA »), we were appointed by the board of directors of the public limited liability company Aedifica (hereinafter the « Company ») by letter of engagement dated 17 April 2025 to report on the report of the board of directors on the contribution in kind.
Our mission is not to rule on the suitability or appropriateness of the transaction, nor on the valuation of the remuneration given in return for the contribution, nor on the question whether this transaction is lawful and equitable (« no fairness opinion »).
We have carried out our assignment in accordance with the Standard on the mission of the auditor in the context of a contribution in kind and quasi-contribution from the Institute of Auditors ("Instituut van de Bedrijfsrevisoren") of 26 May 2021.
Given that the contribution in kind is accompanied by an issue of shares, we have also been appointed in accordance with article 7:179 to report on whether the accounting and financial data included in the report of the board of directors are true and sufficient in all material respects to enable the general meeting to vote on the proposal,

The Company was incorporated on 7 November 2005 by deed executed before notary Bertrand Nerincx in Brussels, published in the annexes to the Belgian Official Gazette of 23 November 2005 under the numbers 2005-11-23/05168051 and 2005-11-23/05168061.
The articles of association were last amended on 4 July 2023 by deed executed before notary Catherine Gillardin in Brussels, published in the annexes to the Belgian Official Gazette of 21 August 2023 under the number 2023-08-21/0108113.
The registered office of the Company is located in the Brussels Region, Rue Belliard 40 (box 11), 1040 Brussels.
The Company is registered with the Crossroads Bank for Enterprises under the company number 0877.248.501.
The contributors are the shareholders of Cofinimmo nv who have chosen to make use of the proposed exchange offer of Aedifica nv for all shares issued by Cofinimmo nv in exchange for new shares of Aedifica nv. Cofinimmo nv has its registered office in the Brussels Region, Avenue de Tervueren 270, 1150 Woluwe-Saint-Pierre and is registered with the Crossroads Bank for Enterprises under the company number 0426.184.049.
As described in the draft report of the board of directors of the Company received on 4 June 2025, it is proposed to increase the capital by a maximum amount of EUR 1,191,250,587.04 by a contribution in kind. The realisation of the intended capital increase by contribution in kind of the Cofinimmo Shares (as defined below) is subject to the realisation of the conditions precedent as described in chapter 2.3 of this report and for this reason no draft notarial deed is available on the date of signature of the present report.
The current capital of the Company amounts to EUR 1,254,742,260.03 and is represented by 47,550,119 shares ordinary shares, without nominal value, which are fully paid up. The par value per share is therefore EUR 26.39 (rounded to the euro cent for readability reasons).

Following discussions between the boards of directors of Aedifica and Cofinimmo in the wake of the Announcement and Aedifica's initial convening of its extraordinary general meeting of shareholders on 13 May 2025 to approve the proposed exchange offer at an exchange ratio of 1.161, the board of directors of Cofinimmo agreed to support the proposed exchange offer, provided that an exchange ratio of 1.185 is applied.
The board of directors of Aedifica acknowledges that this support significantly increases the likelihood of the proposed exchange offer's success and will greatly facilitate the integration of Cofinimmo into Aedifica following the transaction. As a result, Aedifica's board has decided to adjust the exchange ratio to 1.185 New Shares shares per Cofinimmo Share. According to Aedifica, this revised ratio reflects a fair value distribution for the shareholders of both companies. Moreover, it enhances the certainty of acceptance of the Proposed Exchange Offer, supports a smooth integration process, and creates longterm value for all stakeholders.
Through the joint press release of 3 June 2025, (i) Aedifica announced the adjustment of the original exchange ratio of 1.16 under the proposed exchange offer to the revised ratio of 1.185, and the cancellation of its previously scheduled extraordinary general meeting of shareholders on 12 June 2025, replacing it with a newly convened extraordinary general meeting on 11 July 2025, during which the revised Proposed Exchange Offer with an Exchange Ratio of 1.185 will be submitted for approval; and (ii) the board of directors of Cofinimmo formally expressed its support for the revised Proposed Exchange Offer.2
Cofinimmo is a public regulated real estate company under the form of a public limited liability company under Belgian law, with its registered office at Tervurenlaan 270, 1150 Sint-Pieters-Woluwe (Belgium) and registered with the Belgian Crossroads Bank for Enterprises under number 0426.184.049 (RLE Brussels), whose shares are listed on the regulated market of Euronext Brussels.
The capital of Cofinimmo at the date of this report amounts to EUR 2,041,523,111.02 and is represented by 38,096,217 ordinary shares, without nominal value, which are fully paid up. The Company intends to launch a voluntary and conditional public takeover offer by way of exchange for all shares issued by Cofinimmo (with coupon no. 413 et seq. attached) (the "Cofinimmo Shares") against the issuance of new shares of the Company (the "Proposed Exchange Offer").
Accordingly, during the acceptance period of the Proposed Exchange Offer, which may/will be reopened voluntarily or compulsorily in certain cases (including but not limited to reopening pursuant to Article 35 and/or Articles 42 and 43 of the Belgian Royal Decree of 27 April 2007 on public tender offers as amended (the "Takeover Decree")) or as required by the applicable US tender offer rules under the US Securities Exchange Act of 1934, as amended (the "US Exchange Act") (hereinafter also referred to as "Voluntary and/or Mandatory Reopening(s)"), all shareholders of Cofinimmo will be offered the opportunity to tender their Cofinimmo Shares with a view to contributing them in kind to the Company in exchange for new shares to be issued by the Company.
1 https://aedifica.eu/transactions-2025/
2 https://aedifica.eu/transactions-2025/
3 Coupon no. 41 is the dividend coupon that goes attached to the Cofinimmo Share at the moment when the acceptance period of the Proposed Exchange Offer is opened. Coupon no. 40, representing Cofinimmo's Distributed 2024 Gross Dividend, was, following the decision of Cofinimmo's general meeting of shareholders on 14 May 2025, detached from the Cofinimmo share on 19 May 2025 and became payable as of 22 May 2025.

The board of directors of Aedifica proposes to increase the capital of the Company by contribution in kind of all Cofinimmo Shares effectively offered by the shareholders of Cofinimmo under the Proposed Exchange Offer against new shares issued by the Company.
In this context, reference is also made to the contents of the announcement of the intention to make the Proposed Exchange Offer, published by the Company, in application of Article 8 §1 of the Takeover Decree, on 1 May 2025 ( (the "Announcement").1
To maintain consistency with Cofinimmo's financial reporting, the EPRA net tangible asset value ("EPRA NTA")2 per Cofinimmo Share as communicated by Cofinimmo was used in the Announcement. For the calculation of the EPRA NTA per share (a financial parameter used in this report to determine the contribution value per Cofinimmo Share in the context of the Proposed Exchange Offer), as well as the IFRS NAV3 per share, the EPRA NRV4 per share, and the EPRA NDV5 per share (all financial parameters used in this report to provide additional context to the Exchange Ratio, see section 2.5.1(c) of this report), Cofinimmo does not take into account the (18,298) treasury shares it holds. Therefore, these financial parameters as communicated by Cofinimmo only consider 38,077,919 Cofinimmo Shares instead of the total number of outstanding Cofinimmo Shares (38,096,217). Since the Proposed Exchange Offer pertains to all outstanding (38,096,217) Cofinimmo Shares, the mentioned financial parameters, when used in this report6, must take into account all outstanding (38,096,217) Cofinimmo Shares.7 Consequently, the values of these financial parameters in this report differ from those communicated by Cofinimmo, as follows:
Therefore, when this report refers to these financial parameters "as published by Cofinimmo on 25 April 2025, in its Q1 2025" or "as of 31 March 2025," the above corrected values are meant9.
9 Unless expressly stated otherwise.
1 See https://aedifica.eu/transactions-2025/
2 EPRA NTA is a generally recognised financial parameter publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association, and is calculated as IFRS Equity - hybrid instruments that do not contribute to equity attributable to owners + revaluation of investment property (IP) if the IAS 40 cost option is used + revaluation of long-term investments + revaluation of leases held as finance leases + revaluation of trading properties deferred tax (DT) relating to fair value gains on IP (rules -based approach with three options for adding a certain percentage of DT) - fair value of financial instruments - goodwill due to deferred taxes - goodwill as per the IFRS balance sheet - intangible assets as per the IFRS balance sheet + fair value of fixed-income debt + revaluation of intangible assets to fair value + property transfer taxes.
3 The IFRS Net Asset Value ("IFRS NAV") refers to the net asset value calculated in accordance with IFRS.
4 The EPRA Net Reinstatement Value ("EPRA NRV") assumes that the company will never sell its assets and provides an estimate of the amount needed to reconstitute the company's assets.
5 The EPRA Net Disposal Value ("EPRA NDV") represents the value attributable to the company's shareholders in a scenario where the assets are sold, leading to the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, all net after tax.
6 With the exception of the EPRA NTA per share used in the context of the Suspensive Conditions, which pertains to the EPRA NTA per Cofinimmo Share as calculated and communicated by Cofinimmo in its Q1 2025 results.
7 For clarity, the financial parameters as communicated by Aedifica do take into account the total number of outstanding Aedifica shares, and therefore such a correction is not necessary on Aedifica's side. For readability purposes, these figures are rounded to two decimal places throughout this report.
8 For readability purposes, these figures are rounded to two decimal places throughout this report.

The realization of the Proposed Exchange Offer, and as a consequence, the realization of the proposed capital increase by contribution in kind of the Cofinimmo Shares, is subject to the realization of the following conditions precedent (the " Conditions Precedent"):
1 The benchmark stock market index of Euronext Brussels
2 The FTSE EPRA Nareit Developed Europe Index tracks European listed real estate investment trusts (REITs) and real estate companies and provides a diverse representation of the real estate market in developed countries in Europe, both geographically and by property type.

These Conditions Precedent are determined for the sole benefit of the Company, which, in the context of the Proposed Exchange Offer will reserve the right to, pursuant to a decision of its board of directors, waive them, in whole or in part. No later than the last day of the (initial) acceptance period of the Proposed Exchange Offer, Aedifica will announce whether or not the above Conditions Precedent have been satisfied and, as the case may be, if any of the above Conditions Precedent have not been satisfied, whether or not it waives them. In case the Company cahoses to waive such Condition Precedent at that point in time, the (initial) acceptance period of the Proposed Exchange Offer will be closed and the Proposed Exchange Offer will be voluntarily reopened by the Company, in order to comply with the requirement under US law that the Proposed Exchange Offer must then remain open for at least 5 (US) business days (the voluntary reopening then being deemed an opening of the (initial) acceptance period for US purposes), the foregoing without prejudice to the right not to waive the Conditions Precedent yet and to voluntarily extend the Proposed Exchange Offer.
The proposed contribution in kind consists of the Cofinimmo Shares to be effectively tendered to the Company by the shareholders of Cofinimmo under the Proposed Exchange Offer (the "Contribution").
At present, the Company does not hold any Shares in Cofinimmo. Accordingly, the extent to which the Company will succeed in acquiring the issued Cofinimmo Shares through the Proposed Exchange Offer will depend entirely on the extent to which the shareholders of Cofinimmo will accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings).
In connection with the Proposed Exchange Offer and any subsequent Voluntary and/or Mandatory Reopenings, a maximum total of 38,096,217 Cofinimmo Shares will be contributed to the Company by way of contribution in kind in exchange for a maximum of 45,144,018 New Shares (as defined below) issued by the Company based on the Exchange Ratio (as defined below).
Any fractions of New Shares that should be issued pursuant to the Exchange Ratio to a particular Cofinimmo sharehodler (i.e, a holder of Cofinimmo Shares who should receive in exchange for his/her Cofinimmo Shares a number of New Shares which does not solely consist of a whole number and is therefore partly a fraction of a New Share) who accepts the (initial) Proposed Exchange Offer or any Voluntary and/or Mandatory Reopenings (the "Fractions of New Shares"), will not be issued as such to the relevant Cofinimmo shareholder, but will, together with any New Shares that would have been payable to US Non-QIBs pursuant to their contribution of Cofinimmo Shares in the Proposed Exchange Offer, be included in the Dribbling Out (or alternatively - depending on volume - Vendor Placement) at the closing of the (initial) acceptance period of the Proposed Exchange Offer or at the closing of any Voluntary and/or Mandatory Reopenings.

The aforementioned Contribution and the resulting capital increase of the Company under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, will be submitted as a whole for approval to the extraordinary general meeting of shareholders of the Company to be held on or about 11 July 2025. The extraordinary general meeting of shareholders of the Company will also be asked to grant a delegation to any two members of the board of directors (acting together) to, inter alia, in the event of a successful Proposed Exchange Offer (being upon fulfilment - or waiver – of all Conditions Precedent) and, as the case may be, in one or more instances, subject to any Voluntary and/or Mandatory Reopenings based on the number of holders of Cofinimmo Shares who, during such acceptance period(s),accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)), to determine the number of Cofinimmo Shares that were tendered by the shareholders of Cofinimmo in the context of the Proposed Exchange Offer, and thus to determine and implement the realization of the capital increase by contribution in kind to the Company on that basis in one or more times in accordance with Article 7:186 of the BCCA.
If the Proposed Exchange Offer is successful, but the Company has failed to acquire at least 95% of the Cofinimmo Shares during the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)1, the capital, in application of Section 7:181 of the BCCA, will only be increased by the amount of the subscriptions issued.
The value per Cofinimmo Share to be contributed by Cofinimmo shareholders under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, has been determined starting from the EPRA NTA per Cofinimmo Share as per 31 March 2025 of EUR 94.53, as published by Cofinimmo on 25 April 2025 in its Q1 2025 results, where:
1 If, following the acceptance period under the Proposed Exchange Offer, the Company holds at least 95% of the Cofinimmo Shares and has acquired at least 90% of the Cofinimmo Shares that were the subject of the Proposed Exchange Offer (as the Proposed Exchange Offer relates to all Cofinimmo Shares issued by Cofinimmo, the latter condition will always be fulfilled in the event the Company holds 95% of the Cofinimmo Shares following the acceptance period), the Company has the right and the intention, in accordance with Article 7:82, §1 CC and Articles 42 and 43 of the Takeover Decree, to require the remaining Cofinimmo Shareholders to exchange their Cofinimmo Shares for the shares in the Company at the Exchange Ratio.
2 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places throughout this report.
3 For reasons of readability, this number is rounded to two decimal places throughout this report.

Based on the foregoing and the adjustments described in (i) and (ii) above, the contribution value per Cofinimmo Share has thus been established at EUR 87.641 (the "Contribution Value").
The Issue Price has been determined starting from the Company's EPRA NTA as per 31 March 2025 of EUR 77.862, as published by the Company on 29 April 2025 in its Q1 2025 results, deducting Aedifica's gross dividend in respect of financial year 2024 of EUR 3.90 per share (represented by coupon no. 35), which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025 ("Aedifica's Distributed 2024 Gross Dividend").3
In consideration for the contribution of Cofinimmo Shares to its capital, the Company will issue New Shares, according to the Exchange Ratio of 1.185 New Shares per contributed Cofinimmo Share.
EPRA NTA is a generally recognised financial measure publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association. The Company considers EPRA NTA to be the most common and recognised valuation model for assessing the market value of a real estate company's net assets.
In evaluating the relative value of the Company and Cofinimmo to determine the Exchange Ratio, the Company adopted an industry-specific approach. This method effectively takes into account the unique market dynamics and prospects of each segment within the portfolios of Cofinimmo and the Company, particularly healthcare for both entities and office and distribution networks for Cofinimmo
Given these factors, the Company has adjusted the reported EPRA NTA of both Cofinimmo and the Company for the calculation of the Exchange Ratio as follows:
"Cofinimmo's Adjusted EPRA NTA" (this is the total Contribution Value) is calculated based on the last reported EPRA NTA as of 31 March 2025:
1 For reasons of readability, this number is rounded to two decimal places throughout this report.
2 For readability reasons, this number is rounded to two decimal places throughout this report.
3 This deduction constitutes the application of the possibility thereof provided for in Article 26, §2, 2°, second paragraph of the GVV Act. The deduction is applied because Aedifica Distributed 2024 Gross Dividend of EUR 3,90 per existing share has been paid on 20 May 2025, i.e. in any event long in advance of the expected payment date under the Proposed Exchange Offer.
Consequently, the New Shares will only share in the Company's result from 1 January 2025. 4 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places in this report.

Based on the above, the Adjusted EPRA NTA of Cofinimmo is set out below:
| EUR million | |
|---|---|
| Cofinimmo's EPRA NTA as per 31 March 2025 | 3,601 |
| (-) Cofinimmo's Distributed 2024 Gross Dividend | (236) |
| (-) Cofinimmo's GAV Adjustment | (26.5) |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 | 3,339 |
| (/) Last reported number of shares outstanding for | |
| Cofinimmo as per 31 March 2025 (million) | 38.1 |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 per | |
| share (EUR) (Contribution Value) | 87.64 |
"Aedifica's Adjusted EPRA NTA" (this is the total Issue Price) is calculated based on the last reported EPRA NTA as of March 31, 2025, adjusted for Aedifica's Distributed 2024 Gross Dividend, and is outlined in the table below:
| EUR million | |
|---|---|
| Aedifica's EPRA NTA as per 31 March 2025 | 3,702 |
| (-) Aedifica's Distributed 2024 Gross Dividend | (185) |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 | 3,517 |
| (/) Last reported number of shares outstanding for | 47.6 |
| Aedifica as per 31 March 2025 (million) | |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 | |
| per share (EUR) (Issue Price) | 73.96 |
Subsequently, the Exchange Ratio was determined by dividing Cofinimmo's Adjusted EPRA NTA per share (being the Contribution Value) (based on 38,096,217, the last reported number of outstanding shares for Cofinimmo as of 31 March 2025) by Aedifica's Adjusted EPRA NTA per share (being the Issue Price) (based on 47,550,119, the last reported number of outstanding shares for the Company as of 31 March 2025).
| Contribution Value - Cofinimmo (EUR) | 87.64 |
|---|---|
| (/) Issue Price - the Company (EUR) | 73.96 |
| Exchange Ratio | 1.185 |
In the event of a successful Proposed Exchange Offer (being upon the fulfilment of - or waiver of - all Conditions Precedent) the amount by which the capital of the Company (as the case may be in one or more instalments, depending on any Voluntary and/or Mandatory Reopenings of the acceptance period of the Proposed Exchange Offer based on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) will be obtained by multiplying the number of New Shares by the (exact) fractional value of the existing shares (i.e., for reasons of readability, rounded off, EUR 26.39 per share), with the result of this calculation then being rounded upwards to the euro cent. The capital representative value of all existing shares of the Company and all New Shares will then be equalised.
Taking into account the total number of Cofinimmo Shares that are the subject of the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, a maximum of 45,144,018 New Shares of the Company will be issued according to the above Exchange Ratio as a result of the contribution in kind under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings.

The number of New Shares to be effectively issued will depend on the number of Cofinimmo Shares tendered during the initial acceptance period of the Proposed Exchange Offer, or, as a result of a Voluntary and/or Mandatory Reopening thereof, during additional acceptance period(s) of the Proposed Exchange Offer.
The difference between the capital increase and the total contribution value will be shown as an available issue premium in one or more separate accounts "Available Issue Premiums", under equity on the liabilities side of the balance sheet.
Taking into account:
as a result of the proposed contribution and the capital increase arising from a successful Proposed Exchange Offer (considering the Conditions Precedent), including any Voluntary and/or Mandatory Reopenings, a minimum of 22,572,011 New Shares (with a total Issue Price of EUR 1,669,373,590.67) and a maximum of 45,144,018 New Shares (with a total Issue Price of EUR 3,338,746,885.52) will be issued. Consequently, the capital of the Company will be increased by a minimum of EUR 595,625,346.30 (rounded up to the nearest euro cent) (with the balance of EUR 1,073,748,244.37 booked as issue premium) and a maximum of EUR 1,191,250,587.04 (rounded up to the nearest euro cent) (with the balance of EUR 2,147,496,298.48 booked as issue premium). After the capital increase, the capital of the Company (excluding issue premium) will amount to a minimum of EUR 1,850,367,606.33, represented by a minimum of 70.122.130 shares, and a maximum of EUR 2.445.992.847,07, represented by a maximum of 92.694.137 shares. The actual number of New Shares to be issued will depend on the number of Cofinimmo shareholders who accept the Proposed Exchange Offer during the initial acceptance period, or, as a result of any Voluntary and/or Mandatory Reopenings, during additional acceptance periods. Consequently, the capital increase may be determined and executed in one or more instances in accordance with Article 7:186 of the BCCA.
In light of Belgian legislation on public takeover bids2, the Board of Directors will also prepare a prospectus in relation to the Proposed Exchange Offer (the "Prospectus"). The Prospectus will be filed with the FSMA for approval in accordance with Article 5 io Article 6 of the Takeover Decree on or shortly after the date of approval of the Proposed Capital Increase by the Extraordinary General Meeting of the Company.
1 For readability reasons, rounded to two decimal places throughout this report.
2 The Law of 1 April 2007 on public takeover bids, BS 26 April 2007, as amended (the "Takeover Law") and the Takeover Decree.

In accordance with Article 26, §2, 2°, first paragraph of the RREC Act, the Issue Price may not be less than the lower value of (a) a net asset value per share dating from no more than four months prior to the date of the Contribution Agreement or, at the option of the public regulated real estate company, prior to the date of the deed of capital increase, and (b) the average closing price during the thirty calendar days preceding the same date. The reference date was set by the Company as 31 March 2025, being less than four months before 1 May 2025 (i.e. the date on which the intention to launch the Proposed Exchange Offer was published by the Company pursuant to Article 8, §1 of the Takeover Decree). For purposes of the Proposed Exchange Offer, where (i) a public regulated property company makes an exchange offer to another public regulated property company, and (ii) the Extraordinary General Meeting of the bidder must be asked for approval of the Capital Increase, before giving notice of an exchange offer pursuant to Article 5 of the Takeover Decree, "contribution agreement" within the meaning of Article 26, §2, 2°, first paragraph of the RREC Act is to be read, according to the Company, as "the date on which the intention to launch the Proposed Exchange Offer in accordance with Article 8, §1 of the Takeover Decree was published by the Company".
Next, Article 26, §2, 2°, second paragraph of the RREC Act clarifies that, for the purposes of the first paragraph, it is allowed to deduct from the amount thus obtained an amount corresponding to the part of the undistributed gross dividend to which the new shares might not be entitled, provided that the Board of Directors specifically justifies the amount to be deducted from the accumulated dividend in its special report and explains the financial terms of the transaction in its Annual Financial Report.
Article 26, §2 of the RREC Act determines the minimum issue price with which the New Shares issued in the context of the Proposed Exchange Offer must comply (and thus implicitly also the Exchange Ratio), referring for the determination of one of the two parameters to "the date of the contribution agreement" as the reference date for determining the minimum issue price of the New Shares to be issued.
In the case of a public takeover bid, there is strictly speaking no "contribution agreement". For the purposes of §2 of article 26 of the RREC Act, the disclosure in accordance with article 8, §1 Takeover Decree (whereby the Company expressed its intention to issue the Proposed Exchange Offer) should in this case be equated with a "contribution agreement", given that at that time the issue price and thus Exchange Ratio were also fixed and communicated.
Thus, (i) the maximum period of four months provided for in article 26, §2, 3° RREC Act does not apply in the context of the Proposed Exchange Offer and (ii) this allows the determination of the Issue Price and Exchange Ratio that are underlying the Proposed Exchange Offer at the time of disclosure of the Proposed Exchange Offer, on the basis of the most recent financial information at that time (by analogy with the FSMA's practice in the context of a mandatory takeover bid, of allowing the average stock price prior to the announcement of the proposed exchange offer (i.e., the moment of expressing the intention to make the proposed exchange offer) to be used as a reference point for the application of Article 53 of the Takeover Decree, instead of the average stock price prior to the time when the obligation to bid formally and legally comes to rest on the bidder). This reasoning is also analogous to the situation in mergers and demergers, where the RREC Act (Article 26, §3) explicitly equates the date of the transaction proposal with the date of the contribution agreement.
By definition, a public takeover bid is addressed to all shareholders of the target company at the time the takeover bid is open for acceptance. With the exception of BlackRock Inc, which, according to the transparency notification published by Cofinimmo on its website in accordance with the Belgian Law of 2 May 2007 on the disclosure of major shareholdings, held 5.42% of the Cofinimmo Shares on 23 May 2025, the specific identity of the other shareholders of Cofinimmo is not known to Aedifica. For purposes of Article 26, §2, 1° RREC Act, the contributors are thus identified in this report as being the Cofinimmo shareholders who will accept the Proposed Exchange Offer, as well as, as the case may be, the Cofinimmo shareholders whose Cofinimmo Shares would automatically pass to Aedifica in the context of any Squeeze-out Offer following the Proposed Exchange Offer.

The EPRA NTA of the Company's share as per 31 March 2025, as published on 29 April 2025 in the Company's Q1 2025 results, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 73.96, while the average closing price of the Company's share on the regulated market of Euronext Brussels during the thirty calendar days preceding 1 May 2025 (being EUR 64.17), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 60.27. Therefore, the determination of the Issue Price of EUR 73.96 is in accordance with the RREC Act.
Pursuant to section 48 of the RREC Act, the fair value of the assets held by the Company (and its subsidiaries) as referred to in section 47, §1 of the GVV Act must be valued by the expert(s) when the Company issues shares or applies for the admission of shares to trading on a regulated market. However, such valuation is not required when such transaction takes place within four months of the last valuation or update of the valuation of the relevant assets and insofar as the expert(s) confirm that, given the general economic condition and state of such property, no new valuation is required.
In the context of an exchange offer, such as the Proposed Exchange Offer, the relevant reference point for the purposes mentioned above, according to the Company, is the moment of publication by the Company, in accordance with Article 8, §1 of the Takeover Decree, of the intention to make the Proposed Exchange Offer and to proceed with the issuance of the New Shares (instead of the moment when the New Shares are issued or the admission of the New Shares to trading on a regulated market is requested).
The latest (updated) valuation, which relates to the fair value of the assets, is that as per 31 March 2025 (so that the Company has a (updated) valuation which is not older than 4 months at the time of the publication in accordance with Article 8 § 1 of the Takeover Decree by the Company of the intention to launch the Proposed Exchange Offer and to proceed with the issue of the new shares for that purpose). Accordingly, in the context of the present Proposed Exchange Offer and the consequent possible issue, and admission to trading on a regulated market, of the New Shares, the Company's valuation experts were asked to confirm that the underlying premises of the valuation have not changed. The Company's valuation experts confirmed on 2 May 2025 that, given the general economic condition and state of this property, to the extent necessary, no new valuation is required in the context of the (decision in principle to issue) the new shares.
The of board of directors the beneficiary company is of the opinion that this contribution in kind is important for the following reasons:
"Through the transaction, Aedifica's portfolio in its existing core markets (Belgium, Germany, the Netherlands, the United Kingdom, Finland, and Ireland) is combined with that of Cofinimmo, expanding Aedifica's presence in Spain and establishing a foothold in France and Italy.
It is expected that the combined portfolio will further diversify the tenant profile, with the weight of top-10 tenants decreasing from about 47%1 at the Company to about 43%2 in the combined group.
1 As published by the Company on 29 April 2025 in its Q1 2025 results.
2 Based on the combined contractual rent of the Company and Cofinimmo as per 31 March 2025.

The enhanced size of the combined group, with a GAV of EUR 12.1 billion1 and a free float market capitalisation exceeding EUR 5.8 billion2, will strengthen the group's strategic positioning and improve its recourse to capital markets.
The shareholders of the Company will continue to benefit from a strong capital structure, supported by a robust financial framework and a balanced debt profile, with a potential path towards a positive credit rating action by S&P.
Through the combination, the shareholders of the Company are expected to benefit from operational synergies, which are anticipated to lead to a mid-single digit increase in EPRA earnings per share.
In the event of a rating upgrade by S&P from "BBB" to "BBB+", the combined entity could benefit from obtaining financing under more favorable conditions, particularly in the bond market. This would enable the shareholders of the Company to take advantage of financial synergies, in addition to the operational synergies.
Finally, the expected growth in EPRA earnings per share will create additional room to increase future dividend distributions to the shareholders of the Company, while maintaining a sustainable payout ratio of the consolidated EPRA earnings."
With regard to the issuance of the new shares, the board of directors has accounted for the issue price and described the consequences of the transaction for the property and membership rights of the shareholders in its report prepared in accordance with article 7:179 of the Belgian Code of Companies and Associations.
The exact number of Cofinimmo Shares that will be contributed (and therefore the number of New Shares in the Company that will be issued in exchange) will depend on the degree of acceptance of the Proposed Exchange Offer by the shareholders of Cofinimmo.
If the Proposed Exchange Offer is successful, but only the minimum number of Cofinimmo Shares (i.e., 50% + 1 of the Cofinimmo Shares) are tendered under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings (without prejudice to the Company's ability to waive the minimum acceptance threshold condition), a total of 22,572,011 New Shares will be issued. If the Proposed Exchange Offer is successful and (ultimately) all Cofinimmo Shares are tendered under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, a total of 45,144,018 New Shares will be issued.
The table below shows, based on the minimum scenario (contribution of 50%+1 of the Cofinimmo Shares, i.e., 19,048,110 Cofinimmo Shares) and the maximum scenario (contribution of 100% of the Cofinimmo Shares, i.e., 38,096,217 Cofinimmo Shares), the dilution of voting rights, dividend rights, the proceeds from the liquidation of the Company, and other rights attached to the shares of the Company (such as the statutory pre-emptive right or irreducible allocation right in the event of a capital increase in cash, where applicable), which an existing shareholder of the Company who held 1% of the Company's capital before the issuance will undergo with respect to the financial year 2025 and beyond, if the Proposed Exchange Offer (as the case may be after any Voluntary and/or Mandatory Reopenings) is successful.
1 Based on the combined reported GAV of the Company and Cofinimmo as per 31 March 2025.
2 Combined market capitalisation of the Company and Cofinimmo based on FactSet data on 30 April 2025 at 16h02 Brussels time.

| Shareholding participation | |
|---|---|
| Prior to the issue of the New Shares | 1% |
| Following the issue of the New Shares (minimum | 0.68% |
| scenario) | |
| After the issue of the New Shares (maximum scenario) | 0.51% |
Pursuant to the assumptions and forecasts taken into account to determine the Issue Price of the New Shares, the contribution in kind and the resulting capital increase in the context of the Proposed Exchange Offer will not result in any financial dilution relative to the net value of the existing shares for existing shareholders.
Currently, the withholding tax on dividends paid by the Company is only 15% as the Company is a public regulated real estate company that invests more than 80% of its property portfolio in "qualifying" (residential located in the European Economic Area) "care real estate" and whereby it can invoke the so-called "grandfathering" provided for in article 545 of the Belgian Income Tax Code '92, as a result of which the healthcare property held by the Company in the UK is still considered to be located in the European Economic Area, subject to conditions, until 31 December 2025.
As previously indicated by the Company, the ratio of "qualifying healthcare property" will fall below the 80% threshold from 1 January 2026, as a significant proportion of Aedifica's healthcare property is located in the UK (approximately 20%) and that property will no longer qualify as "qualifying healthcare property" due to the expiry as per 31 December 2025 of the so-called "grandfathering".
Thus, for dividends payable in 2026, the reduced rate of 15% withholding tax will no longer apply but the ordinary rate of 30%.
If the Proposed Exchange Offer is successful, in light of the composition of Cofinimmo's portfolio, which also does not meet that condition, this will not result in more than 80% of the consolidated property portfolio of the Company and Cofinimmo again being held in "qualifying" residential European "care property" for the time being.
The Proposed Exchange Offer therefore does not change anything in terms of the applicable withholding tax rate for dividends payable by the Company in 2026.

As remuneration for the contribution of Cofinimmo Shares to its capital, the Company will issue New Shares, according to the Exchange Ratio of 1.185 New Shares per Cofinimmo Share contributed.
The board of directors proposes to remunerate the contribution for a maximum amount of EUR 3,338,746,885.52 by issuing a maximum of 45,144,018 new shares without nominal value.
The New Shares will be ordinary shares issued by the Company and created under Belgian law. They will have the same property and membership rights as the Company's pre-existing shares. They will share in the result of the Company as from 1 January 2025 and will be issued with coupons no. 361 and following attached. From the actual issue of the New Shares (expected mid-October 2025 for the initial acceptance period, and possibly later due to any Voluntary and/or Mandatory Reopenings), both the existing shares and the New Shares will be traded with coupon no. 36 and following attached and will therefore have the same dividend rights.
No special benefits are granted.
1 Coupon No. 35 represented Aedifica's Distributed 2024 Gross Dividend, which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025.

In accordance with articles 7:197 and 7:179 of the Belgian Code of Companies and Associations (hereinafter referred to as the "BCCA"), we hereafter submit to the extraordinary general meeting of the public limited liability company Aedifica (hereinafter the "Company") our conclusions in the context of our assignment as Statutory Auditor, for which we were appointed by letter of engagement of 17 April 2025.
We have carried out our mission in accordance with the Standard on the mission of the auditor in the context of contribution in kind and quasi-contribution of the Institute of Auditors ("Instituut van de Bedrijfsrevisoren").
Our responsibilities under this standard are further described in the section « Responsibilities of the Statutory Auditor with regard to the contribution in kind and the issue of shares ».
In accordance with Article 7:197 of the BCCA, we have examined the following aspects, as included in the report of the board of directors received on 4 June 2025, and have no material findings to report regarding:
Tevens concluderen wij dat de waarden waartoe de weerhouden methoden van waardering voor de inbreng in natura leiden, ten minste overeenkomen met het aantal en de nominale waarde of, bij gebrek aan een nominale waarde, de fractiewaarde van de tegen de inbreng uit te geven aandelen die in het verslag van het bestuursorgaan worden vermeld, in voorkomend geval, met verhoogd met de uitgiftepremie.
We also conclude that the values to which the methods of valuation of the contribution in kind are used correspond at least to the number and nominal value or, in the absence of a nominal value, the par value of the shares to be issued against the contribution that are mentioned in the report of the board of directors, where applicable, increased by the issue premium.
The realisation of the intended capital increase by contribution in kind of the Cofinimmo Shares is subject to the realisation of the conditions precedent as described in chapter 2.3 of this report and for this reason no draft notarial deed is available on the date of signature of the present report.

The actual remuneration of the contribution in kind consists of 1.185 new shares of the Company per share issued by Cofinimmo in the context of the proposed exchange offer. Consequently, the total actual remuneration consists of a maximum of 45,144,018 new shares of the Company, without nominal value, and is related to the choice of the shareholders of Cofinimmo to make use of the proposed exchange offer of Aedifica nv for all shares issued by Cofinimmo in exchange for new shares of Aedifica nv. Taking into account the total value of the contribution, an amount of maximum EUR 1,191,250,587.04 will be subscribed as capital (with the balance of maximum EUR 2,147,496,298.48 being booked as issue premium). The new shares, with coupon no. 361 attached, issued as a result of this capital increase, will be included in the result as of 1 January 2025.
Based on our assessment of the accounting and financial data included in the special report of the board of directors, which has been prepared in accordance with article 7:179 of the BCCA, nothing has come to our attention that leads us to believe that these data, which include the justification of the issue price and the consequences for the property and membership rights of the shareholders, are not faithful in all material respects and sufficient in all their significant aspects to inform the general meeting which is to vote on the proposed transaction.
Our assignment in accordance with Article 7:197 of the BCCA is not to rule on the suitability or opportunity of the transaction, including the valuation of the remuneration given in return for the contribution, nor on the question whether that transaction is lawful and equitable (« no fairness opinion »).
Due to adjustments to the proposed exchange offer, this current report replaces the earlier signed report dated 5 May 2025.
The board of directors is responsible for:
The board of directors is responsible for:
the justification of the issue price; and
1 Coupon No. 35 represented Aedifica's Distributed 2024 Gross Dividend, which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025.

the description of the impact of the transaction on the property and membership rights of the shareholders.
The Statutory Auditor is responsible for:
The Statutory Auditor is responsible for:
the assessment of whether the financial and accounting information – included in the special report of the board of directors that includes the justification of the issue price and the impact on the property and membership rights of the shareholders – is true in all material respects and sufficient to enable the general meeting to vote on the proposal.
This report was drawn up solely pursuant to articles 7:197 and 7:179 of the BCCA in the context of the capital increase of the public limited liability company Aedifica by means of a contribution in kind and the issue of new shares and may not be used for any other purpose.
Brussels, 4 June 2025
EY Bedrijfsrevisoren bv Statutory Auditor Represented by
Christophe Boschmans* Partner *Acting on behalf of a bv
25CBO0256
SUBJECT TO CERTAIN EXCEPTIONS, THIS DOCUMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISCLOSURE OTHERWISE, WHETHER DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA, THE UNITED KINGDOM OR ANY OTHER STATE OR JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE LAWS OF THAT JURISDICTION OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED, OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER BELGIAN LAW.
THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER, OR ANY SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN AEDIFICA OR COFINIMMO.
ANY OFFER WILL BE MADE ONLY IN COMPLIANCE WITH THE BELGIAN TAKEOVER ACT AND THE BELGIAN TAKEOVER DECREE (EACH AS DEFINED HEREIN), AND BY MEANS OF A PROSPECTUS TO BE APPROVED BY THE FSMA PURSUANT TO THE TAKEOVER DECREE AND SUBJECT TO THE TERMS AND CONDITIONS TO BE SET OUT THEREIN.
Limited liability company Public regulated real estate company under Belgian law Registered office: Rue Belliard 40 (box 11), 1040 Brussels Company number: 0877.248.501 (RPR Brussels) ("Aedifica" or the "Company")
This document and the information it contains are provided to you in accordance with the requirements of Belgian law and only in your capacity as a shareholder of Aedifica for the purpose of exercising your voting rights in Aedifica and in no other capacity, and may not be used or relied upon for any other purpose or for any other decision, including an investment decision to acquire, buy, subscribe for, sell or exchange securities (or any offer or solicitation of an offer to do so).
This document does not constitute an offer to acquire, buy, subscribe for, sell or exchange securities (or the solicitation of an offer to acquire, buy, subscribe for, sell or exchange securities) in or from the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Switzerland, South Africa, the United Kingdom or any other jurisdiction where it would constitute a violation of the laws of such jurisdiction, and no such offer (or solicitation) may be made in any such jurisdiction. Any failure to comply with this restriction may constitute a violation of US, Australian, Canadian, Hong Kong, Japanese, South African, Swiss, UK, New Zealand or other applicable securities law. Any persons reading this announcement should inform themselves of and observe any such restrictions.
The securities discussed herein have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act") or the securities laws of any state of the United States, and may not be offered, sold or delivered, directly or indirectly, in or into the United States without registration, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable state and other securities laws of the United States. There will be no public offering of securities in the United States.
In the United Kingdom, this document is being communicated only to persons who are (i) existing members or creditors of Aedifica or other persons falling within Article 43 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or (ii) any other person to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000, as amended) may otherwise lawfully be communicated or caused to be communicated.
This document and the information contained herein are intended solely for the recipient of this document and the publication, distribution, transmission, forwarding or transmission of this document or the information contained herein to any other person may violate the US Securities Act or other applicable laws.
The Proposed Exchange Offer (as defined and as further described herein), if and when made, will be made for all of the issued and outstanding shares of Cofinimmo, which is a public regulated real estate company in the form of a public limited liability company under Belgian law, and will be subject to Belgian disclosure and procedural requirements. The Proposed Exchange Offer will be made to Cofinimmo shareholders in the United States in compliance with the applicable US tender offer rules under the US Securities Exchange Act of 1934, as amended (the "US Exchange Act"), and otherwise in accordance with the requirements of Belgian law. Accordingly, the Proposed Exchange Offer will be subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the proposed timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer law and practice. The financial information included in this document or to be included in the prospectus for the Proposed Exchange Offer has been prepared in accordance with (EU) IFRS, and will not have been prepared in accordance with US GAAP, or derived therefrom, and may therefore differ from, and not be comparable with, financial information of US companies.
Aedifica and Cofinimmo and their respective affiliates or brokers (acting as agents for Aedifica, Cofinimmo or their affiliates, as applicable) may from time to time, and other than pursuant to the Proposed Exchange Offer, directly or indirectly, purchase, or arrange to purchase outside the United States, shares in Cofinimmo or any securities that are convertible into, exchangeable for or exercisable for such shares before or during the period in which the Proposed Exchange Offer remains open for acceptance, to the extent permitted by, and in compliance with, Rule 14e-5 under the US Exchange Act. Any such purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices. To the extent required in Belgium, any information about such purchases will be made public in Belgium in the manner required by Belgian law. To the extent information about such purchases or arrangements to purchase is made public in Belgium, such information will be disclosed by means of a press release or other means reasonably calculated to inform persons in the United States of such information. In addition, affiliates of the financial adviser to Aedifica may engage in ordinary course trading activities in securities of Cofinimmo, which may
include purchases or arrangements to purchase such securities.
Neither the US Securities and Exchange Commission nor any US state securities commission has approved or disapproved of the Proposed Exchange Offer, passed upon the merits or fairness of the Proposed Exchange Offer, or determined if this document, the prospectus or other Proposed Exchange Offer documents are accurate or complete. Any representation to the contrary is a criminal offence in the United States.
The Proposed Exchange Offer, if consummated, may have consequences under US federal income tax and applicable US state and local, as well as non-US, tax laws for Cofinimmo shareholders. Each Cofinimmo shareholder is urged to consult his or her independent professional adviser regarding the tax consequences of the Proposed Exchange Offer.
It may not be possible for Cofinimmo shareholders in the United States to effect service of process within the United States upon Aedifica, Cofinimmo, or their respective officers or directors, some or all of which may reside outside the United States, or to enforce against any of them judgments of the United States courts predicated upon the civil liability provisions of the federal securities laws of the United States or other US law. It may not be possible to bring an action against Aedifica, Cofinimmo, or their respective officers or directors (as applicable), in a non-US court for violations of US law, including the US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgement. In addition, it may be difficult to enforce in Belgium original actions, or actions for the enforcement of judgments of US courts, based on the civil liability provisions of the US federal securities laws
The securities mentioned herein may not be publicly offered, directly or indirectly, in Switzerland within the meaning of the Swiss Financial Services Act ("FinSA") (unless in circumstances falling within article 36 of the FinSA), and no application has been made or will be made to admit the securities to trading on any trading venue (i.e., exchange or multilateral trading facility) in Switzerland. Neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities constitutes a prospectus within the meaning of the FinSA, and neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities may be publicly distributed or otherwise made publicly available in Switzerland.
Neither this document nor the prospectus or any other offering or marketing material relating to the Proposed Exchange Offer or the securities has been or will be filed with or approved by any Swiss regulatory authority. In particular, the prospectus will not be reviewed or approved by a Swiss reviewing body (Prüfstelle) pursuant to article 51 of the FinSA and does not comply with the disclosure requirements applicable to a prospectus within the meaning of article 35 of the FinSA.
The Board of Directors of the Company hereby submits to the shareholders of the Company its special report, which has been prepared in accordance with Articles 7:179, §1, first subparagraph and 7:197, §1, first subparagraph of the Belgian Code of Companies and Associations (the "BCCA") and Article 26, §2 of the Belgian Act of 12 May 2014 on regulated real estate companies, as amended (the "RREC Act"). The special report relates to the proposed capital increase by contribution in kind of shares of Cofinimmo against the issue of new shares of the Company in the context of the Proposed Exchange Offer (as defined below) which the Company intends to issue on all shares issued by Cofinimmo.
In accordance with Article 7:197, §1, first subparagraph of the BCCA, the Board of Directors, in this report, justifies why the contribution is in the interest of the Company, describes each contribution in kind, motivates the valuation of each contribution in kind and indicates the consideration for the contribution. In accordance with Article 7:179, §1, first subparagraph of the BCCA, the Board of Directors also justifies the issue price and describes the impact of the transaction on the shareholders' property and membership rights. In accordance with 7:197, §1, first subparagraph of the BCCA, this report has been submitted in draft form to the Company's Statutory Auditor, Ernst & Young Bedrijfsrevisoren BV, represented by Mr. Christophe Boschmans (the "Statutory Auditor").
Pursuant to Article 26, §2 of the RREC Act, in the event of a capital increase by contribution in kind in a regulated real estate company, the contribution report of the Board of Directors of the company in which the contribution is made must also mention the identity of the contributors (see section 1 of this report), as well as the impact of the proposed contribution on the situation of the former shareholders, in particular as regards their share in the profit, in the net value per share and in the capital, and the impact in terms of voting rights (see section 4 of this report).
The Statutory Auditor has subsequently, in accordance with Articles 7:179, §1, second subparagraph and 7:197, §1, second subparagraph of the BCCA prepared his own report in which he (i) assesses whether the financial and accounting information contained in this report of the Board of Directors is true and fair in all material respects and sufficient to inform the reader thereof and (ii) examines the valuation applied by the Board of Directors in this report and the valuation methods used for that purpose and indicates whether the valuations to which the valuation methods applied by the Board of Directors in this report have led, correspond at least to the number and par value and, if applicable, the issue premium, of the shares to be issued against the contribution (see section 5 of this report). The Statutory Auditor's full report is attached as Annex 1 to this report
This report, as well as the Statutory Auditor's report, will be filed with the registry of the Commercial Court of Brussels in accordance with Articles 7:179, §1, third subparagraph and 7:197, §1, fourth subparagraph of the BCCA.
Both reports will be submitted to the Company's Extraordinary General Meeting to be held on or about 11 July 2025 which will decide, inter alia, on the proposed capital increase by contribution in kind in the context of the Proposed Exchange Offer which the Company intends to launch on all shares issued by Cofinimmo.
Cofinimmo is a public regulated real estate company under the form of a public limited liability company under Belgian law, with its registered office at Tervurenlaan 270, 1150 Sint-Pieters-Woluwe (Belgium) and registered with the Belgian Crossroads Bank for Enterprises under number 0426.184.049 (RLE Brussels), whose shares are listed on the regulated market of Euronext Brussels.
The capital of Cofinimmo at the date of this report amounts to EUR 2.041.523.111,02 and is represented by 38.096.217 ordinary shares, without nominal value, which are fully paid up. The Company intends to launch a voluntary and conditional (see section 2.1 of this report) public takeover offer by way of exchange for all shares issued by Cofinimmo (with coupon no. 411 et seq. attached) (the "Cofinimmo Shares") against the issuance of new shares of the Company (the "Proposed Exchange Offer").
Accordingly, during the acceptance period of the Proposed Exchange Offer, which may/will be reopened voluntarily or compulsorily in certain cases (including but not limited to reopening pursuant to Article 35 and/or Articles 42 and 43 of the Belgian Royal Decree of 27 April 2007 on public tender offers as amended (the "Takeover Decree")) or as required by the applicable US tender offer rules under the US Securities Exchange Act of 1934, as amended (the "US Exchange Act") (hereinafter also referred to as "Voluntary and/or Mandatory Reopening(s)"), all shareholders of Cofinimmo will be offered the opportunity to tender their Cofinimmo Shares with a view to contributing them in kind to the Company in exchange for new shares to be issued by the Company.
With the exception of BlackRock Inc, which, according to the transparency notification published by Cofinimmo on its website pursuant to the Belgian Law of 2 May 2007 on disclosure of major shareholdings, held 5.42% of the Cofinimmo Shares on 23 May 2025 (being 2.064.046 shares), the specific identity of the remaining shareholders of Cofinimmo is not known to the Company. For purposes of Article 26, §2, 1° RREC Act, the contributors are thus identified as being the shareholders of Cofinimmo who will accept the Proposed Exchange Offer, as well as, as the case may be, the shareholders whose Cofinimmo Shares would pass to the Company by operation of law in the context of any (simplified) squeeze-out following the Proposed Exchange Offer pursuant to Articles 42 and 43 of the Takeover Decree (a "Squeeze-out Offer").
1 Coupon no. 41 is the dividend coupon that goes attached to the Cofinimmo Share at the moment when the acceptance period of the Proposed Exchange Offer is opened. Coupon no. 40, representing Cofinimmo's Distributed 2024 Gross Dividend, was , following the decision of Cofinimmo's general meeting of shareholders on 14 May 2025, detached from the Cofinimmo share on 19 May 2025 and became payable as of 22 May 2025..
On 30 April 2025, the stock prices of Cofinimmo and Aedifica were suspended by the FSMA2 due to a significant increase in the trading volume of the Cofinimmo Share on Euronext Brussels. Therefore, (i) the undisturbed stock price of Cofinimmo of EUR 67.00 on April 30, 2025, at 16:02 Brussels time (i.e., Cofinimmo's stock price before the significant increase in trading volume that led to the suspension) ("Cofinimmo's Undisturbed Share Price") and (ii) the undisturbed stock price of Aedifica of EUR 69.75 on April 30, 2025, at 16:02 Brussels time (i.e., Aedifica's stock price before the significant increase in trading volume of the Cofinimmo Share, which subsequently also led to the suspension of the Aedifica share on Euronext Brussels) ("Aedifica's Undisturbed Share Price") are taken into account in the context of the Proposed Exchange Offer.
Following discussions between the boards of directors of Aedifica and Cofinimmo in the wake of the Announcement (as defined hereafter in section 2 of this report) and Aedifica's initial convening of its extraordinary general meeting of shareholders on 13 May 2025 to approve the proposed exchange offer at an exchange ratio of 1.163 , the board of directors of Cofinimmo agreed to support the proposed exchange offer, provided that an exchange ratio of 1.185 is applied.
The board of directors of Aedifica acknowledges that this support significantly increases the likelihood of the proposed exchange offer's success and will greatly facilitate the integration of Cofinimmo into Aedifica following the transaction. As a result, Aedifica's board has decided to adjust the exchange ratio to 1.185 New Sharesshares per Cofinimmo Share. According to Aedifica, this revised ratio reflects a fair value distribution for the shareholders of both companies. Moreover, it enhances the certainty of acceptance of the Proposed Exchange Offer, supports a smooth integration process, and creates long-term value for all stakeholders.
Through the joint press release of 3 June 2025, (i) Aedifica announced the adjustment of the original exchange ratio of 1.16 under the proposed exchange offer to the revised ratio of 1.185, and the cancellation of its previously scheduled extraordinary general meeting of shareholders on 12 June 2025, replacing it with a newly convened extraordinary general meeting on 11 July 2025, during which the revised Proposed Exchange Offer with an Exchange Ratio of 1.185 will be submitted for approval; and (ii) the board of directors of Cofinimmo formally expressed its support for the revised Proposed Exchange Offer.4
The Board of Directors proposes to increase the capital of the Company by contribution in kind of all Cofinimmo Shares effectively offered by the shareholders of Cofinimmo under the Proposed Exchange Offer against new shares issued by the Company.
The aspects of the proposed transaction are explained in detail below. In this context, reference is also made to the contents of the announcement of the intention to make the Proposed Exchange Offer, published by the Company, in application of Article 8 §1 of the Takeover Decree, on 1 May 2025 ( (the "Announcement"). 5
2 The Belgian Financial Services and Markets Authority.
3 https://aedifica.eu/transactions-2025/
4 https://aedifica.eu/transactions-2025/
5 See https://aedifica.eu/transactions-2025/
To maintain consistency with Cofinimmo's financial reporting, the EPRA net tangible asset value ("EPRA NTA")6 per Cofinimmo Share as communicated by Cofinimmo was used in the Announcement. For the calculation of the EPRA NTA per share (a financial parameter used in this report to determine the contribution value per Cofinimmo Share in the context of the Proposed Exchange Offer, see section 2.4.1 of this report), as well as the IFRS NAV7 per share, the EPRA NRV8 per share, and the EPRA NDV9 per share (all financial parameters used in this report to provide additional context to the Exchange Ratio, see section 2.5.1(c) of this report), Cofinimmo does not take into account the (18,298) treasury shares it holds. Therefore, these financial parameters as communicated by Cofinimmo only consider 38,077,919 Cofinimmo Shares instead of the total number of outstanding Cofinimmo Shares (38,096,217). Since the Proposed Exchange Offer pertains to all outstanding (38,096,217) Cofinimmo Shares, the mentioned financial parameters, when used in this report10, must take into account all outstanding (38,096,217) Cofinimmo Shares.11 Consequently, the values of these financial parameters in this report differ from those communicated by Cofinimmo, as follows:
Therefore, when this report refers to these financial parameters "as published by Cofinimmo on 25 April 2025, in its Q1 2025" or "as of 31 March 2025," the above corrected values are meant13.
The realization of the Proposed Exchange Offer, and as a consequence, the realization of the proposed capital increase by contribution in kind of the Cofinimmo Shares, is subject to the realization of the following conditions precedent (the " Conditions Precedent"):
6 EPRA NTA is a generally recognised financial parameter publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association, and is calculated as IFRS Equity - hybrid instruments that do not contribute to equity attributable to owners + revaluation of investment property (IP) if the IAS 40 cost option is used + revaluation of long-term investments + revaluation of leases held as finance leases + revaluation of trading properties - deferred tax (DT) relating to fair value gains on IP (rules based approach with three options for adding a certain percentage of DT) - fair value of financial instruments - goodwill due to deferred taxes - goodwill as per the IFRS balance sheet - intangible assets as per the IFRS balance sheet + fair value of fixed-income debt + revaluation of intangible assets to fair value + property transfer taxes.
7 The IFRS Net Asset Value ("IFRS NAV") refers to the net asset value calculated in accordance with IFRS.
8 The EPRA Net Reinstatement Value ("EPRA NRV") assumes that the company will never sell its assets and provides an estimate of the amount needed to reconstitute the company's assets.
9 The EPRA Net Disposal Value ("EPRA NDV") represents the value attributable to the company's shareholders in a scenario where the assets are sold, leading to the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, all net after tax.
10 With the exception of the EPRA NTA per share used in the context of the Conditions Precedent (as defined in section 2.1 of this report), which pertains to the EPRA NTA per Cofinimmo Share as calculated and communicated by Cofinimmo in its Q1 2025 results.
11 For clarity, the financial parameters as communicated by Aedifica do take into account the total number of outstanding Aedifica shares, and therefore such a correction is not necessary on Aedifica's side. For readability purposes, these figures are rounded to two decimal places throughout this report.
12 For readability purposes, these figures are rounded to two decimal places throughout this report.
13 Unless expressly stated otherwise, as in section 2.1 of this report.
14 The benchmark stock market index of Euronext Brussels
15 The FTSE EPRA Nareit Developed Europe Index tracks European listed real estate investment trusts (REITs) and real estate companies and provides a diverse representation of the real estate market in developed countries in Europe, both geographically and by property type.
These Conditions Precedent are determined for the sole benefit of the Company, which, in the context of the Proposed Exchange Offer will reserve the right to, pursuant to a decision of its Board of Directors, waive them, in whole or in part. No later than the last day of the (initial) acceptance period of the Proposed Exchange Offer, Aedifica will announce whether or not the above Conditions Precedent have been satisfied and, as the case may be, if any of the above Conditions Precedent have not been satisfied, whether or not it waives them. In case the Company cahoses to waive such Condition Precedent at that point in time, the (initial) acceptance period of the Proposed Exchange Offer will be closed and the Proposed Exchange Offer will be voluntarily reopened by the Company, in order to comply with the requirement under US law that the Proposed Exchange Offer must then remain open for at least 5 (US) business days (the voluntary reopening then being deemed an opening of the (initial) acceptance period for US purposes), the foregoing without prejudice to the right not to waive the Conditions Precedent yet and to voluntarily extend the Proposed Exchange Offer.
At the date of this report, the Company has a capital amounting to EUR 1,254,742,260.03 represented by 47,550,119 ordinary shares, without nominal value, which are fully paid up. The par value per share is therefore EUR 26.39 (rounded to the euro cent for readability reasons). The shareholder structure of the Company at the date of this report is as follows:
| Shareholder | Number of shares/voting rights |
Percentage (rounded) |
|---|---|---|
| BlackRock Inc.16 | 3,496,568 | 7.35% |
| Other shareholders | 44,053,551 | 92.65% |
| Total | 47,550,119 | 100% |
The proposed contribution in kind consists of the Cofinimmo Shares to be effectively tendered to the Company by the shareholders of Cofinimmo under the Proposed Exchange Offer (the "Contribution")
At present, the Company does not hold any Shares in Cofinimmo. Accordingly, the extent to which the Company will succeed in acquiring the issued Cofinimmo Shares through the Proposed Exchange Offer
16 On the basis of the transparency notification of 7 October 2024 that was provided to the Company. The capital of the Company (and thus the total number of outstanding shares in the Company) has not changed since the date of this notification.
will depend entirely on the extent to which the shareholders of Cofinimmo will accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings).
In connection with the Proposed Exchange Offer and any subsequent Voluntary and/or Mandatory Reopenings, a maximum total of 38,096,217 Cofinimmo Shares will be contributed to the Company by way of contribution in kind in exchange for a maximum of 45,144,018 New Shares (as defined below) issued by the Company based on the Exchange Ratio (as defined below).
In respect of shareholders outside the Member States of the European Economic Area (whereby applicable securities laws may affect the offer), the sale and delivery of the New Shares pursuant to the Proposed Exchange Offer will take place as follows in the specific below jurisdictions:
(iii) only shareholders of Cofinimmo in Switzerland who qualify as "professional clients" as defined in Article 4 of the Swiss Financial Services Act ("Finanzdienstleistungsgesetz") of 15 June 2018, as amended (the "FinSA") ("Swiss QIBs"), will be entitled to participate in the Proposed Exchange Offer in accordance with the prospectus exemption provided for in Article 36 FinSA.
The Proposed Exchange Offer will not be made in or into, and cannot be accepted in or from, Australia, Canada, Hong Kong, Japan, South Africa, New Zealand, or any other jurisdiction where doing so would constitute a violation of the laws of that jurisdiction.
Any fractions of New Shares that should be issued pursuant to the Exchange Ratio to a particular Cofinimmo sharehodler (i.e, a holder of Cofinimmo Shares who should receive in exchange for his/her Cofinimmo Shares a number of New Shares which does not solely consist of a whole number and is therefore partly a fraction of a New Share) who accepts the (initial) Proposed Exchange Offer or any Voluntary and/or Mandatory Reopenings (the "Fractions of New Shares"), will not be issued as such to the relevant Cofinimmo shareholder, but will, together with any New Shares that would have been payable to US Non-QIBs pursuant to their contribution of Cofinimmo Shares in the Proposed Exchange Offer, be included in the Dribbling Out (or alternatively - depending on volume - Vendor Placement) at the closing of the (initial) acceptance period of the Proposed Exchange Offer or at the closing of any Voluntary and/or Mandatory Reopenings, as defined and further set out in section 2.8 of this report.
The aforementioned Contribution and the resulting capital increase of the Company under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, will be submitted as a whole for approval to the Extraordinary General Meeting of shareholders of the Company to be held on or about 11 July 2025. The Extraordinary General Meeting of shareholders of the Company will also be asked to grant a delegation to any two members of the Board of Directors (acting together) to, inter alia, in the event of a successful Proposed Exchange Offer (being upon fulfilment - or waiver – of all Conditions Precedent) and, as the case may be, in one or more instances, subject to any Voluntary and/or Mandatory Reopenings based on the number of holders of Cofinimmo Shares who, during such acceptance period(s),accept the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)), to determine the number of Cofinimmo Shares that were tendered by the shareholders of Cofinimmo in the context of the Proposed Exchange Offer, and thus to determine and implement the realization of the capital increase by contribution in kind to the Company on that basis in one or more times in accordance with Article 7:186 of the BCCA.
If the Proposed Exchange Offer is successful, but the Company has failed to acquire at least 95% of the Cofinimmo Shares during the Proposed Exchange Offer (including any Voluntary and/or Mandatory Reopenings)17, the capital, in application of Section 7:181 of the BCCA, will only be increased by the amount of the subscriptions issued.
17 If, following the acceptance period under the Proposed Exchange Offer, the Company holds at least 95% of the Cofinimmo Shares and has acquired at least 90% of the Cofinimmo Shares that were the subject of the Proposed Exchange Offer (as the Proposed Exchange Offer relates to all Cofinimmo Shares issued by Cofinimmo, the latter condition will always be fulfilled in the event the Company holds 95% of the Cofinimmo Shares following the acceptance period), the Company has the right and the intention, in accordance with Article 7:82, §1 CC and Articles 42 and 43 of the Takeover Decree, to require the remaining Cofinimmo Shareholders to exchange their Cofinimmo Shares for the shares in the Company at the Exchange Ratio.
The value per Cofinimmo Share to be contributed by Cofinimmo shareholders under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, has been determined starting from the EPRA NTA per Cofinimmo Share as per 31 March 2025 of EUR 94.53, as published by Cofinimmo on 25 April 2025 in its Q1 2025 results, where:
observed on a sample of companies (admitted to trading on regulated markets) comparable to Cofinimmo's office portfolio.
Other than as part of the amount of the EPRA NTA as per 31 March 2025, in determining the Contribution Value of the Cofinimmo Shares and the Issue Price of the New Shares (see section 2.5.2 of this report), and therefore in determining the Exchange Ratio (see section 2.5.1 of this report), no further adjustments have been made for the pro rata earnings for the remainder of 2025, as these earnings appear to be subject to seasonal influences after 31 March 2025 and, in addition, are affected by the commencement of leasing of just-completed development projects (which are often delayed), making a reasonable and accurate forecast thereof impossible.
18 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places throughout this report.
19 For reasons of readability, this number is rounded to two decimal places throughout this report.
Based on the foregoing and the adjustments described in (i) and (ii) above, the contribution value per Cofinimmo Share has thus been established at EUR 87.6420 (the "Contribution Value").
Section 2.5.1 of this report provides an overview of the valuation methods used to determine the Exchange Ratio and the reference points that provide context to the Exchange Ratio, which after the adjustment remains within these reference points.
A detailed explanation of the method and rationale used to determine the value of Cofinimmo and the Cofinimmo Share in connection with this Proposed Exchange Offer is attached to this report as Annex 2. Annex 2 also indicates which valuation methods were not retained given the nature of the transaction and the activities of Cofinimmo and the Company.
In accordance with Article 49, §1, first paragraph of the RREC Act, the fair value of any asset to be acquired or transferred by the Company (and its subsidiaries) that is mentioned in Article 47, §1, of the RREC Act must be appraised by the real estate expert(s) before the transaction takes place. This applies if the transaction, considered as a whole, represents an amount higher than the lower of either 1% of the Company's consolidated assets or EUR 2,500,000.
Since shares in a public regulated company (such as the Cofinimmo Shares) are not included in the assets listed in Article 47, §1, of the RREC Act, the aforementioned rule of Article 49 of the RREC Act does not apply to the present contribution in kind of Cofinimmo Shares to the Company in the context of the Proposed Exchange Offer.
Furthermore, it should be noted that:
Taking the above points into account, the valuation of the assets, listed in Article 47, §1, of the RREC Act, held by Cofinimmo as of 31 March 2025, is thus included in the net value per Cofinimmo Share as per 31 March 2025, of EUR 94.53, which, as indicated above, is used as the basis for the valuation of the Contribution
Based on the foregoing, the method for valuing the Cofinimmo Share is considered adequate for the proposed contribution of Cofinimmo Shares in the context of the Proposed Exchange Offer and is
20 For reasons of readability, this number is rounded to two decimal places throughout this report.
deemed to be an economically justified method. There is no deviation from the report of the Statutory Auditor, attached as Annex 1 to this report.
The Contribution Value per Cofinimmo Share is thus EUR 87.64. Taking into account that the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, covers 38,096,217 Cofinimmo Shares, this means that the total Contribution Value will amount to a maximum of EUR 3,338,746,822.28 .
The Company offers, for each Cofinimmo Share contributed in the Proposed Exchange Offer, 1.185 newly issued shares by the Company (the "New Shares") (the "Exchange Ratio").
The determination of the Exchange Ratio is based on the valuation of both Cofinimmo and the Company, resulting in the Contribution Value of the Cofinimmo Shares and the Issue Price of the New Shares of the Company.
The valuation method used to obtain these values, which lead to the Exchange Ratio, is the "Adjusted EPRA NTA Analysis," as previously mentioned and briefly outlined below in this report, as well as in more detail in section 2.1, I of Annex 2 to this report. To further substantiate the Exchange Ratio (determined based on the aforementioned "Adjusted EPRA NTA Analysis") and provide a comparison point, the Company has also conducted a valuation based on a "Discounted Cash Flow Analysis", briefly outlined below in this report and in more detail in section 2.1, II of Annex 2 to this report.
Additionally, the Company has provided further reference points (for both Cofinimmo and the Company) to give context to the Contribution Value of Cofinimmo and the Issue Price of the Company, and thus to the Exchange Ratio, based on:
These additional reference points are also briefly outlined below in this report and in more detail in section 2.2 of Annex 2 to this report. For information, the transaction comparables valuation approach was not deemed to be appropriate given the lack of recent all-share completed transactions within the listed universe of Healthcare focused Real Estate Investment Trusts in Europe.
Finally, the Company also outlines in this report, as well as in more detail in section 2.3 of Annex 2 to this report, the premium, respectively, discount to which the Implied Offer Price (as defined hereinafter), respectively, the Exchange Ratio lead with respect to a number of reference points.
Both parties operate healthcare-focused real estate portfolios with the same core locations (Belgium, Germany, Ireland, the Netherlands, the UK, and Finland) and use similar methods to evaluate the fair value of their respective assets. The Exchange Ratio is calculated based on the Company's knowledge as of 30 April 2025 (at 16h02 Brussels time), particularly based on the public Q1 2025 results of the Company and Cofinimmo with figures as of 31 March 2025.
EPRA NTA is a generally recognised financial measure publicly disclosed by both the Company and Cofinimmo in accordance with the guidelines of the European Public Real Estate Association. The Company considers EPRA NTA to be the most common and recognised valuation model for assessing the market value of a real estate company's net assets.
In evaluating the relative value of the Company and Cofinimmo to determine the Exchange Ratio, the Company adopted an industry-specific approach. This method effectively takes into account the unique market dynamics and prospects of each segment within the portfolios of Cofinimmo and the Company, particularly healthcare for both entities and office and distribution networks for Cofinimmo.
Since the start of the COVID-19 pandemic, shares of companies in the office real estate sector have consistently traded at a structural undervaluation relative to their GAV. This trend reflects equity investors' view of the sector, given the pandemic's lasting impact on office real estate and concerns about remote working and hybrid work models. These factors have led to decreased demand for traditional office space, highlighting structural challenges and a low growth profile within the sector. Moreover, the Company has evaluated the observed GAV discount for listed office companies comparable to Cofinimmo's office portfolio, consisting of Merlin Properties, Icade, Fabege, CPI Europe, NSI, and CA Immo (the "Office Reference Group"), with an average and median Implied GAV Discount as of 30 April 2025, of 22.8% and 24.9%, respectively. For reference, the current Implied GAV Discount for Aedifica is 6.3%, highlighting the relative undervaluation of office portfolios compared to healthcare portfolios, which are valued without a GAV discount for both the Company and Cofinimmo. Partly based on this, the Company has decided to apply a discount to the GAV of Cofinimmo's office portfolio to account for observed market developments in the office sector, adjusted in function of the agreement reached between the board of directors of both companies (see also section 1 of this report) from 10.45% to 2.85%21. Further details on the observed discounts are described in section 2.1, I, a) of Annex 2 to this report.
Conversely, the Company has valued the assets in the healthcare sector at their full value, disregarding the current listing below GAV in this segment. Since the consideration for the transaction consists entirely of shares and given the comparability of the Company's portfolio with that of Cofinimmo in healthcare, the Company has valued the assets in the healthcare segment for both the Company and
21 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places in this report.
Cofinimmo at their full value. This decision reflects the positive market dynamics and growth potential inherent in the segment, as the healthcare sector continues to show strong growth prospects driven by favorable demographic trends, such as an aging population and increased life expectancy, which fuel the demand for healthcare services and facilities.
Given these factors, the Company has adjusted the reported EPRA NTA of both Cofinimmo and the Company for the calculation of the Exchange Ratio as follows:
"Cofinimmo's Adjusted EPRA NTA" (this is the total Contribution Value) is calculated based on the last reported EPRA NTA as of 31 March 2025:
| Portfolio segment | A | B | A x (1+B) = C |
|---|---|---|---|
| GAV (EUR million) as per 31 March 2025 |
Implied GAV Discount |
Market implied GAV (EUR million) |
|
| Healthcare | 4,626 | 0% | 4,626 |
| Office | 927 | (2.85%)23 | 900 |
| Distribution networks | 470 | 0% | 470 |
| Total | 6,023 | 5,996 | |
| Cofinimmo's GAV Adjustment (Delta between market implied GAV (C) and GAV (A) (EUR million) |
(26.5) |
A summary of Cofinimmo's GAV Adjustment is presented in the table below:
22 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability, it is rounded to two decimal places in this report.
Based on the above, the Adjusted EPRA NTA of Cofinimmo is set out below:
| EUR million | |
|---|---|
| Cofinimmo's EPRA NTA as per 31 March 2025 | 3,601 |
| (-) Cofinimmo's Distributed 2024 Gross Dividend | (236) |
| (-) Cofinimmo's GAV Adjustment | (26.5) |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 | 3,339 |
| (/)Last reported number of shares outstanding for Cofinimmo | |
| as per 31 March 2025 (million) | 38.1 |
| Cofinimmo's Adjusted EPRA NTA as per 31 March 2025 per | |
| share (EUR) (Contribution Value) | 87.64 |
For more details, reference is made to section 2.1, I, a) of Annex 2 attached to this report.
"Aedifica's Adjusted EPRA NTA" (this is the total Issue Price) is calculated based on the last reported EPRA NTA as of March 31, 2025, adjusted for Aedifica's Distributed 2024 Gross Dividend (as defined in section 2.5.2, (b) of this report), and is outlined in the table below:
| EUR million | ||
|---|---|---|
| Aedifica's EPRA NTA as per 31 March 2025 | 3,702 | |
| (-)Aedifica's Distributed 2024 Gross Dividend | (185) | |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 | 3,517 | |
| (/)Last reported number of shares outstanding for | ||
| Aedifica as per 31 March 2025 (million) | 47.6 | |
| Aedifica's Adjusted EPRA NTA as per 31 March 2025 per | ||
| share (EUR) (Issue Price) | 73.9624 |
Subsequently, the Exchange Ratio was determined by dividing Cofinimmo's Adjusted EPRA NTA per share (being the Contribution Value) (based on 38,096,217, the last reported number of outstanding shares for Cofinimmo as of 31 March 2025) by Aedifica's Adjusted EPRA NTA per share (being the Issue Price) (based on 47,550,119, the last reported number of outstanding shares for the Company as of 31 March 2025).
| Contribution Value - Cofinimmo (EUR) | 87.64 |
|---|---|
| (/) Issue Price - the Company (EUR) | 73.96 |
| Exchange Ratio | 1.185 |
This methodology is to calculate the value of the assets (net asset value) by discounting the expected unlevered free cash flows (where "Unlevered Free Cash Flow" means earnings before interest, taxes,
24 For reasons of readability, this number is rounded to two decimal places throughout this report.
depreciation and amortisation, less cash taxes and capital expenditure) that will be generated by these assets based on the business plans (based on equity research analyst estimates) of both Cofinimmo and the Company (with detailed assumptions set out in Annex 2 to this report).
The equity value attributable to the respective shareholders is detailed in the "Cofinimmo DCF valuation summary" and in the "Company DCF valuation summary" in section 2.1, II of Annex 2 to this report.
The valuation period of the DCF analysis includes 1 April 2025 (inclusive) up to and including 31 December 2027. The Unlevered Free Cash Flows were discounted using a conventional mid-year cash flow receipt, with the terminal value calculated using the Gordon Growth formula based on a normalized Unlevered Free Cash Flow. The terminal value was also discounted based on a conventional mid-year cash flow receipt.25
For both Cofinimmo and the Company, the DCF range was calculated based on a low range of 6.76% and 6.75% WACC and 1.50% TGP rate and a high range calculated as 5.76% and 5.75% WACC and 2.50% TGP. After separate DCF calculations for Cofinimmo and the Company, the implied DCF exchange ratio was derived based on:
| Low | Mid | High | |
|---|---|---|---|
| WACC: | WACC: | WACC: | |
| 6.76% / | 6.26% / | 5.76% / | |
| 6.75%26 | 6.25% | 5.75% | |
| TGR: 1.50% | TGR: 2.00% | TGR: 2.50% | |
| DCF Equity Value per share – Cofinimmo (EUR) | 65.20 | 95.33 | 143.95 |
| (/) DCF Equity Value per share – Aedifica (EUR) | 63.80 | 90.06 | 132.50 |
| DCF implied exchange ratio | 1.022x | 1.058x | 1.086x |
The table below shows the (implied) exchange ratios on the basis of historical share prices.
| Summary of the premium of the implied exchange ratio compared to historical exchange ratios: |
Value per Cofinimmo Share |
Value per share of the Company |
exchange ratio |
|---|---|---|---|
| EUR | EUR | X Shares of the Company per 1 Cofinimmo Share |
|
| Undisturbed Share price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x |
| Undisturbed Share price | 67.00 | 69.75 | 0.961x |
25 The terminal value was calculated using the Gordon Growth formula, in which the 2027 Unlevered Free Cash Flow is increased by the terminal growth rate ("TGP") – to reflect the value of future Unlevered Free Cash Flows beyond 2027 – and divided by the weighted average cost of capital or WACC (as defined below) less the TGP (the "Terminal Value").
26 Respectively for Cofinimmo and Aedifica.
| 1-month VWAP up to 29 April 2025 | 61.76 | 63.31 | 0.976x |
|---|---|---|---|
| 3-month VWAP up to 29 April 2025 | 58.00 | 60.37 | 0.961x |
| 6-month VWAP up to 29 April 2025 | 59.16 | 60.47 | 0.978x |
| 12-month VWAP up to 29 April 2025 | 60.43 | 59.41 | 1.017x |
Cofinimmo's adjusted last reported EPRA NTA per share as of 31 March 2025 amounts to EUR 88.33, and is obtained by adjusting Cofinimmo's last reported EPRA NTA per share of EUR 94.53 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NTA per share of the Company as of 31 March 2025, amounts to EUR 73.96, and is obtained by adjusting the Company's last reported EPRA NTA per share of EUR 77.86 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NTA per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 88.33 and EUR 73.96 respectively, implies an exchange ratio of 1.194 New Shares per Cofinimmo Share.
Cofinimmo's adjusted last reported IFRS NAV per share as of 31 March 2025, amounts to EUR 88.27, and is obtained by adjusting Cofinimmo's last reported IFRS NAV per share of EUR 94.47 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported IFRS NAV per share of the Company as of 31 March 2025, amounts to EUR 74.00, and is obtained by adjusting the Company's last reported IFRS NAV per share of EUR 77.90 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported IFRS NAV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 88.27 and EUR 74.00 respectively, implies an exchange ratio of 1.193 New Shares per Cofinimmo Share.
Cofinimmo's adjusted last reported EPRA NRV per share as of 31 March 2025, amounts to EUR 96.63, and is obtained by adjusting Cofinimmo's last reported EPRA NRV per share of EUR 102.83 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NRV per share of the Company as of 31 March 2025, amounts to EUR 83.68, and is obtained by adjusting the Company's last reported EPRA NRV per share of EUR 87.58 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NRV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 96.63 and EUR 83.68 respectively, implies an exchange ratio of 1.155 New Shares per Cofinimmo Share.
• Last reported EPRA NDV adjusted for the Distributed 2024 Gross Dividends
Cofinimmo's adjusted last reported EPRA NDV per share as of 31 March 2025, amounts to EUR 92.03, and is obtained by adjusting Cofinimmo's last reported EPRA NDV per share of EUR 98.23 for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
The adjusted last reported EPRA NDV per share of the Company as of 31 March 2025, amounts to EUR 74.76, and is obtained by adjusting the Company's last reported EPRA NDV per share of EUR 78.66 for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
An exchange ratio based on the adjusted last reported EPRA NDV per share of Cofinimmo and the Company, each adjusted for their respective Distributed 2024 Gross Dividends, i.e., EUR 92.03 and EUR 74.76 respectively, implies an exchange ratio of 1.231 New Shares per Cofinimmo Share.
The median and average target prices of equity research analysts for Cofinimmo are EUR 65.00 and EUR 65.01 respectively as of 30 April 2025 (i.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend).
The median and average target prices of equity research analysts for the Company are EUR 71.00 and EUR 70.59 respectively as of 30 April 2025 (i.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend).
An exchange ratio based on the median and average target prices of equity research analysts for Cofinimmo and the Company implies respective exchange ratios of 0.915 and 0.921 New Shares per Cofinimmo Share.
The table below provides an overview of the (implicit) exchange ratios resulting from the Adjusted EPRA NTA analysis (resulting in the Exchange Ratio), the valuation method based on the "Discounted Cash Flow analysis" (to support and compare with the Exchange Ratio), as well as those resulting from the aforementioned reference points:
| Summary of the implied exchange ratios | A Value per Cofinimmo share |
B Value per Aedifica share |
A / B exchange ratio |
||
|---|---|---|---|---|---|
| EUR | EUR | X Shares of Aedifica per 1 Cofinimmo Share |
|||
| Adjusted EPRA NTA analysis (the valuation method) |
Cofinimmo 2.85%27 discount to Office Portfolio |
87.64 | 73.96 | 1.185 | |
| Valuation methodologies |
Low: Company: 6.75% WACC; Cofinimmo: 6.76% WACC, 1.50% TGR |
65.20 | 63.80 | 1.022 | |
| DCF | Mid: Company: 6.25% WACC; Cofinimmo: 6.26% WACC, 2.0% TGR High: Company: 5.75% WACC; |
95.33 | 90.06 | 1.058 | |
| Cofinimmo: 5.76% WACC, 2.50% TGR |
143.95 | 132.50 | 1.086 | ||
| Reference points to give |
Historical share price |
Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923 |
27 For the purposes of the calculations mentioned in this report, the exact figure is used. However, for readability reasons, it is rounded to two decimal places in this report.
| context to the Exchange Ratio |
performan ce analysis |
Undisturbed Share Price | 67.00 | 69.75 | 0.961 |
|---|---|---|---|---|---|
| 1 month VWAP up to 29 April 2025 | 61.76 | 63.31 | 0.976 | ||
| 3 month VWAP up to 29 April 2025 | 58.00 | 60.37 | 0.961 | ||
| 6 month VWAP up to 29 April 2025 | 59.16 | 60.47 | 0.978 | ||
| 12 month VWAP up to 29 April 2025 |
60.43 | 59.41 | 1.017 | ||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NTA adjusted for Distributed 2024 | 88.33 | 73.96 | 1.194 | |
| EPRA NTA | Gross Dividend | ||||
| Last | 31 March 2025 last reported IFRS | ||||
| reported | NAV adjusted for Distributed 2024 | 88.27 | 74.00 | 1.193 | |
| IFRS NAV | Gross Dividend | ||||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NRV adjusted for Distributed 2024 | 96.63 | 83.68 | 1.155 | |
| EPRA NRV | Gross Dividend | ||||
| Last | 31 March 2025 last reported EPRA | ||||
| reported | NDV adjusted for Distributed 2024 | 92.03 | 74.76 | 1.231 | |
| EPRA NDV | Gross Dividend | ||||
| Equity | Median | 65.00 | 71.00 | 0.915 | |
| research | |||||
| analysts' | |||||
| target price | Mean | 65.01 | 70.59 | 0.921 | |
| analysis28 |
The Exchange Ratio was determined based on the modified EPRA NTA, which is also shaded in the table.
Taking into account Aedifica's Undisturbed Share Price of EUR 69.75, the Exchange Ratio of 1.185 New Shares per Cofinimmo Share represents a value of EUR 82.6529 per Cofinimmo Share (the "Implied Offer Price"). By adjusting Aedifica's Undisturbed Share Price with Aedifica's Distributed 2024 Gross Dividend for the 2024 financial year of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), and multiplying the result by the Exchange Ratio of 1.185 New Shares per Cofinimmo Share, this represents a value of EUR 78.0330 per Cofinimmo Share (the "Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend"), as shown in the table below.
| Exchange Ratio (number of New Shares per Cofinimmo Share) - [A] | 1.185 | 1.185 |
|---|---|---|
| Aedifica's Undisturbed Share Price | 69.75 | 69.75 |
| Decreased with Aedifica's Distributed 2024 Gross Dividend | (3.90) | |
| Aedifica's Undisturbed Share Price adjusted for Aedifica's Distributed 2024 Gross Dividend - [B] |
69.75 | |
| Implied Offer Price per Cofinimmo Share (AxB) | 78.03 | 82.65 |
28 Prior to the payment of Cofinimmo's, respectively, Aedifica's Distributed 2024 Gross Dividend.
29 For readability reasons, this number is rounded to two decimal places throughout this report.
30 For readability reasons, this number is rounded to two decimal places throughout this report.
After analyzing various valuation methods, the Company is convinced that the Implied Offer Price per Cofinimmo Share and the Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend represent attractive and fair value propositions for Cofinimmo shareholders:
The Implied Offer Price of EUR 82.65 per Cofinimmo Share represents:
The Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 78.03 per Cofinimmo Share represents:
• a premium of 28.3% on Cofinimmo's Undisturbed Share Price, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the 2024 financial year (resulting in an adjusted share price of EUR 60.80).
The Exchange Ratio of 1.185 New Shares per Cofinimmo Share represents:
31 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
32 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
IFRS NAV per Aedifica share of 31 March 2025, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the 2024 financial year (resulting in an adjusted share price of EUR 74.00);
The aforesaid Exchange Ratio was determined starting from the Adjusted EPRA NTA of the Cofinimmo Share as per 31 March 2025, as set out in section 2.5.1 of this report, and the Adjusted EPRA NTA of the Company's share, which was determined at EUR 73.9633 per share (the "Issue Price") as further explained immediately below.
In accordance with Article 26, §2, 2°, first paragraph of the RREC Act, the Issue Price may not be less than the lower value of (a) a net asset value per share dating from no more than four months prior to the date of the Contribution Agreement or, at the option of the public regulated real estate company, prior to the date of the deed of capital increase, and (b) the average closing price during the thirty calendar days preceding the same date. The reference date was set by the Company as 31 March 2025, being less than four months before 1 May 2025 (i.e. the date on which the intention to launch the Proposed Exchange Offer was published by the Company pursuant to Article 8, §1 of the Takeover Decree). For purposes of the Proposed Exchange Offer, where (i) a public regulated property company makes an exchange offer to another public regulated property company, and (ii) the Extraordinary General Meeting of the bidder must be asked for approval of the Capital Increase, before giving notice of an exchange offer pursuant to Article 5 of the Takeover Decree, "contribution agreement" within the meaning of Article 26, §2, 2°, first paragraph of the RREC Act is to be read, according to the Company, as "the date on which the intention to launch the Proposed Exchange Offer in accordance with Article 8, §1 of the Takeover Decree was published by the Company".
Next, Article 26, §2, 2°, second paragraph of the RREC Act clarifies that, for the purposes of the first paragraph, it is allowed to deduct from the amount thus obtained an amount corresponding to the part of the undistributed gross dividend to which the new shares might not be entitled, provided that
33 For readability reasons, this number is rounded to two decimal places throughout this report.
the Board of Directors specifically justifies the amount to be deducted from the accumulated dividend in its special report and explains the financial terms of the transaction in its Annual Financial Report.
Article 26, §2 of the RREC Act determines the minimum issue price with which the New Shares issued in the context of the Proposed Exchange Offer must comply (and thus implicitly also the Exchange Ratio), referring for the determination of one of the two parameters to "the date of the contribution agreement" as the reference date for determining the minimum issue price of the New Shares to be issued.
In the case of a public takeover bid, there is strictly speaking no "contribution agreement". For the purposes of §2 of article 26 of the RREC Act, the disclosure in accordance with article 8, §1 Takeover Decree (whereby the Company expressed its intention to issue the Proposed Exchange Offer) should in this case be equated with a "contribution agreement", given that at that time the issue price and thus Exchange Ratio were also fixed and communicated.
Thus, (i) the maximum period of four months provided for in article 26, §2, 3° RREC Act does not apply in the context of the Proposed Exchange Offer and (ii) this allows the determination of the Issue Price and Exchange Ratio that are underlying the Proposed Exchange Offer at the time of disclosure of the Proposed Exchange Offer, on the basis of the most recent financial information at that time (by analogy with the FSMA's practice in the context of a mandatory takeover bid, of allowing the average stock price prior to the announcement of the proposed exchange offer (i.e., the moment of expressing the intention to make the proposed exchange offer) to be used as a reference point for the application of Article 53 of the Takeover Decree, instead of the average stock price prior to the time when the obligation to bid formally and legally comes to rest on the bidder). This reasoning is also analogous to the situation in mergers and demergers, where the RREC Act (Article 26, §3) explicitly equates the date of the transaction proposal with the date of the contribution agreement
As explained in section 1 of this report, pursuant to article 26, §2, 1° of the RREC Act, the identity of the contributors must be disclosed in this report. By definition, a public takeover bid is addressed to all shareholders of the target company at the time the takeover bid is open for acceptance. With the exception of BlackRock Inc, which, according to the transparency notification published by Cofinimmo on its website in accordance with the Belgian Law of 2 May 2007 on the disclosure of major shareholdings, held 5.42% of the Cofinimmo Shares on 23 May 2025, the specific identity of the other shareholders of Cofinimmo is not known to Aedifica. For purposes of Article 26, §2, 1° RREC Act, the contributors are thus identified in this report as being the Cofinimmo shareholders who will accept the Proposed Exchange Offer, as well as, as the case may be, the Cofinimmo shareholders whose Cofinimmo Shares would automatically pass to Aedifica in the context of any Squeeze-out Offer following the Proposed Exchange Offer.
The Issue Price has been determined starting from the Company's EPRA NTA as per 31 March 2025 of EUR 77.8634, as published by the Company on 29 April 2025 in its Q1 2025 results, deducting Aedifica's gross dividend in respect of financial year 2024 of EUR 3.90 per share (represented by coupon no. 35), which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was
34 For readability reasons, this number is rounded to two decimal places throughout this report.
detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025 ("Aedifica's Distributed 2024 Gross Dividend"). 35
A detailed explanation of the method and rationale used to determine the value of the Company and the Issue Price (and therefore, when combined with the valuation of Cofinimmo and the Cofinimmo Share, the Exchange Ratio) is referred to the notes in Annex 2 to this report.
The EPRA NTA of the Company's share as per 31 March 2025, as published on 29 April 2025 in the Company's Q1 2025 results, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 73.96, while the average closing price of the Company's share on the regulated market of Euronext Brussels during the thirty calendar days preceding 1 May 2025 (being EUR 64.17), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 per existing share in accordance with Article 26, §2, 2°, second paragraph of the RREC Act, amounted to EUR 60.27. Therefore, the determination of the Issue Price of EUR 73.96 is in accordance with the RREC Act.
As shown in the table below, the Issue Price of EUR 73.96 per New Share, as used in determining the Exchange Ratio, represents:
35 This deduction constitutes the application of the possibility thereof provided for in Article 26, §2, 2°, second paragraph of the GVV Act. The deduction is applied because Aedifica Distributed 2024 Gross Dividend of EUR 3,90 per existing share has been paid on 20 May 2025, i.e. in any event long in advance of the expected payment date under the Proposed Exchange Offer (see also section 2.6.2 of this report). Consequently, the New Shares will only share in the Company's result from 1 January 2025 (see also paragraph 2.6.1 of this report).
36 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
| Value Aedifica-share | Issue Price of EUR 73.96 per New Share (premium c.q., (discount)) |
|
|---|---|---|
| Aedifica's Undisturbed Share Price | ||
| Aedifica's Undisturbed Share Price, adjusted for Aedifica's Distributed 2024 Gross Dividend | 65.85 | 12.3% |
| Historical share price performance of the Aedifica share Last 1 month, until 29 April 2025 |
VWAP 63.31 |
VWAP 16.8% |
| Last 3 months, until 29 April 2025 | 60.37 | 22.5% |
| Last 6 months, until 29 April 2025 | 60.48 | 22.3% |
| Last 12 months, until 29 April 2025 | 59.41 | 24.5% |
| Most recently reported EPRA NTA per Aedifica share | ||
| Most recently reported EPRA NTA per Aedifica share (EUR), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 |
73.96 | - |
| Most recently reported EPRA NDV per Aedifica share | ||
| Most recently reported EPRA NDV per Aedifica share (EUR), adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 |
74.76 | (1.0%) |
| Target price of equity research analysts (on 30 April 2025) 38 | ||
| Median target price | 71.00 | 4.2% |
| Average target price | 70.59 | 4.8% |
Pursuant to section 48 of the RREC Act, the fair value of the assets held by the Company (and its subsidiaries) as referred to in section 47, §1 of the GVV Act must be valued by the expert(s) when the Company issues shares or applies for the admission of shares to trading on a regulated market. However, such valuation is not required when such transaction takes place within four months of the last valuation or update of the valuation of the relevant assets and insofar as the expert(s) confirm that, given the general economic condition and state of such property, no new valuation is required.
In the context of an exchange offer, such as the Proposed Exchange Offer, the relevant reference point for the purposes mentioned above, according to the Company, is the moment of publication by the Company, in accordance with Article 8, §1 of the Takeover Decree, of the intention to make the Proposed Exchange Offer and to proceed with the issuance of the New Shares (instead of the moment
37 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
38 I.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend.
when the New Shares are issued or the admission of the New Shares to trading on a regulated market is requested).
The latest (updated) valuation, which relates to the fair value of the assets, is that as per 31 March 2025 (so that the Company has a (updated) valuation which is not older than 4 months at the time of the publication in accordance with Article 8 § 1 of the Takeover Decree by the Company of the intention to launch the Proposed Exchange Offer and to proceed with the issue of the new shares for that purpose). Accordingly, in the context of the present Proposed Exchange Offer and the consequent possible issue, and admission to trading on a regulated market, of the New Shares, the Company's valuation experts were asked to confirm that the underlying premises of the valuation have not changed. The Company's valuation experts confirmed on 2 May 2025 that, given the general economic condition and state of this property, to the extent necessary, no new valuation is required in the context of the (decision in principle to issue) the new shares.
J.P. Morgan Securities plc has provided an opinion to the board of directors of the Company, dated 2 June 2025 and subject to the qualifications, limitations, and assumptions set forth therein, regarding the fairness, from a financial point of view, to the Company of the currently proposed Exchange Ratio.
The opinion has been provided solely for the benefit of the Board of Directors of the Company and no other party may rely on it.
Based on the foregoing, the method of valuing the Company's shares is considered adequate for the purpose of determining the Issue Price under the Proposed Exchange Offer and is deemed to be an economically sound method. There is no deviation from the Auditor's Report, attached as Annex 1.
Taking into account the total number of Cofinimmo Shares that are the subject of the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings, a maximum of 45,144,018 New Shares of the Company will be issued according to the above Exchange Ratio as a result of the contribution in kind under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings.
The number of New Shares to be effectively issued will depend on the number of Cofinimmo Shares tendered during the initial acceptance period of the Proposed Exchange Offer, or, as a result of a Voluntary and/or Mandatory Reopening thereof, during additional acceptance period(s) of the Proposed Exchange Offer.
In consideration for the contribution of Cofinimmo Shares to its capital, the Company will issue New Shares, according to the Exchange Ratio of 1.185 New Shares per contributed Cofinimmo Share.
The New Shares will be ordinary shares issued by the Company and created under Belgian law. They will have the same property and membership rights as the Company's pre-existing shares. They will share in the result of the Company as from 1 January 2025 and will be issued with coupons no. 3639 and following attached. From the actual issue of the New Shares (expected mid-October 2025 for the initial acceptance period, and possibly later due to any Voluntary and/or Mandatory Reopenings), both the existing shares and the New Shares will be traded with coupon no. 36 and following attached and will therefore have the same dividend rights.
The New Shares that will be issued to the Cofinimmo shareholders (subject to the limitations set out in section 2.3 of this report) in exchange for their contribution of Cofinimmo Shares into the capital of the Company as part of the Proposed Exchange Offer, will, at the choice of the Cofinimmo shareholder, be either dematerialized shares or registered shares. The dematerialised New Shares will be represented by an entry on account, in the name of the owner or holder, with an authorised account holder or with a settlement institution. The registered New Shares will be registered by the Board of Directors in the Company's share register. The holder of New Shares shall, in accordance with Article 7 of the Company's Articles of Association, request the conversion of registered shares into dematerialised shares or vice versa at any time in writing and at its own expense. The Company itself will not charge for such conversion.
The Company will in connection with the Proposed Exchange Offer, and subject to the condition precedent of their effective issuance (which, if any, will take place in one or more tranches depending on any Voluntary and/or Mandatory Re-openings of the acceptance period of the Proposed Exchange Offer based on the number of holders of Cofinimmo Shares that accept the Proposed Exchange Offer during such acceptance period(s)), apply to Euronext for the listing of the New Shares on the regulated markets of Euronext Brussels and Euronext Amsterdam . The New Shares with coupon no. 36 and following attached will at the earliest and expectedly be admitted to trading on those markets from the date of their issue, in particular on their Payment Date (as defined below) in the context of a successful Proposed Exchange Offer.
The New Shares will not be listed on any stock exchange in the United States or quoted on any interdealer quotation system in the United States. The Company does not intend to take any action to facilitate a market in the New Shares in the United States.
The New Shares will not be listed on any regulated market in the UK.
In principle, for the offer of the New Shares to the Cofinimmo shareholders and for the admission of the New Shares to trading on a Belgian regulated market, pursuant to Regulation 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when
39 Coupon No. 35 represented Aedifica's Distributed 2024 Gross Dividend, which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025 .
securities are offered to the public or admitted to trading on a regulated market and repealing Directive 2003/71/EC, as amended (the "Prospectus Regulation"), a prospectus must be published.
However, there is an exception to this rule, applying Articles 1(4)(f) and 1(5)(e) of the Prospectus Regulation for securities offered in a takeover by way of a public exchange offer, provided that a document is made available to the public containing information describing the transaction and its effect on the issuer.
Commission Delegated Regulation (EU) 2021/528 of 16 December 2020 supplementing Regulation (EU) 2017/1129 of the European Parliament and of the Council as regards the minimum information to be included in the document to be published for a prospectus exemption in connection with an acquisition by means of a public exchange offer, a merger or a demerger determines the further content of the exemption document.
In accordance with the aforementioned European regulations, the Board of Directors will prepare an exemption document in relation to the Proposed Exchange Offer (the "Exemption Document"). The Exemption Document is not a prospectus within the meaning of the Prospectus Regulation. The Exemption Document is not subject to review and approval by the relevant competent authority pursuant to Article 20 of the Prospectus Regulation.
In light of Belgian legislation on public takeover bids40, the Board of Directors will also prepare a prospectus in relation to the Proposed Exchange Offer (the "Prospectus"). The Prospectus will be filed with the FSMA for approval in accordance with Article 5 io Article 6 of the Takeover Decree on or shortly after the date of approval of the Proposed Capital Increase by the Extraordinary General Meeting of the Company.
The UK Prospectus Regulation and the FSMA 2000 require that, prior to making an offer of the New Shares to the Cofinimmo shareholders in the United Kingdom, an approved prospectus must be published and made available to the public.
Article 1(4)(f) of the UK Prospectus Regulation, subject to certain conditions, provides for an exception to this rule in relation to offers of securities to the public in connection with an acquisition by way of an exchange offer, including the condition that a document is made available to the public containing information about the transaction and its impact on the issuer.
Accordingly, the Board of Directors of Aedifica will prepare an exemption document in relation to the Proposed Exchange Offer (the "UK Exemption Document"). The UK Exemption Document is not a prospectus within the meaning of the UK Prospectus Regulation. The UK Exemption Document is not subject to review and approval by the relevant competent authority under Article 20 of the UK Prospectus Regulation.
40 The Law of 1 April 2007 on public takeover bids, BS 26 April 2007, as amended (the "Takeover Law") and the Takeover Decree.
The Proposed Exchange Offer will be made for all issued and outstanding shares of Cofinimmo, a public regulated real estate company in the form of a public limited company under Belgian law, and will be subject to Belgian disclosure and procedural requirements. With respect to Cofinimmo shareholders in the United States, the Proposed Exchange Offer will be made in accordance with the applicable US tender offer rules under the US Exchange Act, and otherwise in accordance with the requirements of Belgian law. Consequently, the Proposed Exchange Offer will be subject to disclosures and other procedural requirements, including withdrawal rights, proposed timetable, settlement procedures, and timing of payments, which differ from those applicable under US national legislation and public offer practices.
The financial information included or to be included in the Exemption Document, the Prospectus, or other documents related to the Proposed Exchange Offer is prepared in accordance with (EU) IFRS and is not prepared in accordance with, or derived from, US GAAP, and may therefore differ from, and not be comparable to, financial information of US companies.
Neither the US Securities and Exchange Commission nor any US state securities commission has approved or disapproved the Proposed Exchange Offer, passed judgment on the merits or fairness of the Proposed Exchange Offer, or determined whether the Exemption Document, the Prospectus, or other documents related to the Proposed Exchange Offer are accurate or complete, nor will any of these authorities do so.
Further details on which Cofinimmo shareholders in the United States are eligible to receive the New Shares, and the procedural steps these individuals must take to receive these New Shares, as well as the procedures for US shareholders who are not eligible to receive the New Shares, will be set out in the Prospectus and the Exemption Document.
The FinSA requires an approved prospectus to be published and made available to the public prior to making a public offer to shareholders in Switzerland.
However, Article 36(1)(a) FinSA provides an exception for offers directed exclusively at Swiss QIBs, as defined in Article 4(3) FinSA. The Proposed Exchange Offer will thus be open in Switzerland exclusively to Swiss QIBs. Cofinimmo shareholders who do not qualify as Swiss QIBs will not be able to participate in the Proposed Exchange Offer.
In the event of a successful Proposed Exchange Offer (being upon the fulfilment of - or waiver of - all Conditions Precedent) the amount by which the capital of the Company (as the case may be in one or more instalments, depending on any Voluntary and/or Mandatory Reopenings of the acceptance period of the Proposed Exchange Offer based on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) will be obtained by multiplying the number of New Shares by the (exact) fractional value of the existing shares (i.e., for reasons of readability, rounded off, EUR 26.39 per share), with the result of this calculation then being rounded
upwards to the euro cent. The capital representative value of all existing shares of the Company and all New Shares will then be equalised.
The difference between the capital increase and the total contribution value will be shown as an available issue premium in one or more separate accounts "Available Issue Premiums", under equity on the liabilities side of the balance sheet.
Taking into account:
as a result of the proposed contribution and the capital increase arising from a successful Proposed Exchange Offer (considering the Conditions Precedent), including any Voluntary and/or Mandatory Reopenings, a minimum of 22,572,011 New Shares (with a total Issue Price of EUR 1,669,373,590.67) and a maximum of 45,144,018 New Shares (with a total Issue Price of EUR 3,338,746,885.52) will be issued. Consequently, the capital of the Company will be increased by a minimum of EUR 595,625,346.30 (rounded up to the nearest euro cent) (with the balance of EUR 1,073,748,244.37 booked as issue premium) and a maximum of EUR 1,191,250,587.04 (rounded up to the nearest euro cent) (with the balance of EUR 2,147,496,298.48 booked as issue premium).
After the capital increase, the capital of the Company (excluding issue premium) will amount to a minimum of EUR 1,850,367,606.33, represented by a minimum of 70.122.130 shares, and a maximum of EUR 2.445.992.847,07, represented by a maximum of 92.694.137 shares. The actual number of New Shares to be issued will depend on the number of Cofinimmo shareholders who accept the Proposed Exchange Offer during the initial acceptance period, or, as a result of any Voluntary and/or Mandatory Reopenings, during additional acceptance periods. Consequently, the capital increase may be determined and executed in one or more instances in accordance with Article 7:186 of the BCCA.
As described above, Aedifica will not deliver:
(i) Fractions of New Shares to Cofinimmo shareholders who, as a result of the application of the Exchange Ratio, would have been entitled to receive as consideration for the contribution of
41 For readability reasons, rounded to two decimal places throughout this report.
their Cofinimmo Shares to the Proposed Exchange Offer a number of New Shares not equal to a whole number of New Shares; nor
(ii) issue New Shares to US Non-QIBs as consideration for the contribution of their Cofinimmo Shares to the Proposed Exchange Offer.
Instead:
will be offered and sold by banks yet to be appointed by the Company:
Cofinimmo shareholders who will tender their Cofinimmo Shares in the Proposed Exchange Offer but are not permitted to receive New Shares (i.e., the US Non-QIBs) or are only entitled to Fractions of New Shares, will appoint the Company as their representative in accordance with the terms of the acceptance form by way of which they confirm the tender of their Cofinimmo Shares in the Proposed Exchange Offer. This will allow the Company, in the name and on behalf of each such Cofinimmo shareholder, to sell their (potential Fractions of) New Shares through a Dribbling Out c.q. Vendor Placement.
A Dribbling Out c.q. Vendor Placement will each time be organised to the extent that, at the close of the relevant acceptance period, (i) sufficient Fractions of New Shares would need to be allotted to constitute at least one whole New Share and/or (ii) New Shares would need to be allotted to US Non-
42 Being, in the context of a successful Proposed Exchange Offer upon fulfilment of - or waiver of - all Conditions Precedent; the payment date of the initial acceptance period or of any additional acceptance period(s) following a Voluntary and/or Mandatory Reopening thereof, such payment date(s) (the "Payment Date").
QIBs.
If, following the acceptance of Cofinimmo Shares during the relevant acceptance period, a Vendor Placement is required, and if the (Fractions of) New Shares included in that Vendor Placement have not yet been fully placed and the Vendor Placement has not yet been completed, then, at the opening of the regulated markets of Euronext Brussels and Euronext Amsterdam, trading in Aedifica shares (including the newly issued New Shares) shall, at Aedifica's request, be immediately suspended until the time of publication of the results of the relevant Vendor Placement.
The ask price of the (bundled Fractions of) New Shares in a Dribbling Out will be determined by the Company in consultation with banks yet to be appointed by the Company in function of the market conditions with a view to a realisation of the sale within a reasonable time after the opening of the market on the trading day on which the sale transactions will be realised.
The sale price of the (bundled Fractions of) New Shares in a Vendor Placement will be determined by the Company in consultation with banks yet to be appointed by the Company, based on the results of the accelerated private placement under the Vendor Placement.
The net proceeds of the sale of the (bundled Fractions of) New Shares that are the subject of a Dribbling Out c.q. Vendor Placement, i.e. after deduction of the costs, expenses and charges of all nature incurred by Aedifica in the context of the Dribbling Out c.q. Vendor Placement (whereby the tax on stock exchange transactions payable by Belgian residents will be borne by the Company) (the "Proceeds"), will be distributed on a pro rata basis to the original beneficial owners of the (Fractions of) New Shares sold in the Dribbling Out c.q. Vendor Placement, and paid in cash into the bank account specified by the relevant holder of Cofinimmo Shares in its acceptance form.
Immediately after the closing of a Dribbling Out or Vendor Placement, as the case may be, the Proceeds per New Share will be communicated through a press release, and paid to the relevant Cofinimmo shareholders as set out below.
Payment in cash (euro) of the relevant portion of the Proceeds to the relevant Cofinimmo shareholders who have validly contributed their Cofinimmo Shares in the Proposed Exchange Offer will be made as soon as practicable after the closing of the relevant Dribbling Out c.q. Vendor Placement to the bank account specified by the relevant Cofinimmo shareholder in the Acceptance Form.
The significance to the Company of the proposed capital increase by contribution in kind of the Cofinimmo Shares under the Proposed Exchange Offer is as follows:
Through the transaction, Aedifica's portfolio in its existing core markets (Belgium, Germany, the Netherlands, the United Kingdom, Finland, and Ireland) is combined with that of Cofinimmo, expanding Aedifica's presence in Spain and establishing a foothold in France and Italy.
It is expected that the combined portfolio will further diversify the tenant profile, with the weight of top-10 tenants decreasing from about 47%43 at the Company to about 43%44 in the combined group.
The enhanced size of the combined group, with a GAV of EUR 12.1 billion45 and a free float market capitalisation exceeding EUR 5.8 billion46, will strengthen the group's strategic positioning and improve its recourse to capital markets.
The shareholders of the Company will continue to benefit from a strong capital structure, supported by a robust financial framework and a balanced debt profile, with a potential path towards a positive credit rating action by S&P.
Through the combination, the shareholders of the Company are expected to benefit from operational synergies, which are anticipated to lead to a mid-single digit increase in EPRA earnings per share.
In the event of a rating upgrade by S&P from "BBB" to "BBB+", the combined entity could benefit from obtaining financing under more favorable conditions, particularly in the bond market. This would enable the shareholders of the Company to take advantage of financial synergies, in addition to the operational synergies.
Finally, the expected growth in EPRA earnings per share will create additional room to increase future dividend distributions to the shareholders of the Company, while maintaining a sustainable payout ratio of the consolidated EPRA earnings.
The transaction will result in improved geographical diversification, with increased exposure in the United Kingdom, Finland (with its in-house development team), and Ireland. It will also lead to a reduction in Belgium's contribution to the real estate portfolio from approximately 47%47 to 34%48, resulting in a more balanced geographical presence.
The combined portfolio will improve tenant diversification, with the share of Cofinimmo's top-10 tenants decreasing from approximately 62%49 to about 43%50 based on contractual (combined) rents, while the WAULT51 will increase to 1652 years (from 13 years at present).
43 As published by the Company on 29 April 2025 in its Q1 2025 results.
44 Based on the combined contractual rent of the Company and Cofinimmo as per 31 March 2025.
45 Based on the combined reported GAV of the Company and Cofinimmo as per 31 March 2025.
46 Combined market capitalisation of the Company and Cofinimmo based on FactSet data on 30 April 2025 at 16h02 Brussels time.
47 Based on the GAV of Cofinimmo as per 31 March 2025.
48 Based on the combined GAV of the Company and Cofinimmo as per 31 March 2025.
49 As published by Cofinimmo on 25 April 2025 in its Q1 2025 results.
50 Based on the combined contractual rent of the Company and Cofinimmo as per 31 March 2025.
51 Weighted average unexpired lease term.
52 Based on the weighted average remaining lease terms of the Company and Cofinimmo, weighted by each company's respective GAV as per 31 March 2025.
The weight of the structurally pressured and slow-growing office segement, as wel as the weight of the distribution network within Cofinimmo's portfolio is expected to be halved in the combined portfolio. It would be reduced from GAV's current 15%53 and 8%54 to 8%55 and 4%56 , respectively.
Additionally, the shareholders of Cofinimmo are expected to benefit from improved scale and stock liquidity, as well as a more robust financial structure. This includes a potential path towards a positive credit rating action by S&P, linked to an anticipated reduction in the debt ratio to 40.9%57.
By being part of the combined group, the shareholders of Cofinimmo are expected to benefit from operational and financial synergies.
The Proposed Exchange Offer will result in immediate value creation for the shareholders of Cofinimmo as it represents a premium of 23.4%58 and 28.3%59 compared to Cofinimmo's Undisturbed Share Price, respectively, Cofinimmo's Undisturbed Share Price adjusted for Cofinimmo's Distributed 2024 Gross Dividend.
Overall, the shareholders of Cofinimmo are expected to benefit from a stronger, more competitive entity that is better positioned to capitalize on market opportunities.
The exact number of Cofinimmo Shares that will be contributed (and therefore the number of New Shares in the Company that will be issued in exchange) will depend on the degree of acceptance of the Proposed Exchange Offer by the shareholders of Cofinimmo.
If the Proposed Exchange Offer is successful, but only the minimum number of Cofinimmo Shares (i.e., 50% + 1 of the Cofinimmo Shares) are tendered under the Proposed Exchange Offer, including any Voluntary and/or Mandatory Reopenings (without prejudice to the Company's ability to waive the minimum acceptance threshold condition), a total of 22.572.011 New Shares will be issued. If the Proposed Exchange Offer is successful and (ultimately) all Cofinimmo Shares are tendered under the Proposed Exchange Offer and any Voluntary and/or Mandatory Reopenings, a total of 45,144,018 New Shares will be issued.
The table below shows, based on the minimum scenario (contribution of 50%+1 of the Cofinimmo Shares, i.e., 19,048,110 Cofinimmo Shares) and the maximum scenario (contribution of 100% of the Cofinimmo Shares, i.e., 38,096,217 Cofinimmo Shares), the dilution of voting rights, dividend rights, the proceeds from the liquidation of the Company, and other rights attached to the shares of the
53 Based on the GAV of Cofinimmo as per 31 March 2025.
54 Based on the GAV of Cofinimmo as per 31 March 2025.
55 Based on the combined GAV of the Company and Cofinimmo as per 31 March 2025.
56 Based on the combined GAV of the Company and Cofinimmo as at 31 March 2025.
57 Based on the Company's debt-to-asset ratio of 39.9% and of Cofinimmo of 41.8% as per 31 March 2025.
58 Based on a comparison of the Implied Offer Price with Cofinimmo's Undisturbed Share Price of EUR 67.00.
59 Based on a comparison of EUR 78.03 per Cofinimmo Share, calculated using the Exchange Ratio of 1.185 multiplied by Aedifica's Undisturbed Share Price of EUR 69.75, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), with EUR 60.80, calculated based on Cofinimmo's Undisturbed Share Price of EUR 67.00, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
Company (such as the statutory pre-emptive right or irreducible allocation right in the event of a capital increase in cash, where applicable), which an existing shareholder of the Company who held 1% of the Company's capital before the issuance will undergo with respect to the financial year 2025 and beyond, if the Proposed Exchange Offer (as the case may be after any Voluntary and/or Mandatory Reopenings) is successful.
| Shareholding participation | |
|---|---|
| Prior to the issue of the New Shares | 1% |
| Following the issue of the New Shares (minimum scenario) |
0.68% |
| After the issue of the New Shares (maximum scenario) | 0.51% |
Pursuant to the assumptions and forecasts taken into account to determine the Issue Price of the New Shares (see section 2.5.2 of this report), the contribution in kind and the resulting capital increase in the context of the Proposed Exchange Offer will not result in any financial dilution relative to the net value of the existing shares for existing shareholders.
Currently, the withholding tax on dividends paid by the Company is only 15% as the Company is a public regulated real estate company that invests more than 80% of its property portfolio in "qualifying" (residential located in the European Economic Area) "care real estate" and whereby it can invoke the so-called "grandfathering" provided for in article 545 of the Belgian Income Tax Code '92, as a result of which the healthcare property held by the Company in the UK is still considered to be located in the European Economic Area, subject to conditions, until 31 December 2025.
As previously indicated by the Company, the ratio of "qualifying healthcare property" will fall below the 80% threshold from 1 January 2026, as a significant proportion of Aedifica's healthcare property is located in the UK (approximately 20%) and that property will no longer qualify as "qualifying healthcare property" due to the expiry as per 31 December 2025 of the so-called "grandfathering".
Thus, for dividends payable in 2026, the reduced rate of 15% withholding tax will no longer apply but the ordinary rate of 30%.
If the Proposed Exchange Offer is successful, in light of the composition of Cofinimmo's portfolio, which also does not meet that condition, this will not result in more than 80% of the consolidated property portfolio of the Company and Cofinimmo again being held in "qualifying" residential European "care property" for the time being.
The Proposed Exchange Offer therefore does not change anything in terms of the applicable withholding tax rate for dividends payable by the Company in 2026.
Pursuant to Articles 7:179, §1, second subparagraph and 7:197, §1, second subparagraph2 of the WVV, the Board of Directors requested the Statutory Auditor to prepare an audit report on the contribution in kind discussed in this report. This report is attached as Annex 1.
The conclusion of the Statutory Auditor's report on the contribution in kind is as follows:
"[●]"
The Board of Directors agrees with the findings as set out in the Statutory Auditor's audit report and makes no additional comments. The Board of Directors agrees and therefore does not deviate from the conclusion of the Statutory Auditor as set out in his audit report.
The Extraordinary General Meeting of shareholders of the Company shall also resolve to amend accordingly (as the case may be, in one or more times, depending on any Voluntary and/or Mandatory Reopenings of the (initial) acceptance period of the Proposed Exchange Offer depending on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) to amend Article 6 of the coordinated articles of association of the Company in the event of a successful Proposed Exchange Offer (being upon fulfilment of - or waiver of - all Conditions Precedent) and each time when required in the context of any Voluntary and/or Mandatory Reopenings. In this respect, the Extraordinary General Meeting of shareholders of the Company will be asked to grant a delegation to any two members of the Board of Directors (acting together).
The FSMA's prior approval of the amendment to the Articles of Association resulting (as the case may be, in one or more times, depending on any Voluntary and/or Mandatory Reopenings of the (initial) acceptance period of the Proposed Exchange Offer, based on the number of holders of Cofinimmo Shares accepting the Proposed Exchange Offer during such acceptance period(s)) from the capital increase of the Company in the event of a successful Proposed Exchange Offer has(in accordance with Article 12 RREC Act) been obtained.
As the present contribution in kind will be decided by the general meeting of shareholders of the Company, article 37 RREC Act, in accordance with article 38, 3° GVV Act, is not applicable.
As explained in section 3 of this report, the planned transaction is in the interest of the Company. This transaction will also be carried out under normal market conditions, treating all shareholders equally.
* * *
In view of the presentation, explanation and justification of the legal, prudential and financial considerations in this report, the Board of Directorsis of the opinion that the proposed capital increase by contribution in kind of shares under the Proposed Exchange Offer is in the interest of the Company.
For this reason, the Board of Directors wishes to request the Company's shareholders to approve the present proposal at the Extraordinary General Meeting of shareholders be held on or around 11 July 2025, and therefore vote in favour of the capital increase by contribution in kind of shares.
[signature page follows immediately below]
Approved on 4 June 2025
On behalf of the Board of Directors of Aedifica NV,
Name: Serge Wibaut Name: Stefaan Gielens
Function: Director Function: Director
Statutory Auditor's report pursuant to Article 7:197, § 1, second subparagraph in conjunction with Article 7:179, § 1, second subparagraph of the BCCA
For each 1 Cofinimmo Share held by the shareholders of Cofinimmo, Aedifica, in the context of the Proposed Exchange Offer, offers 1.185x New Shares (the "Exchange Ratio").
The distribution of Cofinimmo's distributed gross dividend for financial year 2024 of EUR 6.20 per share (which, following the decision of Cofinimmo's general meeting of shareholders on 14 May 2025, was detached from the Cofinimmo share on 19 May 2025 and became payable as of 22 May 2025) ("Cofinimmo's Distributed 2024 Gross Dividend"), as well as the distribution of Aedifica's distributed gross dividend for financial year 2024 of EUR 3.90 per share (which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025) ( "Aedifica's Distributed 2024 Gross Dividend"), have both been accounted for in the Exchange Ratio.
The determination of the Exchange Ratio is based on the valuation assessment performed on both Cofinimmo and Aedifica, resulting in the Contribution Value of the Cofinimmo Shares and the Issue Price of the new shares to be issued by Aedifica.
The main valuation method for obtaining both of these values is the Adjusted EPRA NTA analysis (c.f. section 2.1, I below), leading to the Exchange Ratio. To provide further support to the Exchange Ratio, a "Discounted Cash Flow analysis" (cf. section 2.1, II below) has been performed. Further reference points (for both Cofinimmo and Aedifica) are provided to offer context to the total Contribution Value of Cofinimmo and the total Issue Price of Aedifica.
Both parties operate healthcare-focused real estate portfolios with the same core locations (Belgium, Germany, Ireland, the Netherlands, the UK and Finland) and use similar methods to evaluate the fair value of their respective assets. The Exchange Ratio was calculated on the basis of Aedifica's knowledge as of 30 April 2025, in particular on the basis of the public Q1 2025 results of Aedifica and Cofinimmo with figures as of 31 March 2025.
Last reported EPRA NRV adjusted for Distributed 2024 Gross Dividend
Last reported EPRA NDV adjusted for Distributed 2024 Gross Dividend
Transaction comparables valuation approach was not deemed to be appropriate given the lack of recent all-share completed transactions within the listed universe of Healthcare focused Real Estate Investment Trusts in Europe.
On 30 April 2025 at 16h02 CEST, Betaville published an uncooked alert60 stating that "people following the situation had heard talk two American PE firms were working together in a consortium on the potential acquisition of Cofinimmo". At the same time, the share price of Cofinimmo started to show a large uptick from EUR 67.00 to EUR 70.65 at 16.24 CEST61 accompanied with increased volumes from 16h02 CEST onwards. The 10-year average daily trading volume ("ADTV") in Cofinimmo's stock is 51,400 shares per day whereas the number of shares trading until the stock suspension was 137,985 shares. This resulted in the FSMA suspending trading in both Aedifica and Cofinimmo pending the publication of a press release. Following the abnormal trading volumes and suspension of the stock, the undisturbed date is therefore based on 30 April 2025 at 16h02 CEST (the "Undisturbed Date") with an undisturbed share price of EUR 67.00 for Cofinimmo ("Cofinimmo's Undisturbed Share Price") and EUR 69.75 for Aedifica ("Aedifica's Undisturbed Share Price").

Price evolution of the Cofinimmo Share on 30 April 2024 until the suspension of trading by the FSMA:
Source: FactSet as of 30 April 2025
The EPRA net tangible asset value ("EPRA NTA") is a widely recognized financial metric, publicly disclosed by both Aedifica and Cofinimmo, in accordance with the European Public Real Estate
60 https://www.betaville.co.uk/betaville-intelligence/o2wwzpy3bnrti8c5zzb45k8yi5pam7u8t0en
61 Factset as of 30 April 2025
Association ("EPRA") guidelines. Aedifica considers EPRA NTA to be the most prevalent and acknowledged valuation model for assessing the market value of a real estate company's net assets.
In evaluating the relative value of Aedifica and Cofinimmo to determine the Exchange Ratio, Aedifica has adopted a sector-specific approach. This method effectively captures the unique market dynamics and outlook of each segment within Cofinimmo's and Aedifica's portfolios, specifically healthcare for both entities, and office and distribution networks for Cofinimmo.
Since the onset of the COVID-19 pandemic, companies in the office real estate sector have consistently traded at a structural undervaluation relative to their Gross Asset Value. This trend reflects public equity investors' outlook on the sector, given the pandemic's lasting impact on office real estate, and concerns about remote work and hybrid working models. These factors have led to decreased demand for traditional office spaces, highlighting structural challenges and a low growth profile within the sector. Furthermore, Aedifica has reviewed the observed Gross Asset Value discount for the office listed comparable companies consisting of Merlin Properties, Icade, Fabege, CPI Europe, NSI and CA Immo (the "Office Reference Group") with a mean and median Implied GAV Discount of 22.8% and 24.9% respectively. For reference, the Implied GAV Discount for Aedifica stands at 6.3% as of 30 April 2025, underscoring the comparative undervaluation of the office portfolios to healthcare portfolios, which are valued at no discount to the GAV for both Aedifica and Cofinimmo. The Exchange Ratio that is proposed in this report implies that the discount of 10.45% applied to the GAV of Cofinimmo's office portfolio is brought down to 2.85%. Further details on the observed discounts are described in section 2.1.a.
Conversely, Aedifica has attributed full value to assets within the healthcare sector, disregarding the trading below Gross Asset Value in this segment as of 30 April 2025. Given the all-share nature of the transaction and the comparability of Aedifica's portfolio with Cofinimmo's in the healthcare segment, Aedifica has assigned full value to healthcare assets at both Aedifica and Cofinimmo. This decision reflects the positive market dynamics and growth potential inherent in the segment, as the healthcare sector continues to show strong growth prospects driven by favorable demographic trends, such as an ageing population and increased life expectancy, which are fuelling demand for healthcare services and facilities.
Considering these factors, Aedifica has made adjustments to the reported EPRA NTA of both Cofinimmo and Aedifica for the purpose of calculating the Exchange Ratio as follows:
applied to Cofinimmo's last reported office portfolio's GAV (leading to a correction on the office portfolio "Cofinimmo's GAV Adjustment") (the "Cofinimmo's Adjusted EPRA NTA")
38.1 million62 last reported number of shares outstanding for Cofinimmo as of 31 March 2025) by Aedifica's Adjusted EPRA NTA per share (assuming 47.6 million63 last reported number of shares outstanding for Aedifica as of 31 March 2025).
| Portfolio segment |
GAV (EURmm) as of 31 Mar 2025 |
Approach to valuation |
|---|---|---|
| Healthcare | 4,626 | Valued at par to last reported GAV |
| Office | 927 | Cofinimmo's GAV Adjustment, amongst other things, based on the Implied GAV Discounts observed on the sample of the office listed comparable companies ("Office Reference Group") to Cofinimmo's last reported office's GAV |
| Distribution network |
470 | Valued at par to last reported GAV |
| Total | 6,023 |
The below tables outline the sample of the office listed comparable companies used for office segment of Cofinimmo and Implied GAV Discount.
The selection of comparable companies for the office portfolio is primarily based on business and portfolio characteristics, focusing on real estate companies with predominantly office real estate portfolios in Western Europe, and to a lesser extent, Northern Europe and Central Eastern Europe. In addition, these companies own and operate office portfolios with comparable operational performance, including occupancy rates and rental growth performance. Selection of comparable companies ensures that these companies operate in a similar economic environment and encounter comparable trends in inflation and interest rate dynamics, with portfolios that closely align with Cofinimmo's office portfolio. However, it is important to acknowledge that the companies in the selected sample do differ in certain financial metrics and geographic exposure to Cofinimmo. Since Befimmo's take-private in 2022, there are no listed office-focused real estate investors concentrating on the Belgian office real estate market.
62 Fully diluted share count (including treasury shares) of Cofinimmo is equal to 38,096,217 shares.
63 Fully diluted share count (including treasury shares) of Aedifica is equal to 47,550,119 shares.
| Name | Implied Market Enterprise Value as of 30 April 2025 (EURmm)64 |
GAV65 (EURmm, last reported) |
Implied GAV Discount |
|---|---|---|---|
| Merlin Properties | 8,069 | 10,865 | (25.7%) |
| Icade | 5,039 | 7,059 | (28.6%) |
| Fabege | 5,544 | 7,300 | (24.1%) |
| CPI Europe | 6,205 | 8,234 | (24.6%) |
| NSI | 745 | 995 | (25.1%) |
| CA Immo | 4,548 | 4,965 | (8.4%) |
| Mean ratio discount | (22.8%) | ||
| Median ratio discount | (24.9%) |
For reference purpose only:
| Name | Implied Market Enterprise Value as of Undisturbed Date (EURmm) |
GAV (EURmm, last reported) |
Implied GAV Discount |
|---|---|---|---|
| Cofinimmo | 5,124 | 6,023 | (14.9%) |
| Aedifica | 5,736 | 6,121 | (6.3%) |
64 Market close on day of Undisturbed Date, following suspension of trading of Aedifica and Cofinimmo
65 Gross Asset Value (GAV) consists of fair value of marketable investment properties including assets classified as held for sale, development projects, right of use related to plots of land held in 'leasehold' in accordance with IFRS 16 and land reserve.
| Portfolio segment | A GAV (EURmm) as of 31 March 2025 |
B Implied GAV Discount |
A x (1+B) = C Implied GAV (EURmm) |
|---|---|---|---|
| Healthcare | 4,626 | 0% | 4,626 |
| Office | 927 | (2.85%) | 900 |
| Distribution networks | 470 | 0% | 470 |
| Total | 6,023 | 5,996 | |
| Cofinimmo's GAV Adjustment (Delta between implied GAV (C) and GAV (A) (EURmm) |
(26.5) |
| EURmm | |
|---|---|
| Cofinimmo's EPRA NTA as of 31 March 25 | 3,601 |
| (-) Cofinimmo's Distributed 2024 Gross Dividends |
(236) |
| (-) Cofinimmo's GAV Adjustment | (26.5) |
| Cofinimmo's Adjusted EPRA NTA as of 31 March | |
| 25 | 3,339 |
| (/) Last reported number of shares outstanding for Cofinimmo as of 31 March 2025 (mm) |
38.166 |
| Cofinimmo's Adjusted EPRA NTA as of 31 March | |
| 25 per share (EUR) (Contribution Value) | 87.64 |
For the avoidance of doubt, Cofinimmo's Adjusted EPRA NTA represents the Contribution Value used for the purposes of calculating the Exchange Ratio.
| Portfolio segment |
GAV (EURmm) as of 31 March 25 |
Approach to valuation |
|---|---|---|
| Healthcare | 6,121 | Valued at par to last reported GAV |
| Total | 6,121 |
Based on the above, Aedifica's EPRA NTA is adjusted for Aedifica's Distributed 2024 Gross Dividend, resulting in Aedifica's Adjusted EPRA NTA.
For the avoidance of doubt, Aedifica only has exposure to Healthcare portfolio segment (i.e. no exposure to office or distribution network portfolio segments). Therefore adjustments to GAVs on the
66 More precisely, the total number of outstanding Cofinimmo shares is 38,096,217 (of which 18,298 are treasury shares held by Cofinimmo itself).
office and distribution network portfolio segments are not applicable for the consideration of Aedifica's Adjusted EPRA NTA.
| EURmm | |
|---|---|
| EPRA NTA as of 31 March 25 | 3,702 |
| (-) Aedifica's Distributed 2024 Gross Dividends | (185) |
| Aedifica's Adjusted EPRA NTA as of 31 March 25 | 3,517 |
| (/) Last reported number of shares outstanding | |
| for Aedifica as of 31 March 2025 (mm) | 47.6 |
| Aedifica's Adjusted EPRA NTA as of 31 March 25 | |
| per share (EUR) (Issue price) | 73.96 |
For the avoidance of doubt, Aedifica's Adjusted EPRA NTA represents the Issue Price used for the purposes of calculating the Exchange Ratio.
Following the separately Adjusted EPRA NTA calculations for Cofinimmo and Aedifica (explained above), which provides the Contribution Value and the Issue price, respectively, the Exchange Ratio is derived as follows:
| Contribution Value – Cofinimmo (EUR) | 87.64 |
|---|---|
| (/) Issue Price – Aedifica (EUR) | 73.96 |
| Exchange Ratio | 1.185x |
This methodology consists of computing the value of the assets (intrinsic value) by discounting the expected unlevered free cash flows (whereby "Unlevered Free Cash Flow" means: Earnings Before Interest, Taxes, Depreciation and Amortization, minus cash taxes, minus capital expenditures) to be generated by these assets based on the business plans (based on Research Analysts' Estimates) of both Cofinimmo and Aedifica (detailed assumptions explained below).
The equity value attributable to the respective Shareholders is detailed in the "Cofinimmo DCF valuation summary" and in the "Company DCF valuation summary" below.
The discounted cash flow analysis was computed as of 31 March 2025. The valuation period encompasses the financial years 2025 to 2027 (from 1 April 2025 (included) until (and including) 31 December 2027). The Unlevered Cash Flows were discounted using a conventional cash flow reception at mid-year. This valuation methodology has been applied over the financial years 2025 to 2027, with a terminal value computation using the Gordon Growth formula based on a normalized Unlevered Free Cash Flow. The terminal value was also discounted using a conventional cash flow reception at midyear.67
67 The terminal value computation using the Gordon Growth formula defined as Unlevered Free Cash Flow in 2027 increased by the terminal growth rate ("TGR"), to reflect the value of the future Unlevered Free Cash Flow to be generated after 2027, divided by the weighted average cost of capital (defined below) subtracted by the TGR ("Terminal Value").
The sum of (i) the discounted Unlevered Free Cash Flow over the financial years 2025 to 2027 and (ii) the discounted Terminal Value results in the implied enterprise value ("DCF Enterprise value", "EV"). The DCF equity value is obtained by deducting from the implied Enterprise value the gross financial debt, plus cash and cash equivalents (including marketable securities), minus preferred equity, minus pension liabilities, minus minority interests, plus investments in associates ("DCF Equity Value"). The DCF Equity Value divided by the last reported shares outstanding results in the implied Equity Value per share.
Aedifica confirms that it is not aware of any events that would have a material impact on the valuation between the reference date, being the date of the valuation based on the discounted cash flow analysis, and the date of this report, i.e., 4 June 2025.
| All figures in EURmm unless otherwise indicated | 2025E | 2026E | 2027E | Terminal year |
|---|---|---|---|---|
| Rental income | 344 | 357 | 365 | 372 |
| EBITDA | 285 | 297 | 304 | 310 |
| (-) Cash taxes | (11) | (12) | (12) | (12) |
| (-) Capex | (148) | (29) | (32) | (22) |
| Unlevered Free Cash Flows | 126 | 256 | 260 | 276 |
A weighted average cost of capital ("WACC") has been computed based on the following assumptions and input parameters:
68 As per MSCI
On the basis of the above calculations and assumptions, a WACC of 6.26% has been determined for Cofinimmo. This has been used in the analysis to discount the Unlevered Free Cash Flow and the Terminal Value.
| Low | Mid | High | ||
|---|---|---|---|---|
| WACC / | 6.76% / | 6.26% / | 5.76% / | |
| TGR | 1.50% | 2.00% | 2.50% | |
| Sum of discounted Unlevered Free Cash Flow (2025-2027E) | EUR mm | 522 | 556 | 560 |
| (+) Discounted Terminal Value | EUR mm | 4,503 | 5,647 | 7,495 |
| DCF Enterprise Value | EUR mm | 5,056 | 6,204 | 8,056 |
| (-) Gross financial debt (as at Mar-25) | EUR mm | (2,545) | ||
| (+) Cash and cash equivalents incl. marketable securities (as at Mar 25) |
EUR mm | 29 |
| (-) Preferred equity (as at Mar-25) (-) Pension liabilities (as at Mar-25) (-) Minority interests (as at Mar-25) (+) Investments in associates (as at Mar-25) |
EUR mm EUR mm EUR mm EUR mm |
- - (81) 25 |
||
|---|---|---|---|---|
| DCF Equity Value Adjusted | EUR mm | 2,484 | 3,632 | 5,484 |
| (/) Shares outstanding (as at Mar-25) | mm | 38 | ||
| DCF Equity Value per share | EUR | 65.20 | 95.33 | 143.95 |
Low range calculated at 6.76% WACC and 1.50% TGR rate; High range calculated as 5.76% WACC and 2.50% TGR
| All figures in EURmm unless otherwise indicated | 2025E | 2026E | 2027E | Terminal year |
|---|---|---|---|---|
| Rental income | 357 | 372 | 383 | 390 |
| EBITDA | 306 | 319 | 329 | 335 |
| (-) Cash taxes | (12) | (13) | (13) | (13) |
| (-) Capex | (58) | (125) | (53) | (23) |
| Unlevered Free Cash Flows | 237 | 181 | 263 | 298 |
A weighted average cost of capital ("WACC") has been computed based on the following assumptions and input parameters:
ownership of freehold or long leasehold interests in modern purpose-built healthcare facilities. The company operates only in the UK. PHP is listed on the London Stock Exchange and has a market capitalisation of EUR 1.6bn as of 30 April 2025.
On the basis of the above calculations and assumptions, a WACC of 6.25% has been determined for Aedifica. This has been used in the analysis to discount the Unlevered Free Cash Flow and the Terminal Value.
| Low | Mid | High | ||
|---|---|---|---|---|
| WACC / | 6.75% / | 6.25% / | 5.75% / | |
| TGR | 1.50% | 2.00% | 2.50% | |
| Sum of discounted Unlevered Free Cash Flow (2025-2027E) | EUR mm | 567 | 571 | 574 |
| (+) Discounted Terminal Value | EUR mm | 4,884 | 6,131 | 8,146 |
| DCF Enterprise Value | EUR mm | 5,453 | 6,702 | 8,720 |
| (-) Gross financial debt (as at Mar-25) | EUR mm | (2,494) | ||
| (+) Cash and cash equivalents incl. marketable securities (as at Mar 25) |
EUR mm | 52 | ||
| (-) Preferred equity (as at Mar-25) | EUR mm | - | ||
| (-) Pension liabilities (as at Mar-25) | EUR mm | - | ||
| (-) Minority interests (as at Mar-25) | EUR mm | (5) | ||
| (+) Investments in associates (as at Mar-25) | EUR mm | 28 | ||
| DCF Equity Value Adjusted | EUR mm | 3,034 | 4,283 | 6,301 |
| (/) Shares outstanding (as at Mar-25) | mm | 48 | ||
| DCF Equity Value per share | EUR | 63.80 | 90.06 | 132.50 |
Low range calculated at 6.75% WACC and 1.50% TGR; High range calculated as 5.75% WACC and 2.50% TGR.
Following separate DCF calculations for Cofinimmo and Aedifica, DCF implied exchange ratio is derived based on:
| Low | Mid | High | |
|---|---|---|---|
| WACC: 6.75% | WACC: 6.25% | WACC: 5.75% | |
| TGR: 1.50% | TGR: 2.00% | TGR: 2.50% | |
| DCF Equity Value per share – Cofinimmo (EUR) | 65.20 | 95.33 | 143.95 |
| (/) DCF Equity Value per share – Aedifica (EUR) | 63.80 | 90.06 | 132.50 |
| DCF implied exchange ratio | 1.022x | 1.058x | 1.086x |
|---|---|---|---|
The graph below shows the price evolution (expressed in EUR/share) and the daily traded volume in Cofinimmo Shares for the period from 30 April 2024 to 30 April 2025.

Source: FactSet as of 30 April 2025
The main movements in the Cofinimmo share price since 30 April 2024 are detailed below.
The table below shows the historical share price performance of the Cofinimmo Share:
| Summary of historical share price performance of the Cofinimmo Share | Value per Cofinimmo Share |
|---|---|
| EUR | |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) adjusted for Cofinimmo's Distributed 2024 Gross Dividend |
60.80 |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 67.00 |
| Cofinimmo 1 month VWAP until 29 April 2025 | 61.76 |
| Cofinimmo 3 month VWAP until 29 April 2025 | 58.00 |
| Cofinimmo 6 month VWAP until 29 April 2025 | 59.16 |
| Cofinimmo 12 month VWAP until 29 April 2025 | 60.43 |
The graphs below shows the price evolution (expressed in EUR/share) and the daily traded volume in Aedifica Shares for the period from 30 April 2024 to 30 April 2025.
69 https://www.fsma.be/en/news/press-release-suspension-trading-cofinimmo-6
70 https://www.betaville.co.uk/betaville-intelligence/o2wwzpy3bnrti8c5zzb45k8yi5pam7u8t0en

The main movements in Aedifica's share price since 30 April 2024 are detailed below.
(ix) 3 March 2025: Aedifica announces the conclusion of the divestment of its entire Swedish portfolio.
(x) 29 April 2025: Aedifica reports its Q1 2025 results, with EPRA earnings growing 5% year-onyear to EUR 63 million and rental income growing 13% year-on-year to EUR 93 million.
The table below shows the historical share price performance of the Aedifica Share:
| Summary of historical share price performance of the Aedifica Share | Value per Share of Aedifica |
|---|---|
| EUR | |
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) adjusted for Aedifica's Distributed 2024 Gross Dividend | 65.85 |
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 69.75 |
| Aedifica 1 month VWAP until 29 April 2025 | 63.31 |
| Aedifica 3 month VWAP until 29 April 2025 | 60.37 |
| Aedifica 6 month VWAP until 29 April 2025 | 60.47 |
| Aedifica 12 month VWAP until 29 April 2025 | 59.41 |
The graph below shows the implied exchange ratio of Aedifica and Cofinimmo for the period 30 April 2024 to 30 April 2025 based on the share price of Aedifica and Cofinimmo in relation to the Exchange Ratio.

Source: FactSet as of 30 April 2025
The exchange ratio evolution over time can be summarised as follows:
71 https://www.fsma.be/en/news/press-release-suspension-trading-aedifica-8
The table below provides a summary of exchange ratios as per historical share price performance of Cofinimmo and Aedifica:
| Summary of the premium of the implied exchange ratio on historical exchange ratios: |
Value per Cofinimmo Share |
Value per Aedifica share |
Implied exchange ratio |
Implied Offer Price premium to value per Cofinimmo Share |
|---|---|---|---|---|
| EUR | EUR | Shares of Aedifica per 1 Cofinimmo Share |
% | |
| Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x | 28.3%74 |
| Undisturbed Share Price | 67.00 | 69.75 | 0.961x | 23.4% |
| 1 month VWAP until 29 April 2025 | 61.76 | 63.31 | 0.976x | 33.8% |
| 3 month VWAP until 29 April 2025 | 58.00 | 60.37 | 0.961x | 42.5% |
| 6 month VWAP until 29 April 2025 | 59.16 | 60.47 | 0.978x | 39.7% |
| 12 month VWAP until 29 April 2025 | 60.43 | 59.41 | 1.017x | 36.8% |
EPRA net tangible assets (EPRA NTA) per share is a common metric in the real estate sector, conventionally referred to as a reference point which represents adjusted IFRS shareholders' equity per share. There are certain conventional differences (add-backs and subtractions) between EPRA NTA and IFRS shareholders' equity, that are undertaken on a consistent basis across the European real estate industry, for all companies that report EPRA NTA. EPRA net tangible assets (NTA) is focused on reflecting a company's tangible assets and assumes that entities buy and sell assets. Effectively, EPRA NTA per share reflects the value per share of the real estate portfolios of the respective companies, as appraised by an external expert, net of liabilities.
Cofinimmo's last reported EPRA NTA amounts to EUR 94.53 per share as of 31 March 2025.
72 Cofinimmo's and Aedifica's Undisturbed Share Prices adjusted for respectively Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 and Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
73 VWAPs are not adjusted for Cofinimmo's and Aedifica's respective Distributed 2024 Gross Dividend.
74 Based on a comparison of EUR 78.03 per Cofinimmo Share, calculated using the Exchange Ratio of 1.185 multiplied by Aedifica's Undisturbed Share Price of EUR 69.75, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), with EUR 60.80, calculated based on Cofinimmo's Undisturbed Share Price of EUR 67.00, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
• The Contribution Value per share of EUR 87.64 per share thus implies a discount of 0.8% compared to Cofinimmo's last reported EPRA NTA per share and adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024 (resulting in an adjusted share price of EUR 88.33). The key reason for the discount relates to the GAV Adjustment, while Cofinimmo's last reported EPRA NTA does not include these adjustments.
Aedifica's last reported EPRA NTA amounts to EUR 77.86 per share as of 31 March 2025.
• The Issue Price per share of EUR 73.96 implies a discount of 0% compared to Aedifica's last reported EPRA NTA per share adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024 (resulting in an adjusted share price of EUR 73.96).
Cofinimmo's and Aedifica's last reported EPRA NTA's per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 88.33 and EUR 73.96 respectively, implies exchange ratio of 1.194x New Shares per Cofinimmo Share.
IFRS net asset value (IFRS NAV) per share represents the net asset value of a company as per International Financial Reporting Standards. It is calculated by taking the total assets minus total liabilities, as reported in the company's financial statements.
Cofinimmo's adjusted last reported IFRS NAV as of 31 March 2025 per share is calculated as EUR 88.27 based on Cofinimmo's last reported IFRS NAV per share of EUR 94.47, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported IFRS NAV as of 31 March 2025 per share is calculated as EUR 74.00 based on Aedifica's last reported IFRS NAV per share of EUR 77.90, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported IFRS NAV's as of 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 88.27 and EUR 74.00 respectively, implies an exchange ratio of 1.193x New Shares per Cofinimmo Share.
The EPRA net reinstatement value (NRV) assumes that entities never sell assets and provides an estimation of the value required to reconstitute the entity.
Cofinimmo's adjusted last reported EPRA NRV as of 31 March 2025 per share is calculated as EUR 96.63 based on Cofinimmo's last reported EPRA NRV per share of EUR 102.83, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported EPRA NRV as of 31 March 2025 per share is calculated as EUR 83.68 based on Aedifica's last reported EPRA NRV per share of EUR 87.58, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported EPRA NRV's as of 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 96.63 and EUR 83.68 respectively, implies exchange ratio of 1.155x New Shares per Cofinimmo Share.
EPRA net disposal value (EPRA NDV) per share represents the value accruing to the company's shareholders under an asset disposal scenario, resulting in the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, net of any resulting tax.
Cofinimmo's adjusted last reported EPRA NDV as of 31 March 2025 per share is calculated as EUR 92.03 based on Cofinimmo's last reported EPRA NDV per share of EUR 98.23, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported EPRA NDV as of 31 March 2025 per share is calculated as EUR 74.76 based on Aedifica's last reported EPRA NDV per share of EUR 78.66, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported EPRA NDV's per 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 92.03 and EUR 74.76 respectively, implies exchange ratio of 1.231x New Shares per Cofinimmo Share.
In the period between Cofinimmo releasing its results for the fiscal year 2024 on 21 February 2025 and 30 April 2025, based on the information provided by Bloomberg and Refinitiv Eikon (LSEG), 15 equity research analysts (i.e. Barclays, Berenberg, Bernstein, BNP Paribas, BofA Securities, Degroof Petercam, ING, Jefferies, J.P. Morgan, KBC Securities, Kempen, Kepler Cheuvreux, Morgan Stanley, Oddo BHF – ABN Amro and UBS) covered Cofinimmo and published a non-restricted note or a report, including a target price for the shares. Their most recent publications before 30 April 2025 date between 21 February 2025 and 25 April 2025.
As shown in the table below, the median and mean target price amounts to EUR 65.00 and EUR 65.01 per Cofinimmo share respectively as of 30 April 2025 (i.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend).
| Equity research analyst | Report date | Target price (EUR / share) |
|---|---|---|
| Barclays | 25-Apr-25 | 60.00 |
| Berenberg | 21-Feb-25 | 70.00 |
| Bernstein | 25-Apr-25 | 68.50 |
| Exane BNP Paribas | 25-Apr-25 | 50.00 |
| BofA Securities | 14-Apr-25 | 58.00 |
| Degroof Petercam | 25-Apr-25 | 65.00 |
| ING | 25-Apr-25 | 68.00 |
| Jefferies | 25-Apr-25 | 77.00 |
| J.P. Morgan | 25-Apr-25 | 63.00 |
| KBC Securities | 25-Apr-25 | 72.00 |
| Kempen | 25-Apr-25 | 62.00 |
| Kepler Cheuvreux | 25-Apr-25 | 61.00 |
| Morgan Stanley | 25-Apr-25 | 70.00 |
| Oddo BHF - ABN Amro | 25-Apr-25 | 56.00 |
| UBS | 25-Apr-25 | 74.70 |
| Median | 65.00 | |
| Mean | 65.01 | |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 67.00 |
Source: Cofinimmo company information, Refinitiv Eikon (LSEG), Bloomberg as of 30 April 2025. Note: Cofinimmo mentions a total of 18 research analysts in the analyst coverage section on its website. Reports from 2 research analysts are not available for public reference, and as such have been excluded from this reference valuation analysis. The analysts in question are Green Street and Kolytics. Additionally, HSBC has not published any report post Cofinimmo's results for the 2024 fiscal year, published on 21 February 2025 and as such has been excluded from this reference valuation analysis.
Equity research analysts' median and mean target prices of Cofinimmo represent a respective discount of 3.0% and 3.0% respectively to Cofinimmo's Undisturbed Share Price.
In the period Aedifica releasing its results for the fiscal year 2024 on 19 February 2025 and 30 April 2025, based on the information provided by Bloomberg and Refinitiv Eikon (LSEG), 16 equity research analysts (i.e. Barclays, Berenberg, Bernstein, BNP Paribas, BofA Securities, Citi, Degroof Petercam, ING, Jefferies, J.P. Morgan, KBC Securities, Kempen, Kepler Cheuvreux, Morgan Stanley, Oddo BHF – ABN Amro and UBS) covered Aedifica and published a non-restricted note or a report, including a target price for the shares. Their most recent publications before 30 April 2025, date between 7 March 2025 and 30 April 2025 (i.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend).
As shown in the table below, the median and mean target price amounts to EUR 71.00, respectively EUR 70.59 per Company share as of 30 April 2025.
| Equity research analyst | Report date | Target price (EUR / share) |
|---|---|---|
| Barclays | 30-Apr-25 | 60.00 |
| Berenberg | 30-Apr-25 | 76.00 |
| Bernstein | 29-Apr-25 | 72.00 |
| Exane BNP Paribas | 30-Apr-25 | 60.00 |
| BofA Securities | 14-Apr-25 | 74.00 |
| Citi | 29-Apr-25 | 79.70 |
|---|---|---|
| Degroof Petercam | 30-Apr-25 | 70.00 |
| ING | 30-Apr-25 | 74.00 |
| Jefferies | 29-Apr-25 | 68.00 |
| J.P. Morgan | 29-Apr-25 | 69.00 |
| KBC Securities | 30-Apr-25 | 70.00 |
| Kempen | 30-Apr-25 | 75.00 |
| Kepler Cheuvreux | 30-Apr-25 | 71.00 |
| Morgan Stanley | 29-Apr-25 | 71.00 |
| Oddo BHF - ABN Amro | 29-Apr-25 | 75.00 |
| UBS | 07-Mar-25 | 64.80 |
| Median | 71.00 | |
| Mean | 70.59 | |
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) |
69.75 |
Source: Company information, Refinitiv Eikon (LSEG), Bloomberg as of 30 April 2025. Note: Aedifica mentions a total of 18 research analysts in the analyst coverage section on its website. Recent reports from 1 research analyst is not available for public reference, and as such has been excluded from this reference valuation analysis. The analyst in question is Green Street. Additionally, HSBC has not published any report post Aedifica's results for the 2024 fiscal year, published on 19 February 2025 and as such has been excluded from this reference valuation analysis.
Equity research analysts' median and mean target prices of Aedifica's share represent a respective premium of 1.8% and 1.2% respectively to the share price of Aedifica's Undisturbed Share Price.
Equity research analysts' median and mean target prices of Cofinimmo and Aedifica imply respective exchange ratios of respectively 0.915x and 0.921x New Shares per Cofinimmo Share.
Summary of the implied exchange ratios as per the various valuation methodologies and reference points
| Summary of the implied exchange ratios | A Value per Cofinimmo Share |
B Value per Aedifica share |
A / B exchange ratio |
||
|---|---|---|---|---|---|
| EUR | EUR | Shares of Aedifica per 1 Cofinimmo share |
|||
| Valuation methodologies DCF |
Adjusted EPRA NTA analysis (the main valuation method) |
Cofinimmo 2.85% discount to Office portfolio |
87.64 | 73.96 | 1.185x |
| Low: Company: 6.75% WACC; Cofinimmo: 6.76% WACC, 1.50% TGR |
65.20 | 63.80 | 1.022x | ||
| Mid: Company: 6.25% WACC; Cofinimmo: 6.26% WACC, 2.0% TGR |
95.33 | 90.06 | 1.058x | ||
| High: Company: 5.75% WACC; Cofinimmo: 5.76% WACC, 2.50% TGR |
143.95 | 132.50 | 1.086x | ||
| Reference points to give context to the Exchange Ratio |
Historical share price performance analysis |
Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x |
| Undisturbed Share Price | 67.00 | 69.75 | 0.961x | ||
| 1 month VWAP until 29 April 2025 | 61.76 | 63.31 | 0.976x | ||
| 3 month VWAP until 29 April 2025 | 58.00 | 60.37 | 0.961x |
| 6 month VWAP until 29 April 2025 | 59.16 | 60.47 | 0.978x | |
|---|---|---|---|---|
| 12 month VWAP until 29 April 2025 | 60.43 | 59.41 | 1.017x | |
| Last reported EPRA NTA75 |
31 March 2025 last reported EPRA NTA adjusted for Distributed 2024 Gross Dividend |
88.33 | 73.96 | 1.194x |
| Last reported IFRS NAV |
31 March 2025 last reported IFRS NAV adjusted for Distributed 2024 Gross Dividend |
88.27 | 74.00 | 1.193x |
| Last reported EPRA NRV76 |
31 March 2025 last reported EPRA NRV adjusted for Distributed 2024 Gross Dividend |
96.63 | 83.68 | 1.155x |
| Last reported EPRA NDV77 |
31 March 2025 last reported EPRA NDV adjusted for Distributed 2024 Gross Dividend |
92.03 | 74.76 | 1.231x |
| Equity research |
Median | 65.00 | 71.00 | 0.915x |
| analysts' target price analysis78 |
Mean | 65.01 | 70.59 | 0.921x |
Exchange Ratio in relation to historical exchange ratios since 30 April 2024:

Source: FactSet as of 30 April 2025
The chart above compares the Exchange Ratio of 1.185x with the historical exchange ratio implied by the stock prices of Aedifica and Cofinimmo. The historical evolution of the exchange ratio over time can be summarized as follows:
75 The EPRA Net Tangible Assets (NTA) assumes that the company acquires and disposes assets, which would result in the materialisation of certain deferred taxes that cannot be avoided.
76 The EPRA Net Reinstatement Value (NRV) assumes that the company will never sell its assets, and provides an estimate of the amount required to reconstitute the company
77 The EPRA Net Disposal Value (NDV) represents the value accruing to the company's shareholders in a scenario of disposal of its assets, resulting in the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, all net of taxes
78 Prior to the payment of Cofinimmo's, respectively, Aedifica's Distributed 2024 Gross Dividend.
79 Cofinimmo's and Aedifica's Undisturbed Share Prices adjusted for respectively Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 and Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
a premium of 28.3% to Cofinimmo's Undisturbed Share Price as adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024 (resulting in an adjusted share price of EUR 60.80);
a discount of 0.8% based on each the last reported EPRA NTA per Cofinimmo Share of EUR 94.53 on 31 March 2025 as adjusted for Cofinimmo's Distributed 2024 Gross Dividend of
80 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
81 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
EUR 6.20 for the financial year 2024 (resulting in an adjusted share price of EUR 88.33) and last reported EPRA NTA per Aedifica share of EUR 77.96 on 31 March 2025 as adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024 (resulting in an adjusted share price of EUR 73.96);
In conclusion, having analysed different valuation methods, Aedifica is convinced that the Implied Offer Price per Cofinimmo Share and the Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend represent an attractive and fair value proposition for the shareholders of Cofinimmo.
For each 1 Cofinimmo Share held by the shareholders of Cofinimmo, Aedifica, in the context of the Proposed Exchange Offer, offers 1.185x New Shares (the "Exchange Ratio").
The distribution of Cofinimmo's distributed gross dividend for financial year 2024 of EUR 6.20 per share (which, following the decision of Cofinimmo's general meeting of shareholders on 14 May 2025, was detached from the Cofinimmo share on 19 May 2025 and became payable as of 22 May 2025) ("Cofinimmo's Distributed 2024 Gross Dividend"), as well as the distribution of Aedifica's distributed gross dividend for financial year 2024 of EUR 3.90 per share (which, following the decision of Aedifica's general meeting of shareholders on 13 May 2025, was detached from the Aedifica share on 15 May 2025 and became payable as of 20 May 2025) ( "Aedifica's Distributed 2024 Gross Dividend"), have both been accounted for in the Exchange Ratio.
The determination of the Exchange Ratio is based on the valuation assessment performed on both Cofinimmo and Aedifica, resulting in the Contribution Value of the Cofinimmo Shares and the Issue Price of the new shares to be issued by Aedifica.
The main valuation method for obtaining both of these values is the Adjusted EPRA NTA analysis (c.f. section 2.1, I below), leading to the Exchange Ratio. To provide further support to the Exchange Ratio, a "Discounted Cash Flow analysis" (cf. section 2.1, II below) has been performed. Further reference points (for both Cofinimmo and Aedifica) are provided to offer context to the total Contribution Value of Cofinimmo and the total Issue Price of Aedifica.
Both parties operate healthcare-focused real estate portfolios with the same core locations (Belgium, Germany, Ireland, the Netherlands, the UK and Finland) and use similar methods to evaluate the fair value of their respective assets. The Exchange Ratio was calculated on the basis of Aedifica's knowledge as of 30 April 2025, in particular on the basis of the public Q1 2025 results of Aedifica and Cofinimmo with figures as of 31 March 2025.
Last reported EPRA NRV adjusted for Distributed 2024 Gross Dividend
Last reported EPRA NDV adjusted for Distributed 2024 Gross Dividend
Transaction comparables valuation approach was not deemed to be appropriate given the lack of recent all-share completed transactions within the listed universe of Healthcare focused Real Estate Investment Trusts in Europe.
On 30 April 2025 at 16h02 CEST, Betaville published an uncooked alert61 stating that "people following the situation had heard talk two American PE firms were working together in a consortium on the potential acquisition of Cofinimmo". At the same time, the share price of Cofinimmo started to show a large uptick from EUR 67.00 to EUR 70.65 at 16.24 CEST62 accompanied with increased volumes from 16h02 CEST onwards. The 10-year average daily trading volume ("ADTV") in Cofinimmo's stock is 51,400 shares per day whereas the number of shares trading until the stock suspension was 137,985 shares. This resulted in the FSMA suspending trading in both Aedifica and Cofinimmo pending the publication of a press release. Following the abnormal trading volumes and suspension of the stock, the undisturbed date is therefore based on 30 April 2025 at 16h02 CEST (the "Undisturbed Date") with an undisturbed share price of EUR 67.00 for Cofinimmo ("Cofinimmo's Undisturbed Share Price") and EUR 69.75 for Aedifica ("Aedifica's Undisturbed Share Price").

Source: FactSet as of 30 April 2025
The EPRA net tangible asset value ("EPRA NTA") is a widely recognized financial metric, publicly disclosed by both Aedifica and Cofinimmo, in accordance with the European Public Real Estate
61 https://www.betaville.co.uk/betaville-intelligence/o2wwzpy3bnrti8c5zzb45k8yi5pam7u8t0en
62 Factset as of 30 April 2025
Association ("EPRA") guidelines. Aedifica considers EPRA NTA to be the most prevalent and acknowledged valuation model for assessing the market value of a real estate company's net assets.
In evaluating the relative value of Aedifica and Cofinimmo to determine the Exchange Ratio, Aedifica has adopted a sector-specific approach. This method effectively captures the unique market dynamics and outlook of each segment within Cofinimmo's and Aedifica's portfolios, specifically healthcare for both entities, and office and distribution networks for Cofinimmo.
Since the onset of the COVID-19 pandemic, companies in the office real estate sector have consistently traded at a structural undervaluation relative to their Gross Asset Value. This trend reflects public equity investors' outlook on the sector, given the pandemic's lasting impact on office real estate, and concerns about remote work and hybrid working models. These factors have led to decreased demand for traditional office spaces, highlighting structural challenges and a low growth profile within the sector. Furthermore, Aedifica has reviewed the observed Gross Asset Value discount for the office listed comparable companies consisting of Merlin Properties, Icade, Fabege, CPI Europe, NSI and CA Immo (the "Office Reference Group") with a mean and median Implied GAV Discount of 22.8% and 24.9% respectively. For reference, the Implied GAV Discount for Aedifica stands at 6.3% as of 30 April 2025, underscoring the comparative undervaluation of the office portfolios to healthcare portfolios, which are valued at no discount to the GAV for both Aedifica and Cofinimmo. The Exchange Ratio that is proposed in this report implies that the discount of 10.45% applied to the GAV of Cofinimmo's office portfolio is brought down to 2.85%. Further details on the observed discounts are described in section 2.1.a.
Conversely, Aedifica has attributed full value to assets within the healthcare sector, disregarding the trading below Gross Asset Value in this segment as of 30 April 2025. Given the all-share nature of the transaction and the comparability of Aedifica's portfolio with Cofinimmo's in the healthcare segment, Aedifica has assigned full value to healthcare assets at both Aedifica and Cofinimmo. This decision reflects the positive market dynamics and growth potential inherent in the segment, as the healthcare sector continues to show strong growth prospects driven by favorable demographic trends, such as an ageing population and increased life expectancy, which are fuelling demand for healthcare services and facilities.
Considering these factors, Aedifica has made adjustments to the reported EPRA NTA of both Cofinimmo and Aedifica for the purpose of calculating the Exchange Ratio as follows:
applied to Cofinimmo's last reported office portfolio's GAV (leading to a correction on the office portfolio "Cofinimmo's GAV Adjustment") (the "Cofinimmo's Adjusted EPRA NTA")
38.1 million63 last reported number of shares outstanding for Cofinimmo as of 31 March 2025) by Aedifica's Adjusted EPRA NTA per share (assuming 47.6 million64 last reported number of shares outstanding for Aedifica as of 31 March 2025).
| Portfolio segment |
GAV (EURmm) as of 31 Mar 2025 |
Approach to valuation |
|---|---|---|
| Healthcare | 4,626 | Valued at par to last reported GAV |
| Office | 927 | Cofinimmo's GAV Adjustment, amongst other things, based on the Implied GAV Discounts observed on the sample of the office listed comparable companies ("Office Reference Group") to Cofinimmo's last reported office's GAV |
| Distribution network |
470 | Valued at par to last reported GAV |
| Total | 6,023 |
The below tables outline the sample of the office listed comparable companies used for office segment of Cofinimmo and Implied GAV Discount.
The selection of comparable companies for the office portfolio is primarily based on business and portfolio characteristics, focusing on real estate companies with predominantly office real estate portfolios in Western Europe, and to a lesser extent, Northern Europe and Central Eastern Europe. In addition, these companies own and operate office portfolios with comparable operational performance, including occupancy rates and rental growth performance. Selection of comparable companies ensures that these companies operate in a similar economic environment and encounter comparable trends in inflation and interest rate dynamics, with portfolios that closely align with Cofinimmo's office portfolio. However, it is important to acknowledge that the companies in the selected sample do differ in certain financial metrics and geographic exposure to Cofinimmo. Since Befimmo's take-private in 2022, there are no listed office-focused real estate investors concentrating on the Belgian office real estate market.
63 Fully diluted share count (including treasury shares) of Cofinimmo is equal to 38,096,217 shares.
64 Fully diluted share count (including treasury shares) of Aedifica is equal to 47,550,119 shares.
| Name | Implied Market Enterprise Value as of 30 April 2025 (EURmm)65 |
GAV66 (EURmm, last reported) |
Implied GAV Discount |
|---|---|---|---|
| Merlin Properties | 8,069 | 10,865 | (25.7%) |
| Icade | 5,039 | 7,059 | (28.6%) |
| Fabege | 5,544 | 7,300 | (24.1%) |
| CPI Europe | 6,205 | 8,234 | (24.6%) |
| NSI | 745 | 995 | (25.1%) |
| CA Immo | 4,548 | 4,965 | (8.4%) |
| Mean ratio discount | (22.8%) | ||
| Median ratio discount | (24.9%) |
For reference purpose only:
| Name | Implied Market Enterprise Value as of Undisturbed Date (EURmm) |
GAV (EURmm, last reported) |
Implied GAV Discount |
|---|---|---|---|
| Cofinimmo | 5,124 | 6,023 | (14.9%) |
| Aedifica | 5,736 | 6,121 | (6.3%) |
65 Market close on day of Undisturbed Date, following suspension of trading of Aedifica and Cofinimmo
66 Gross Asset Value (GAV) consists of fair value of marketable investment properties including assets classified as held for sale, development projects, right of use related to plots of land held in 'leasehold' in accordance with IFRS 16 and land reserve.
| Portfolio segment | A GAV (EURmm) as of 31 March 2025 |
B Implied GAV Discount |
A x (1+B) = C Implied GAV (EURmm) |
|---|---|---|---|
| Healthcare | 4,626 | 0% | 4,626 |
| Office | 927 | (2.85%) | 900 |
| Distribution networks | 470 | 0% | 470 |
| Total | 6,023 | 5,996 | |
| Cofinimmo's GAV Adjustment (Delta between implied GAV (C) and GAV (A) (EURmm) |
(26.5) |
| EURmm | |
|---|---|
| Cofinimmo's EPRA NTA as of 31 March 25 | 3,601 |
| (-) Cofinimmo's Distributed 2024 Gross Dividends |
(236) |
| (-) Cofinimmo's GAV Adjustment (26.5) |
|
| Cofinimmo's Adjusted EPRA NTA as of 31 March | |
| 25 | 3,339 |
| (/) Last reported number of shares outstanding | |
| 38.167 for Cofinimmo as of 31 March 2025 (mm) |
|
| Cofinimmo's Adjusted EPRA NTA as of 31 March | |
| 87.64 25 per share (EUR) (Contribution Value) |
For the avoidance of doubt, Cofinimmo's Adjusted EPRA NTA represents the Contribution Value used for the purposes of calculating the Exchange Ratio.
| Portfolio segment |
GAV (EURmm) as of 31 March 25 |
Approach to valuation |
|---|---|---|
| Healthcare | 6,121 | Valued at par to last reported GAV |
| Total | 6,121 |
Based on the above, Aedifica's EPRA NTA is adjusted for Aedifica's Distributed 2024 Gross Dividend, resulting in Aedifica's Adjusted EPRA NTA.
For the avoidance of doubt, Aedifica only has exposure to Healthcare portfolio segment (i.e. no exposure to office or distribution network portfolio segments). Therefore adjustments to GAVs on the
67 More precisely, the total number of outstanding Cofinimmo shares is 38,096,217 (of which 18,298 are treasury shares held by Cofinimmo itself).
office and distribution network portfolio segments are not applicable for the consideration of Aedifica's Adjusted EPRA NTA.
| EURmm | |
|---|---|
| EPRA NTA as of 31 March 25 | 3,702 |
| (-) Aedifica's Distributed 2024 Gross Dividends | (185) |
| Aedifica's Adjusted EPRA NTA as of 31 March 25 | 3,517 |
| (/) Last reported number of shares outstanding | |
| for Aedifica as of 31 March 2025 (mm) | 47.6 |
| Aedifica's Adjusted EPRA NTA as of 31 March 25 | |
| per share (EUR) (Issue price) | 73.96 |
For the avoidance of doubt, Aedifica's Adjusted EPRA NTA represents the Issue Price used for the purposes of calculating the Exchange Ratio.
Following the separately Adjusted EPRA NTA calculations for Cofinimmo and Aedifica (explained above), which provides the Contribution Value and the Issue price, respectively, the Exchange Ratio is derived as follows:
| Contribution Value – Cofinimmo (EUR) | 87.64 |
|---|---|
| (/) Issue Price – Aedifica (EUR) | 73.96 |
| Exchange Ratio | 1.185x |
This methodology consists of computing the value of the assets (intrinsic value) by discounting the expected unlevered free cash flows (whereby "Unlevered Free Cash Flow" means: Earnings Before Interest, Taxes, Depreciation and Amortization, minus cash taxes, minus capital expenditures) to be generated by these assets based on the business plans (based on Research Analysts' Estimates) of both Cofinimmo and Aedifica (detailed assumptions explained below).
The equity value attributable to the respective Shareholders is detailed in the "Cofinimmo DCF valuation summary" and in the "Company DCF valuation summary" below.
The discounted cash flow analysis was computed as of 31 March 2025. The valuation period encompasses the financial years 2025 to 2027 (from 1 April 2025 (included) until (and including) 31 December 2027). The Unlevered Cash Flows were discounted using a conventional cash flow reception at mid-year. This valuation methodology has been applied over the financial years 2025 to 2027, with a terminal value computation using the Gordon Growth formula based on a normalized Unlevered Free Cash Flow. The terminal value was also discounted using a conventional cash flow reception at midyear.68
68 The terminal value computation using the Gordon Growth formula defined as Unlevered Free Cash Flow in 2027 increased by the terminal growth rate ("TGR"), to reflect the value of the future Unlevered Free Cash Flow to be generated after 2027, divided by the weighted average cost of capital (defined below) subtracted by the TGR ("Terminal Value").
The sum of (i) the discounted Unlevered Free Cash Flow over the financial years 2025 to 2027 and (ii) the discounted Terminal Value results in the implied enterprise value ("DCF Enterprise value", "EV"). The DCF equity value is obtained by deducting from the implied Enterprise value the gross financial debt, plus cash and cash equivalents (including marketable securities), minus preferred equity, minus pension liabilities, minus minority interests, plus investments in associates ("DCF Equity Value"). The DCF Equity Value divided by the last reported shares outstanding results in the implied Equity Value per share.
Aedifica confirms that it is not aware of any events that would have a material impact on the valuation between the reference date, being the date of the valuation based on the discounted cash flow analysis, and the date of this report, i.e., 4 June 2025.
| All figures in EURmm unless otherwise indicated | 2025E | 2026E | 2027E | Terminal year |
|---|---|---|---|---|
| Rental income | 344 | 357 | 365 | 372 |
| EBITDA | 285 | 297 | 304 | 310 |
| (-) Cash taxes | (11) | (12) | (12) | (12) |
| (-) Capex | (148) | (29) | (32) | (22) |
| Unlevered Free Cash Flows | 126 | 256 | 260 | 276 |
A weighted average cost of capital ("WACC") has been computed based on the following assumptions and input parameters:
69 As per MSCI
On the basis of the above calculations and assumptions, a WACC of 6.26% has been determined for Cofinimmo. This has been used in the analysis to discount the Unlevered Free Cash Flow and the Terminal Value.
| Low | Mid | High | ||
|---|---|---|---|---|
| WACC / | 6.76% / | 6.26% / | 5.76% / | |
| TGR | 1.50% | 2.00% | 2.50% | |
| Sum of discounted Unlevered Free Cash Flow (2025-2027E) | EUR mm | 522 | 556 | 560 |
| (+) Discounted Terminal Value | EUR mm | 4,503 | 5,647 | 7,495 |
| DCF Enterprise Value | EUR mm | 5,056 | 6,204 | 8,056 |
| (-) Gross financial debt (as at Mar-25) | EUR mm | (2,545) | ||
| (+) Cash and cash equivalents incl. marketable securities (as at Mar 25) |
EUR mm | 29 |
| (-) Preferred equity (as at Mar-25) (-) Pension liabilities (as at Mar-25) (-) Minority interests (as at Mar-25) (+) Investments in associates (as at Mar-25) |
EUR mm EUR mm EUR mm EUR mm |
- - (81) 25 |
||
|---|---|---|---|---|
| DCF Equity Value Adjusted | EUR mm | 2,484 | 3,632 | 5,484 |
| (/) Shares outstanding (as at Mar-25) | mm | 38 | ||
| DCF Equity Value per share | EUR | 65.20 | 95.33 | 143.95 |
Low range calculated at 6.76% WACC and 1.50% TGR rate; High range calculated as 5.76% WACC and 2.50% TGR
| All figures in EURmm unless otherwise indicated | 2025E | 2026E | 2027E | Terminal year |
|---|---|---|---|---|
| Rental income | 357 | 372 | 383 | 390 |
| EBITDA | 306 | 319 | 329 | 335 |
| (-) Cash taxes | (12) | (13) | (13) | (13) |
| (-) Capex | (58) | (125) | (53) | (23) |
| Unlevered Free Cash Flows | 237 | 181 | 263 | 298 |
A weighted average cost of capital ("WACC") has been computed based on the following assumptions and input parameters:
• Levered barra beta69 of 1.02 based on the levered beta as of 31 March 2025 of each of Aedifica's peers in the social infrastructure space ("Company's Social Infrastructure Reference Group");
Primary Health Properties PLC (PHP): UK-based REIT, with a portfolio GAV of EUR 3.3bn, which acquires and provides leasing back through indirect property investment. PHP engages in the ownership of freehold or long leasehold interests in modern purpose-built healthcare facilities. The company operates only in the UK. PHP is listed on the London Stock Exchange and has a market capitalisation of EUR 1.6bn as of 30 April 2025.
Target Healthcare REIT PLC (Target): UK-based REIT, with a portfolio GAV of EUR 1.1bn, focused on a diversified portfolio of freehold and long leasehold care homes, as well as other healthcare assets, which are let to care home operators. The company operates exclusively in the UK. Target is listed on the London Stock Exchange and has a market capitalisation of EUR 0.7bn as of 30 April 2025.
On the basis of the above calculations and assumptions, a WACC of 6.25% has been determined for Aedifica. This has been used in the analysis to discount the Unlevered Free Cash Flow and the Terminal Value.
| Low | Mid | High | ||
|---|---|---|---|---|
| WACC / | 6.75% / | 6.25% / | 5.75% / | |
| TGR | 1.50% | 2.00% | 2.50% | |
| Sum of discounted Unlevered Free Cash Flow (2025-2027E) | EUR mm | 567 | 571 | 574 |
| (+) Discounted Terminal Value | EUR mm | 4,884 | 6,131 | 8,146 |
| DCF Enterprise Value | EUR mm | 5,453 | 6,702 | 8,720 |
| (-) Gross financial debt (as at Mar-25) | EUR mm | (2,494) | ||
| (+) Cash and cash equivalents incl. marketable securities (as at Mar 25) |
EUR mm | 52 | ||
| (-) Preferred equity (as at Mar-25) | EUR mm | - | ||
| (-) Pension liabilities (as at Mar-25) | EUR mm | - | ||
| (-) Minority interests (as at Mar-25) | EUR mm | (5) | ||
| (+) Investments in associates (as at Mar-25) | EUR mm | 28 | ||
| DCF Equity Value Adjusted | EUR mm | 3,034 | 4,283 | 6,301 |
| (/) Shares outstanding (as at Mar-25) | mm | 48 | ||
| DCF Equity Value per share | EUR | 63.80 | 90.06 | 132.50 |
Low range calculated at 6.75% WACC and 1.50% TGR; High range calculated as 5.75% WACC and 2.50% TGR.
Following separate DCF calculations for Cofinimmo and Aedifica, DCF implied exchange ratio is derived based on:
| Low | Mid | High | |
|---|---|---|---|
| WACC: 6.75% | WACC: 6.25% | WACC: 5.75% | |
| TGR: 1.50% | TGR: 2.00% | TGR: 2.50% | |
| DCF Equity Value per share – Cofinimmo (EUR) | 65.20 | 95.33 | 143.95 |
| (/) DCF Equity Value per share – Aedifica (EUR) | 63.80 | 90.06 | 132.50 |
| DCF implied exchange ratio | 1.022x | 1.058x | 1.086x |
The graph below shows the price evolution (expressed in EUR/share) and the daily traded volume in Cofinimmo Shares for the period from 30 April 2024 to 30 April 2025.


The main movements in the Cofinimmo share price since 30 April 2024 are detailed below.
(vi) 29 October 2024: Cofinimmo divests the Luxemburg 40 office building in Brussels, for total proceeds of EUR 27 million, in line with its latest fair value.
(vii) 19 December 2024: Cofinimmo completes the divestment of 11 office buildings and 5 healthcare real estate assets for EUR 110 million, allowing it to surpass its objective of EUR 215 million in disposals for 2024. In parallel, Cofinimmo reduced its investment target to EUR 175 million for the year, due to the postponement of a project in Germany to 2025.
The table below shows the historical share price performance of the Cofinimmo Share:
| Summary of historical share price performance of the Cofinimmo Share | Value per Cofinimmo Share |
|---|---|
| EUR | |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) adjusted for Cofinimmo's Distributed 2024 Gross Dividend |
60.80 |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 67.00 |
| Cofinimmo 1 month VWAP until 29 April 2025 | 61.76 |
| Cofinimmo 3 month VWAP until 29 April 2025 | 58.00 |
| Cofinimmo 6 month VWAP until 29 April 2025 | 59.16 |
| Cofinimmo 12 month VWAP until 29 April 2025 | 60.43 |
The graphs below shows the price evolution (expressed in EUR/share) and the daily traded volume in Aedifica Shares for the period from 30 April 2024 to 30 April 2025.
70 https://www.fsma.be/en/news/press-release-suspension-trading-cofinimmo-6
71 https://www.betaville.co.uk/betaville-intelligence/o2wwzpy3bnrti8c5zzb45k8yi5pam7u8t0en

The main movements in Aedifica's share price since 30 April 2024 are detailed below.
(ix) 3 March 2025: Aedifica announces the conclusion of the divestment of its entire Swedish portfolio.
(x) 29 April 2025: Aedifica reports its Q1 2025 results, with EPRA earnings growing 5% year-onyear to EUR 63 million and rental income growing 13% year-on-year to EUR 93 million.
The table below shows the historical share price performance of the Aedifica Share:
| Summary of historical share price performance of the Aedifica Share | Value per Share of Aedifica |
|
|---|---|---|
| EUR | ||
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) adjusted for Aedifica's Distributed 2024 Gross Dividend | 65.85 | |
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 69.75 | |
| Aedifica 1 month VWAP until 29 April 2025 | 63.31 | |
| Aedifica 3 month VWAP until 29 April 2025 | 60.37 | |
| Aedifica 6 month VWAP until 29 April 2025 | 60.47 | |
| Aedifica 12 month VWAP until 29 April 2025 | 59.41 |
The graph below shows the implied exchange ratio of Aedifica and Cofinimmo for the period 30 April 2024 to 30 April 2025 based on the share price of Aedifica and Cofinimmo in relation to the Exchange Ratio.

72 https://www.fsma.be/en/news/press-release-suspension-trading-aedifica-8
Source: FactSet as of 30 April 2025
The exchange ratio evolution over time can be summarised as follows:
The table below provides a summary of exchange ratios as per historical share price performance of Cofinimmo and Aedifica:
| Summary of the premium of the implied exchange ratio on historical exchange ratios: |
Value per Cofinimmo Share |
Value per Aedifica share |
Implied exchange ratio |
Implied Offer Price premium to value per Cofinimmo Share |
|---|---|---|---|---|
| EUR | EUR | Shares of Aedifica per 1 Cofinimmo Share |
% | |
| Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x | 28.3%75 |
| Undisturbed Share Price | 67.00 | 69.75 | 0.961x | 23.4% |
| 1 month VWAP until 29 April 2025 | 61.76 | 63.31 | 0.976x | 33.8% |
| 3 month VWAP until 29 April 2025 | 58.00 | 60.37 | 0.961x | 42.5% |
| 6 month VWAP until 29 April 2025 | 59.16 | 60.47 | 0.978x | 39.7% |
| 12 month VWAP until 29 April 2025 | 60.43 | 59.41 | 1.017x | 36.8% |
EPRA net tangible assets (EPRA NTA) per share is a common metric in the real estate sector, conventionally referred to as a reference point which represents adjusted IFRS shareholders' equity per share. There are certain conventional differences (add-backs and subtractions) between EPRA NTA and IFRS shareholders' equity, that are undertaken on a consistent basis across the European real estate industry, for all companies that report EPRA NTA. EPRA net tangible assets (NTA) is focused on reflecting a company's tangible assets and assumes that entities buy and sell assets. Effectively, EPRA
73 Cofinimmo's and Aedifica's Undisturbed Share Prices adjusted for respectively Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 and Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
74 VWAPs are not adjusted for Cofinimmo's and Aedifica's respective Distributed 2024 Gross Dividend.
75 Based on a comparison of EUR 78.03 per Cofinimmo Share, calculated using the Exchange Ratio of 1.185 multiplied by Aedifica's Undisturbed Share Price of EUR 69.75, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 (resulting in an adjusted share price of EUR 65.85), with EUR 60.80, calculated based on Cofinimmo's Undisturbed Share Price of EUR 67.00, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20.
NTA per share reflects the value per share of the real estate portfolios of the respective companies, as appraised by an external expert, net of liabilities.
Cofinimmo's last reported EPRA NTA amounts to EUR 94.53 per share as of 31 March 2025.
• The Contribution Value per share of EUR 87.64 per share thus implies a discount of 0.8% compared to Cofinimmo's last reported EPRA NTA per share and adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024 (resulting in an adjusted share price of EUR 88.33). The key reason for the discount relates to the GAV Adjustment, while Cofinimmo's last reported EPRA NTA does not include these adjustments.
Aedifica's last reported EPRA NTA amounts to EUR 77.86 per share as of 31 March 2025.
• The Issue Price per share of EUR 73.96 implies a discount of 0% compared to Aedifica's last reported EPRA NTA per share adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024 (resulting in an adjusted share price of EUR 73.96).
Cofinimmo's and Aedifica's last reported EPRA NTA's per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 88.33 and EUR 73.96 respectively, implies exchange ratio of 1.194x New Shares per Cofinimmo Share.
IFRS net asset value (IFRS NAV) per share represents the net asset value of a company as per International Financial Reporting Standards. It is calculated by taking the total assets minus total liabilities, as reported in the company's financial statements.
Cofinimmo's adjusted last reported IFRS NAV as of 31 March 2025 per share is calculated as EUR 88.27 based on Cofinimmo's last reported IFRS NAV per share of EUR 94.47, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported IFRS NAV as of 31 March 2025 per share is calculated as EUR 74.00 based on Aedifica's last reported IFRS NAV per share of EUR 77.90, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported IFRS NAV's as of 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 88.27 and EUR 74.00 respectively, implies an exchange ratio of 1.193x New Shares per Cofinimmo Share.
The EPRA net reinstatement value (NRV) assumes that entities never sell assets and provides an estimation of the value required to reconstitute the entity.
Cofinimmo's adjusted last reported EPRA NRV as of 31 March 2025 per share is calculated as EUR 96.63 based on Cofinimmo's last reported EPRA NRV per share of EUR 102.83, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported EPRA NRV as of 31 March 2025 per share is calculated as EUR 83.68 based on Aedifica's last reported EPRA NRV per share of EUR 87.58, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported EPRA NRV's as of 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 96.63 and EUR 83.68 respectively, implies exchange ratio of 1.155x New Shares per Cofinimmo Share.
EPRA net disposal value (EPRA NDV) per share represents the value accruing to the company's shareholders under an asset disposal scenario, resulting in the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, net of any resulting tax.
Cofinimmo's adjusted last reported EPRA NDV as of 31 March 2025 per share is calculated as EUR 92.03 based on Cofinimmo's last reported EPRA NDV per share of EUR 98.23, adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024.
Aedifica's adjusted last reported EPRA NDV as of 31 March 2025 per share is calculated as EUR 74.76 based on Aedifica's last reported EPRA NDV per share of EUR 78.66, adjusted for Aedifica's Distributed 2024 Gross Dividend of EUR 3.90 for the financial year 2024.
Cofinimmo's and Aedifica's last reported EPRA NDV's per 31 March 2025 per share, each time adjusted for their respective Distributed 2024 Gross Dividends, i.e. EUR 92.03 and EUR 74.76 respectively, implies exchange ratio of 1.231x New Shares per Cofinimmo Share.
In the period between Cofinimmo releasing its results for the fiscal year 2024 on 21 February 2025 and 30 April 2025, based on the information provided by Bloomberg and Refinitiv Eikon (LSEG), 15 equity research analysts (i.e. Barclays, Berenberg, Bernstein, BNP Paribas, BofA Securities, Degroof Petercam, ING, Jefferies, J.P. Morgan, KBC Securities, Kempen, Kepler Cheuvreux, Morgan Stanley, Oddo BHF – ABN Amro and UBS) covered Cofinimmo and published a non-restricted note or a report, including a target price for the shares. Their most recent publications before 30 April 2025 date between 21 February 2025 and 25 April 2025.
As shown in the table below, the median and mean target price amounts to EUR 65.00 and EUR 65.01 per Cofinimmo share respectively as of 30 April 2025 (i.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend).
| Equity research analyst | Report date | Target price (EUR / share) |
|---|---|---|
| Barclays | 25-Apr-25 | 60.00 |
| Berenberg | 21-Feb-25 | 70.00 |
| Bernstein | 25-Apr-25 | 68.50 |
| Exane BNP Paribas | 25-Apr-25 | 50.00 |
| BofA Securities | 14-Apr-25 | 58.00 |
| Degroof Petercam | 25-Apr-25 | 65.00 |
| ING | 25-Apr-25 | 68.00 |
| Jefferies | 25-Apr-25 | 77.00 |
| J.P. Morgan | 25-Apr-25 | 63.00 |
| KBC Securities | 25-Apr-25 | 72.00 |
| Kempen | 25-Apr-25 | 62.00 |
| Kepler Cheuvreux | 25-Apr-25 | 61.00 |
| Morgan Stanley | 25-Apr-25 | 70.00 |
| Oddo BHF - ABN Amro | 25-Apr-25 | 56.00 |
| UBS | 25-Apr-25 | 74.70 |
| Median | 65.00 | |
| Mean | 65.01 | |
| Cofinimmo's Undisturbed Share Price (30 April 2025 at 16h02 CEST) | 67.00 |
Source: Cofinimmo company information, Refinitiv Eikon (LSEG), Bloomberg as of 30 April 2025. Note: Cofinimmo mentions a total of 18 research analysts in the analyst coverage section on its website. Reports from 2 research analysts are not available for public reference, and as such have been excluded from this reference valuation analysis. The analysts in question are Green Street and Kolytics. Additionally, HSBC has not published any report post Cofinimmo's results for the 2024 fiscal year, published on 21 February 2025 and as such has been excluded from this reference valuation analysis.
Equity research analysts' median and mean target prices of Cofinimmo represent a respective discount of 3.0% and 3.0% respectively to Cofinimmo's Undisturbed Share Price.
In the period Aedifica releasing its results for the fiscal year 2024 on 19 February 2025 and 30 April 2025, based on the information provided by Bloomberg and Refinitiv Eikon (LSEG), 16 equity research analysts (i.e. Barclays, Berenberg, Bernstein, BNP Paribas, BofA Securities, Citi, Degroof Petercam, ING, Jefferies, J.P. Morgan, KBC Securities, Kempen, Kepler Cheuvreux, Morgan Stanley, Oddo BHF – ABN Amro and UBS) covered Aedifica and published a non-restricted note or a report, including a target price for the shares. Their most recent publications before 30 April 2025, date between 7 March 2025 and 30 April 2025 (i.e., prior to the payment of Aedifica's Distributed 2024 Gross Dividend).
As shown in the table below, the median and mean target price amounts to EUR 71.00, respectively EUR 70.59 per Company share as of 30 April 2025.
| Equity research analyst | Report date | Target price (EUR / share) | |
|---|---|---|---|
| ------------------------- | ------------- | ---------------------------- | -- |
| Barclays | 30-Apr-25 | 60.00 |
|---|---|---|
| Berenberg | 30-Apr-25 | 76.00 |
| Bernstein | 29-Apr-25 | 72.00 |
| Exane BNP Paribas | 30-Apr-25 | 60.00 |
| BofA Securities | 14-Apr-25 | 74.00 |
| Citi | 29-Apr-25 | 79.70 |
| Degroof Petercam | 30-Apr-25 | 70.00 |
| ING | 30-Apr-25 | 74.00 |
| Jefferies | 29-Apr-25 | 68.00 |
| J.P. Morgan | 29-Apr-25 | 69.00 |
| KBC Securities | 30-Apr-25 | 70.00 |
| Kempen | 30-Apr-25 | 75.00 |
| Kepler Cheuvreux | 30-Apr-25 | 71.00 |
| Morgan Stanley | 29-Apr-25 | 71.00 |
| Oddo BHF - ABN Amro | 29-Apr-25 | 75.00 |
| UBS | 07-Mar-25 | 64.80 |
| Median | 71.00 | |
| Mean | 70.59 | |
| Aedifica's Undisturbed Share Price (30 April 2025 at 16h02 CEST) |
69.75 |
Source: Company information, Refinitiv Eikon (LSEG), Bloomberg as of 30 April 2025. Note: Aedifica mentions a total of 18 research analysts in the analyst coverage section on its website. Recent reports from 1 research analyst is not available for public reference, and as such has been excluded from this reference valuation analysis. The analyst in question is Green Street. Additionally, HSBC has not published any report post Aedifica's results for the 2024 fiscal year, published on 19 February 2025 and as such has been excluded from this reference valuation analysis.
Equity research analysts' median and mean target prices of Aedifica's share represent a respective premium of 1.8% and 1.2% respectively to the share price of Aedifica's Undisturbed Share Price.
Equity research analysts' median and mean target prices of Cofinimmo and Aedifica imply respective exchange ratios of respectively 0.915x and 0.921x New Shares per Cofinimmo Share.
| Summary of the implied exchange ratios | A Value per Cofinimmo Share |
B Value per Aedifica share |
A / B exchange ratio |
||
|---|---|---|---|---|---|
| EUR | EUR | Shares of Aedifica per 1 Cofinimmo share |
|||
| Valuation methodologies |
Adjusted EPRA NTA analysis (the main valuation method) |
Cofinimmo 2.85% discount to Office portfolio |
87.64 | 73.96 | 1.185x |
| TGR DCF |
Low: Company: 6.75% WACC; Cofinimmo: 6.76% WACC, 1.50% |
65.20 | 63.80 | 1.022x | |
| Mid: Company: 6.25% WACC; Cofinimmo: 6.26% WACC, 2.0% TGR |
95.33 | 90.06 | 1.058x |
| High: Company: 5.75% WACC; Cofinimmo: 5.76% WACC, 2.50% TGR |
143.95 | 132.50 | 1.086x | ||
|---|---|---|---|---|---|
| Reference points to give context to the Exchange Ratio |
Historical share price performance analysis |
Undisturbed Share Price adjusted for Distributed 2024 Gross Dividend |
60.80 | 65.85 | 0.923x |
| Undisturbed Share Price | 67.00 | 69.75 | 0.961x | ||
| 1 month VWAP until 29 April 2025 | 61.76 | 63.31 | 0.976x | ||
| 3 month VWAP until 29 April 2025 | 58.00 | 60.37 | 0.961x | ||
| 6 month VWAP until 29 April 2025 | 59.16 | 60.47 | 0.978x | ||
| 12 month VWAP until 29 April 2025 | 60.43 | 59.41 | 1.017x | ||
| Last reported EPRA NTA76 |
31 March 2025 last reported EPRA NTA adjusted for Distributed 2024 Gross Dividend |
88.33 | 73.96 | 1.194x | |
| Last reported IFRS NAV |
31 March 2025 last reported IFRS NAV adjusted for Distributed 2024 Gross Dividend |
88.27 | 74.00 | 1.193x | |
| Last reported EPRA NRV77 |
31 March 2025 last reported EPRA NRV adjusted for Distributed 2024 Gross Dividend |
96.63 | 83.68 | 1.155x | |
| Last reported EPRA NDV78 |
31 March 2025 last reported EPRA NDV adjusted for Distributed 2024 Gross Dividend |
92.03 | 74.76 | 1.231x | |
| Equity research |
Median | 65.00 | 71.00 | 0.915x | |
| analysts' target price analysis79 |
Mean | 65.01 | 70.59 | 0.921x |
Exchange Ratio in relation to historical exchange ratios since 30 April 2024:

Source: FactSet as of 30 April 2025
The chart above compares the Exchange Ratio of 1.185x with the historical exchange ratio implied by the stock prices of Aedifica and Cofinimmo. The historical evolution of the exchange ratio over time can be summarized as follows:
76 The EPRA Net Tangible Assets (NTA) assumes that the company acquires and disposes assets, which would result in the materialisation of certain deferred taxes that cannot be avoided.
77 The EPRA Net Reinstatement Value (NRV) assumes that the company will never sell its assets, and provides an estimate of the amount required to reconstitute the company
78 The EPRA Net Disposal Value (NDV) represents the value accruing to the company's shareholders in a scenario of disposal of its assets, resulting in the settlement of deferred taxes, the liquidation of financial instruments and the recognition of other liabilities for their maximum amount, all net of taxes
79 Prior to the payment of Cofinimmo's, respectively, Aedifica's Distributed 2024 Gross Dividend.
Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividends of EUR 78.03 per Cofinimmo Share represents:
80 Cofinimmo's and Aedifica's Undisturbed Share Prices adjusted for respectively Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 and Aedifica's Distributed 2024 Gross Dividend of EUR 3.90.
81 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
82 I.e., prior to the payment of Cofinimmo's Distributed 2024 Gross Dividend.
▪ a premium of 28.3% to Cofinimmo's Undisturbed Share Price as adjusted for Cofinimmo's Distributed 2024 Gross Dividend of EUR 6.20 for the financial year 2024 (resulting in an adjusted share price of EUR 60.80);
In conclusion, having analysed different valuation methods, Aedifica is convinced that the Implied Offer Price per Cofinimmo Share and the Implied Offer Price Adjusted for Aedifica's Distributed 2024 Gross Dividend represent an attractive and fair value proposition for the shareholders of Cofinimmo.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.